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Abstract 
 
Dicaffeoylquinic acid (DCQA) is a natural polyphenolic compound widely 
distributed in plants such as coffee beans, which possesses a range of 
pharmacological activities. Herein, is reported studies undertaken towards 
the first total synthesis of 3,5-DCQA conjugates. Two synthetic routes were 
investigated. The first route involves a seven step sequence beginning from 
quinic acid. The overall yield via this synthetic approach was 30%. The key 
steps involved in the sequence were a regioselective benzylation of the C-3-
hydroxyl group followed by silyl protection of the C-1 and C-4 hydroxyl 
groups. Deprotection of the benzyl group by hydrogenolysis and opening of 
the lactone afforded the 3,5-diol. Esterification of the 3,5-diol with 3,4-tert-
butyldimethylsilyl caffeoyl chloride afforded the di-ester. Removal of the 
protecting groups afforded 3,5-DCQA. The second route involved selective 
protection of the C-3-hydroxyl group with silyl followed by benzylation of the 
C-1 and C-3 hydroxyl groups. Saponification of the lactone ring followed by 
benzylation of the carboxylic acid gave the benzyl ester. Silyl deprotection 
afforded the 3,5-diol. The 3,5-diol was subsequently esterified by refluxing in 
toluene with commercially available Meldrum’s acid. In the final step, the 
synthesis of 3,5-DCQA was achieved by a Knoevenagel condensation of 3,4-
dihydroxybenzaldehyde and a malonate ester of quinic acid. An efficient 
method for the synthesis of possible metabolites of quinic acid conjugates 
was also described. This protocol employs N-(4-methoxyphenyl)-
trifluoroacetimidate  glucuronyl as the donor. The key reaction in this 
sequence was the coupling of N-(4-methoxyphenyl)-trifluoroacetimidate 
glucuronyl with 4-hydroxy-3-methoxy-benzaldehyde.
 vii 
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Chapter One 
 
1.0 Introduction 
 
1.1 Caffeoylquinic Acid Chemistry and Natural 
Occurrence 
 
1.1.1 Discovery 
 
Caffeoylquinic acid (CQA) derivatives were first reported in 1837. 3-
Caffeoylquinic acid (3-CQA) 1, initially known as chlorogenic acid, was the 
first to be reported. The trivial name chlorogenic acid was first introduced in 
1846. (Figure 1).1 Eliel and Ramirez have indicated an alternative 
nomenclature.2 However, through this thesis the historic nomeclature was 
used as shown in Figure 1, numbering anticlockwise from carbon 1. 
 
CO2H
OHOHO
OH
1
O
HO
HO
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4 5 6
 
Figure 1. Chemical structure of 3-CQA 1.1  
 
CQA derivatives are formed naturally by esterification of hydroxycinnamic 
acids, caffeic acid 2 ferulic acid, 3, and p-coumaric acid 4 (p-CoQA), with 
quinic acid 5 (Figure 2).3, 4 
 
 2 
quinic acid 5
CO2H
OHOHHO
OH
HOOC
OH
OCH3
 ferulic acid 3
HOOC
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HOOC
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Figure 2 Chemical structures of caffeic acid 2, ferulic acid 3, p-coumaric acid 4 and quinic 
acid 5.3 
 
CQA derivatives are a class of natural polyphenolic (e.g. polyphenolic Table 
1) compounds widely distributed in plants4 such as Tanacetum parthenium,5 
sweetpotato leaf,6 Eleutherococcus senticosus,7 Chrysanthemum coronarium 
L,8 Phyllostachys edulis,9 potato,10 sweet potato11, 12 and Ipomoea batatas 
L.13 CQA derivatives are also found in olives, fruits, vegetables,14 and coffee 
beans.15, 16 The most abundant natural source are coffee beans, which 
contain more than eighteen caffeoyl derivatives that are not acylated at the 
C-1 position.3 
 
 
 
 
 
 
 
 
 3 
Table 1. Basic structural skeletons of phenolic and polyphenolic compounds.17 
Skeleton Classification Basic structure 
   
 
C6-C1 Benzoic acid COOH
C6-C2 Acetophenones
O
CH3
C6-C2 Phenylacetic acid
COOH
C6-C3 Hydroxycinnamic acid
COOH
C6-C3 Coumarins
O O
HO
 
 
 
 
C6-C4 Naphthoquinones
O
O
C6-C1-C6 Xanthones
O
O
C6-C1-C6 Stilbenes
C6-C3-C6 Flavonoids
O
 4 
CQA derivatives can be subdivided by the identity, number and position of 
the acyl residues.18, 19 The following subgroups are known: 
 
1.1.2 Mono-ester 
 
3-CQA 1 is a mono-ester of caffeic acid 2, which is the only commercially 
available compound. 5-CQA 6 and 4-CQA 7 are synonymous with 
neochlorogenic acid and cryptogenic acid and the two names are often used 
interchangeably. 4-O-Feruloylquinic acid 7 (FQA), 3-FQA 9 and 5-FQA 10 
are monoferuloylquinic acids. The structures of some of the CQA and FQA 
are shown in Figure 3.20  
 
3-O-caffeoylquinic acid 1
CO2H
OHOHO
OH
feruloyl
CO2H
OHOHHO
O
3-O-feruloylquinic acid 9
feruloyl
CO2H
OHOHHO
O caffeoyl
CO2H
OHOHO
OH
caffeoyl
CO2H
OHOHO
OH
feruloyl
4-O-caffeoylquinic acid 7
CO2H
OHOHO
OH
caffeoyl
5-O-caffeoylquinic acid 6
4-O-feruloylquinic acid 8 5-O-feruloylquinic acid 10  
Figure 3. Structure of CQA and FQA derivatives.20 
 
1.1.3 Di-esters 
 
Three di-esters, 3,5-dicaffeoylquinic acid 11 (DCQA), 3,4-DCQA 12 and 4,5-
DCQA 13, have been isolated from plants. Methyl esters of 3,5-DCQA 11 
and 4,5-DCQA 13 have been also found to occur naturally in plants. 3,5-
DCQA 11 and 4,5-DCQA 13 can be formed from 3-CQA 1 because most of 
 5 
the CQAs have a caffeoyl group at C3-OH.20 4,5-DCQA 13 is more abundant 
in nature than 3,5-DCQA 11. 1,3-DCQA 15 is the least common of all the 
DCQAs with the caffeoyl group attached to the tertiary alcohol (C1-OH). In 
2005 Kim et al.21 reported the first isolation of 1,3-DCQA 15. The most 
common moiety of DCQA is the caffeoyl, however other phenulpropanoids 
such as 1,3-FQA 16 exist (Figure 4). The mixed di-esters of caffeic acid 2 
ferulic acid 3, e.g 3-O-caffeoyl-4-O-feruloylquinic acid 17 3-O-caffeoyl-5-O-
feruloylquinic acid 18, and 4-O-caffeoyl-O-feruloylquinic acid 19 can be found 
in robusta coffee.21, 22 
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3,4-di-O-caffeoylquinic acid 12
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Figure 4. Structure of di-esters.20 
 
 
 
1.1.4 Tri and Tetra-esters 
 
Tri- and tetra-caffeoylquinic acid (tri-CQAs and tetra-CQAs) are less common 
in nature than CQAs and DCQAs. 1,3,4-tri-CQA 20 has one tert-hydroxyl and 
two sec-hydroxyls of the quinic acid esterified, and in 3,4,5 tri-CQA 21, every 
 7 
secondary hydroxyl group is coupled with a caffeoyl moiety. 1,3,4,5-tri-CQA 
22 has one tert-hydroxyl and three sec-hydroxyl groups of the quinic acid 
esterified (Figure 5).20 
 
1,3,4-tri-O-caffeoylquinic acid 20
CO2H
OHOO
O
caffeoyl
caffeoyl
3,4,5-tri-O-caffeoylquinic acid 21
1,3,4,5-tetra-O-caffeoylquinic acid 22
CO2H
OOO
OH
caffeoyl
caffeoyl
caffeoyl
caffeoyl
CO2H
OOO
O
caffeoyl
caffeoyl
caffeoyl
caffeoyl
 
Figure 5. Structure of tris-CQAs and tetra-CQAs derivatives. 20 
 
1.2 Caffeoylquinic Acid Biosynthesis 
 
CQA derivatives are biosynthesised via the shikimic acid pathway (Scheme 
1). Quinic acid 5 is the reduction product of 3-dehydroquinic acid 30. The 
proposed biosynthesis of CQA starts with the coupling of 
phosphoenopyruvate (PEP) 24 and D-erythrose-4-phosphate 23 to give 3-
deoxy-D-arabino-heptulosonic acid 7-phosphate (DAHP) 25. Hydrolysis of the 
phosphate releases the C7 α-keto-acid 26. Removal of the hydrogen at C-6 
could be problematic since it is not at all acidic. In this case, the hydroxyl 
group at C-5 is initially oxidised to a ketone (NAD+ oxidation) and increased 
acidity of the C-6 proton promotes an E1cB elimination followed by an 
intramolecular cyclisation. Reduction of the cyclised product, 3-dehydroquinic 
acid 30, leads to quinic acid 5.23-29 In the final steps, esterification of the 
 8 
caffeic acid moiety on various hydroxyl groups of quinic acid gives mono-, di-
, tri-, and tetra- CQA derivatives (Scheme 1). 20 
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Scheme 1. Proposed biosynthesis of CQA derivatives.20 
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1.3 Caffeoylquinic acid in foods & beverages 
 
1.3.1 Coffee 
 
The origin of the coffee crop can be traced back to the Ethiopian highlands 
(today Yemen) as early as 14th century. Moreover, the Arabic textbook the 
Encyclopedia of Islam suggests that coffee was used as a beverage in 14th 
Century, and spread to the Middle Eastern countries in the 15th Century and 
across the Arabian Sea to India.30, 31 
 
The coffee plant belongs to the family Rubiaceae and genus Coffea. Coffee 
is one of the world’s most popular beverages,32-34 and comprises about 1% of 
the overall value of world trade. It is the second most important trade 
commodity in the world after oil.35 In 2004-2005 the total world coffee 
production was 6.9 million tons, valued at 11.2 billion US dollars.32, 36 It has 
been reported that 100 million people work in the industry, growing, 
processing and marketing coffee, and that the crop is being grown by 25-30 
million coffee farmers across 68 countries.30 
 
 
 
 
 
 
 
 
 
 10 
 
Figure 6. Total world coffee production, 1985-2005 (60 kg bags x 1000).30 
 
In the last 150 years coffee production has grown significantly. The market 
price of coffee is rising due to increased demand in developed countries. In 
the past, increase in price was attributed to either natural disasters or political 
influence. In 1963, the United Nations established the International Coffee 
Organization, which represents both exporting and importing countries, and 
aims to provide price stabilisation. The 2007 International Coffee Agreement 
unites 77 member countries (45 producers and 32 importers). The 
Agreement is an instrument to facilitate international coffee trade, to provide 
a legal framework for inter-governmental cooperation, and is particularly 
focused on the needs of the least developed member-countries and small 
scale producers.30, 37, 38 
 
About 70% of the world’s coffee production comes from 25 million small-
scale farmers. Therefore, fluctuations in market prices have a strong impact 
on the economies of the least developed countries and strongly affect the 
revenue of millions of small-scale producers in Latin America, Africa and 
 11 
Asia. Since the value of the world retail trade increased from 30 to 70 billion 
US dollars (1993-2003), and the earnings of coffee-exporting countries fell 
from 12 to 5.5 billion US dollars at the same time, it is important to provide a 
sustainable international coffee market.36, 37 
 
Two main types of coffee trees have great commercial importance, C. 
arabica which accounts for 90% of the world market and C. canephora (also 
know as robusta coffee) accounting for 10%.17, 34, 39-42 C. arabica coffee is 
favoured by consumers due to its more subtle flavour which tends to be less 
bitter.18, 35 
 
According to Clifford et al.43 the most important source of caffeoyl derivatives 
are green coffee beans which contain about 6-10% 3-CQA 1 on a dry weight 
basis.43, 44 3-CQA 1 is the most abundant caffeoyl derivative found in green 
beans accounting for 50% of the total weight, alongside 4-CQA 7, 1,3-FQA 
15 and 3,4-DCQA 12, 3,5-DCQA 11 and 4,5-DCQA 13.1 In 2006, Clifford et 
al. found many minor mono-acyl and diacyl 3-CQA derivatives in green 
coffee beans, this also included p-coumaric acid 4 and caffeic acid 2 and a 
series of amino acid conjugates.43 Tests have also shown that robusta coffee 
has a greater content of 3-CQA 1 than arabica.45, 46 
 
1.3.1.1 Coffee Field Processing  
 
After harvesting, coffee berries can be processed in two different ways: dry- 
or wet-processes. The dry process, also known as the natural method, 
involves drying the whole fruit. The coffee berries are sorted and cleaned, 
 12 
then dried in the sun for up to 4 weeks until they reach a maximum moisture 
content of 12.5%. This is a key stage of the process and determines the final 
quality of the coffee. Next, the dried fruit is hulled and the seeds (beans) are 
ready for grading and packing as green coffee. Most of the robusta coffees 
are processed by the dry-method and these are also known as unwashed 
robusta.45, 47, 48 This method is also used for 90% of arabica coffee in dry 
regions with low humidity such as Brazil, Ethiopia, Haiti and Ecuador.45 
 
The wet-process is known as the “washed method”. Shortly after harvesting 
the coffee, cherries are sorted and cleaned and the outer layers of the fruit 
are removed by pulping. In the next step, the beans undergo a fermentation 
process (24-36 h) in which the remaining mucilage is removed by natural 
enzymes. In the final stage the coffee berries are hulled and go through 
sorting and grading processes. The wet-process yields mild coffee and is 
used for arabica coffee. This type of coffee, also known as washed arabica, 
has the best quality and the highest price.45, 47, 48 
 
Next, coffee beans are roasted at air temperatures as high as 230 ºC for a 
few minutes, or at 180 ºC for up to 20 minutes. During this roasting process, 
up to 8-10% of the 3-CQA 1 is transformed.49 A study conducted by Clifford 
showed that coffee beverages are the major dietary source of 3-CQA.50 In 
fact, in the early stages of the roasting process, when there is still plenty of 
water, isomerisation via acyl migration occurs followed by some hydrolysis, 
releasing cinnamic acid 31 and quinic acid 5. In the later stages the free 
 13 
quinic acid 5 isomerises and lactonises to form 3-O-caffeoyl-1-quinide 32 and 
4-O-caffeoyl-1-quinide 33 (Figure 7).51, 52 
 
O
O
OHO
O
HO
HO
OH
O
O
OHHO
O
O
OH
OH
4-caffeoyl-1,5-quinide 333-caffeoyl-1,5-quinide 32
HOOC
cinnamic acid 31  
Figure 7. Structure of CQA derivatives in coffee beverage.52 
 
1.3.2 Fruits 
 
CQs derivatives have also been found in apples and pears.53 A study 
conducted by Galvis-Sanchez et al.54 showed that the total phenolic content 
in pears is between 1235 and 2500 mg/kg in peel and 28-81 mg/kg in flesh. 
The phenolic composition of pears is similar to that of apples with both 
containing 3-CQA 1, and 4-O-p-CoQA 34.55 However, the main difference is 
that pears contain 1-hydroxyphenyl-4-O-glucoside 35 and apples 
dihydrochalcones (Figure 8).20 
 
O
O
HO
CO2H
OHHO
OH
4-O-p-Coumaroylquinic acid 34
O
O OH
HO
HO
HO
OH
1-hydroxyphenyl-4-O-glucoside 35  
Figure 8. Phenolic composition of pears.17 
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According to Spanos et al.56 apples contain 62-385 mg/kg of 3-CQA 1, up to 
40 mg/kg 4-O-p-CoQA and some amounts of caffeoylglucose 36, p-
coumaroylglucose 37 and feruloylglucose 38 (Figure 9). 
 
O
O
HO
HO
HO
OH
O
OH
OH
O
O
HO
HO
HO
OH
O
OH
O
O
HO
HO
HO
OH
O
OH
OCH3
caffeoylglucose 36 p-coumaroylglucose 37
feruloylglucose 38  
Figure 9. Structure of caffeoylglucose 36, p-coumaroglucose 37, and feruloylglucose 38.17 
 
Stone fruits contain 3-CQA 1 and 4-O-p-CoQA 34 in about 150-600 mg/kg 
and 3-200 mg/kg, respectively, at least in cherries found mainly adjacent to 
the peel. Levels of 3-CQA 1 were 3 to 4 times greater than 5-CQA 6 in peach 
and apricot juice.1 
 
1.3.3 Vegetables 
 
Vegetables contain a variety of caffeoyl derivatives e.g. 3-CQA 1 and 5-CQA 
5, 3 4-O-p-CoQA 39, 3-CQA 1 and 3,5-DCQA 11 (Figure 10). A study by 
Alasalvar et al.57 showed that 3-CQA 1 can be found in orange, purple, 
yellow and white carrots, with the levels of 3-CQA 1 in purple carrots being 
10-fold higher than that amount present in the other varieties.57 
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Figure 10. Phenolic composition in vegetables.17 
 
In 1983, Winter et al.23 found 3-CQA 1, 3-O-p-CoQA 39 and 3-FCQA 21 in 
the leafy Brassicas (kale, cabbage and brussels sprouts) at levels of 6-120 
mg/kg, 104 mg/kg and up to 37 mg/kg respectively along with different 
amounts of the 4- and 5-isomers. Winter et al.23 also reported a greater 
amount of sugar derivatives with feruloylglucose 38 dominating with levels up 
to 350 mg/kg in kale in red cabbage and radish, cinnamoyl esters of 
anthocyanins.17 
 
1.3.4 Cider and Beer 
 
Cider is one of the most popular alcoholic beverages in developed countries 
and is produced by yeast fermentation of apples (Malus domestica).17 A 
study conducted in England showed that cider contains 44 mg/L of phenolic 
compounds.58 Furthermore, the study revealed that the major components 
were 5-CQA 1 and procyanidins, (+)- catechin 40, (-)-epicatechin 41, the 
dihydrochalcones phloretin-2’-O-glucoside (phloridzin) 42, and phloretin-2’-O-
(2’’-O-xylosyl)-glucoside 43, hydroxycinnamates (Figure 11).17 
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Figure 11. Phenolic composition of cider.17 
 
Beer is another popular alcoholic beverage made from malted grains, barley 
(Hordeum vulgae), hops (Humulus lupulus), yeast (Saccharomyces spp) and 
water. In fact, beer contains a variety of phenolic and polyphenolic 
compounds. Flavan-3-ols 44 can be found in both hops and malt. These 
include monomers, for example (+)-catechin 40, and (-)-epicatechin 41, and 
the dimers procyanidin B1 46, and procyanidin B3 47. 3,4-dihydroxybenzoic 
acid (protocatechuic acid) 45, caffeic acid 2, and ferulic acid 3 are found in 
malt.17 
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Figure 12. Flavonols composition of beer.17 
 
1.4 Pharmacological effects of caffeoylquinic acid 
derivatives 
 
CQA derivatives possess a wide range of pharmacological properties, 
including antiviral, antioxidant, antibacterial, and antihistaminic activities.59 
According to Saito et al.60 their activity increases in proportion to the number 
of caffeoyl residues. 
 
1.4.1 Antiviral effect of caffeoylquinic acid derivatives 
 
CQA derivatives have been recognised as one of the most promising class of 
human immunodeficiency virus (HIV) integrase inhibitors.61-65 
Epidemiological study shows that HIV infects an estimated 33 million people 
globally and poses a significant healthcare challenge. In 1996 Robinson et 
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al.66 reported selective inhibitory effect of DCQA derivatives for HIV-1 
integrase. However, 3-CQA showed no anti-HIV activity.63, 67 
 
Experiments conducted by Wang et al.68 have shown that CQA derivatives 
act against the human hepatitis B virus (HBV), which is the major 
epidemiological agent of acute and chronic hepatitis. HBV carriers can 
develop cirrhosis and hepatocellular carcinoma. Wang et al.68 used the 
HepG2.2.15 cell line to assess the antiviral activity of CQA derivatives. The 
results showed that 3-CQA 1 inhibited HBV replication in a dose-dependent 
manner in vitro and also in vivo.68 However, the mechanism of action of 3-
CQA 1 against HBV replication is still unknown. 
 
In 2005 Ojwang et al.69 reported that CQA can inhibit respiratory syncytial 
virus (RSV). RSV is the leading cause of severe lower respiratory tract 
infections in infants and children under 2 years of age. Statistical data had 
revealed that RSV is responsible for 40-50% of hospitalisations for bronchitis 
in the United States and 25% of pediatric hospitalisations for pneumonia.69 
The virus is an important factor in the development of otitis media infections 
and hyper-reactive airway disease in later life.69 Epidemiological studies have 
revealed the impact of RSV mortality in the United States, showing 17,000 
people died from RSV infection in 2005, with 80% of these deaths occurring 
in people over the age of 65. At present no vaccine is available for 
prophylactic use to prevent RSV infections. The only drug available for the 
treatment of the RSV infection is ribavirin, which is a nucleotide analogue. 
However, experimental studies have shown that ribavirin is teratogenic.69 
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Ojqang et al.69 have demonstrated that 3,5-DCQA 11 can inhibit RSV in vivo 
and in vitro. This study showed that 3,5-DCQA 11 is a highly selective and 
potent inhibitor of RSV replication in tissue culture with activity against both 
the A and B subgroups of RSV. In a rat model, 3,5-DCQA 11 reduced the 
viral titre in the lungs of RSV-infected rats. The results from both in vitro and 
in vivo studies using 3,5-DCQA 11 demonstrated powerful antiviral activity 
against RSV, which was considered to be more effective than ribavirin. 
However, the mechanism of action of 3,5-DCQA 11 against RSV is still 
unclear.69 
 
1.4.2 Antibacterial effect of caffeoylquinic acid derivatives 
 
A study conducted in 2010 confirmed that Streprococcus mutans, a gram-
positive bacteria that causes dental problems in humans, can be inhibited by 
CQA derivatives.70 In this study it was found that 3-CQA 1 inhibits the growth 
of S. mutans, with a minimum inhibitory concentration of 0.8 mg/mL. Another 
study by Almeida et al.71 showed antibacterial effects of CQA derivatives 
against Enterobacterial and S. mutans. Recently, Lee et al 72 have shown an 
anti-candidal effect of CQA derivatives in septic arthritis caused by Candida 
albican in mice. 
 
1.4.3 Antioxidant effects of caffeoylquinic acid derivatives 
 
Experimental studies have shown that oxidised low density lipoprotein (LDL) 
is a risk factor for developing cardiovascular disease because of its role in 
atherosclerosis. A study by Gordon et al.73 has demonstrated that 3-CQA 1 
can inhibit oxidative modification of LDL. It is well known that oxidation 
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processes promote a change in LDL particle structure, and oxidised LDL is 
taken up by the scavenger receptors of macrophages and not from normal 
LDL receptors. Oxidised LDL particles also initiate the expression of 
adhesion molecules, growth factors and cytokines, which are important 
factors in the progression of atherosclerosis.74 
 
An in vitro study by Tanaka et al.75 showed that 3-CQA 1 can decrease the 
incidence of chemical carcinogenesis in the colon and liver in animal models. 
The activity of 3-CQA 1 against chemical carcinogenesis can be related to its 
anti-oxidative and anti-inflammatory properties. Another study on the A549 
human lung cancer cell line by Feng et al.76 showed that 3-CQA 1 can up-
regulate cellular antioxidant enzymes. 
 
1.4.4 Antihypertensive effects of caffeoylquinic acid derivatives 
 
Numerous studies have revealed the hypotensive effects of CQA derivatives. 
In experiments conducted by Woodiwiss et al.77 a single injection of 3-CQA 1 
(30-600 mg/kg) reduced blood pressure in spontaneously hypertensive 
(SHR) rats. Also, when a diet containing 0.5% 3-CQA 1 was administrated to 
rats for a period of 8 weeks, the development of hypertension was inhibited. 
In another study by Kagawa et al. 78 a single oral ingestion (50-200 mg/kg) of 
3-CQA 1, using SHR rats decreased blood pressure. Furthermore, the study 
revealed that the metabolites of 3-CQA 1 induced anti-hypertensive activities. 
The effect of chlorogenic acid as a anti-hypertensive agent has also been 
studied in humans. Watanabe et al.79 3-CQA 1 showed anti-hypertensive 
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effects against mildly hypertensive subjects, whose blood pressure dropped 
significantly. 
 
Recent studies have shown the neuroprotective effect of 3,5-DCQA 11. Kim 
et al.80 described the anticarcinogenic effect of 3,5-DCQA 11 on hydrogen 
peroxide induced SH-SY5Y human neuroblastoma cytotoxicity. 
 
In a study by Cho et al.81 3-CQA 1 an anti-obesity effect against high-fat diet 
obese mice was observed. In this study, Cho et al.81 demonstrated that 3-
CQA 1 can reduce body weight by 16%. 
 
1.5 Metabolism of Caffeoylquinic Acid 
Derivatives 
 
The mechanism and site of absorption of CQA derivatives are still debated 
and remain unconfirmed. However, several theories have been published. 
 
Camarasa et al.82 Choudhury et al.83 Azuma et al.16 Booth et al.84 and 
Bourne et al.85 reported the presence of caffeic acid 2 in the plasma of rats 
after dosing of 3-CQA 1. In fact, Camarasa et al.82 shows the presence of 
caffeic acid 2 in the plasma of rats and rabbits after dosing of 3-CQA 1 at 40 
or 120 mg/kg bw and 10 mg/kg bw respectively. In rats the half-life of 
absorption was 4 min and the half-life for plasma clearance was just over 3 h. 
In rabbits given 10 mg/kg bw, a maximal plasma level of ?1 ?g/ml was 
achieved within 30 min and declined steadily to about half that value over 4h, 
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whereas rats given 100 mg/kg bw achieved a plasma level of 85 ?g/ml 
within 30 min.86 
 
However, Gonthier et al.87 Cremin et al.88 Olthof et al.89 and Rechner et al.90 
the reported the presence of both intact CQA and a variety of metabolites in 
the urine and plasma of rats. The detection of intact chlorogenic acid in the 
rodent urine indicated that it has been absorbed in its native form. In fact, 
Olthof et al.89 recover 33% of chlorogenic acid in a gut using ileostommized 
volunteers. The Author, speculate that the low recovery of chlorogenic acid in 
urine can be explained by its hydrolysis in the body. 
 
The proposed metabolic pathway of 3-CQA 1 is shown below (Figure 13). 
There is evidence that 3-CQA is not absorbed in the proximal part of the gut, 
but that it reaches, the large intestine where it is hydrolysed to caffeic acid 2 
and quinic acid 5 by microflora, which exhibit esterase activities. Quinic acid 
5 is further metabolised into hippuric acid 49, which is formed by 
aromatisation of quinic acid 5 into benzoic acid 48 by the microflora and 
subsequent conjugation with glycine in the liver and kidney.83, 87, 91-93 Caffeic 
acid 3 can also be metabolised into ferulic acid 3, isoferulic acid 50, 3,4-
dihydroxyphenylpropionic acid 52, and m-coumaric acid 51. The 
hydroxylated derivatives of phenylpropionic, benzoic acid 48 and hippuric 
acid 49 derive from the metabolism of caffeic acid 2 by the gut microflora. 3-
Hydroxyphenylpropionic acid 53 is further dehydroxylated to give the 3-
hydroxybenzoic acid 54. Conjugation of benzoic acid 48 with glycine leads to 
the formation of 3-hydroxylhippuric acid 55 and hippuric acid 49. 83, 84, 87, 91, 92 
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Figure 13. Proposed metabolic pathway of 3-CQA 1.87, 90 
 
1.6 Previous synthesis of Caffeoylquinic acid 
Derivatives 
 
In 1964, Haslam et al.94 reported the first regioselective synthesis of 5-CQA 6 
and 1-CQA 60. 1-CQA 60 was synthesised from the acetone quinide 56 and 
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di-O-ethylcarbonate-protected caffeoyl chloride. However, neither the 
conditions used or the yields obtained for each stage in the protocol were 
reported in detail. 5-CQA 6 was obtained in six steps from 5 in a 5% overall 
yield.94 Numerous reports have since appeared regarding the synthesis of 
CQAs. 
 
1.6.2 Synthesis of 1-, 4-, and 5-caffeoylquinic acids 
 
In 2001, Sefkow et al.95, 96 reported the total synthesis of 1-, 3-, 4-, and 5-
CQAs starting from quinic acid 5. The reaction of quinic acid 5 with 2,2-
dimethoxypropane, p-toluenesulfonic acid monohydrate in acetone under 
reflux, afforded two products 56 and 57 with 56 being formed as the major 
product in a 82% and 57 the minor in an 8% yield (Scheme 2). Sefkow et 
al.94 utilised this particular protecting group because it could be easily 
removed in the final steps of the synthesis in the present of ester. The 
unexpected synthesis of 57 paved the way for a synthesis of 5-CQA 6 
because the C-4 hydroxyl group is left unprotected, and it could therefore be 
used in the coupling reaction to provide the 5-CQA 6. In fact, an attempt to 
improved the yield of 57 without success.  
a
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Scheme 2. Synthesis of quinide acetal 56 and bisacetonide 57 from quinic acid 5. Reagents 
and conditions: a) MeC(OMe)2, p-TsOH, acetone, reflux, 2 h, 92% and 8%. 
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Esterification of 57 utilising 1.5 eq of di-O-acetylcaffeoyl chloride in CH2CI2 at 
room temperature for 5 h afforded the ester 58 in a 92% yield. Global 
deprotection in the final step of the synthesis was achieved with 1 N aqueous 
HCI in 15% THF for 10 days to afford 5-CQA 6 in a 91% yield (Scheme 3). 
When 2 N aqueous HCI was used, esterification of caffeic ester 58 was 
observed.  
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Scheme 3. Synthesis96 of 5-CQA, Reagents and conditions: a) DMAP, CH2CI2, di-O-
acetylcaffeoyl chloride, pyridine, room temperature, 5 h, 91%. b) i) LiOH, THF-H2O, ii) 2 N 
HCI, room temperature, 5 h, 79% over two steps. 
 
In the synthesis of 1-CQA 60, acetone quinide 56 was reacted with the di-O-
acetylcaffeoyl chloride to afford the ester 59 in a 58% yield (Scheme 2). 
Hydrolysis of 59 was achieved in two-steps with the lactone and acetate 
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protecting groups being cleaved using LiOH in THF-H2O, while the removal 
of the acetal group was then accomplished using 2 N HCl, affording 1-CQA 
60 in a 79% yield (Scheme 4). 
 
 
Scheme 4. Synthesis 96 of 1-CQA 60. Reagents and conditions: a) di-O-acetylcaffeoyl 
chloride, pyridine, room temperature, 4 h, 58%; b) i) LiOH, THF-H2O, ii) 2 M HCI, room 
temperature, 5 h, 79% over two steps. 
 
In a study conducted by Manthey et al.97 differentiation of the secondary 
hydroxyl groups at C-4 and C-5 of the quinide was successfully achieved 
with tert-butyldimethylsilyl (TBS) chloride, yielding the silyl ether 61 in a 75% 
yield. Esterification of 61 utilising 1.2 eq of di-O-acetylcaffeoyl chloride in 
pyridine afforded the ester 62 in 55% yield. Global deprotection was 
accomplished with 1 N HCl at room temperature, affording 4-CQA 7 in an 
83% yield (Scheme 5). 
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Scheme 5. Synthesis 96 of 4-CQA 7. Reagents and conditions: a) di-O-acetylcaffeoyl 
chloride, pyridine, room temperature, 17 h, 55%; b) 1N HCI, room temperature, 6 days, 83%. 
 
Protection of the C-3 and C-4 vicinal diequatorial hydroxyls was achieved 
using 2,2,3,3,-tetramethoxybutane (TMB). Selective esterification of the 
hydroxyl group at the C-5 was then carried out utilising 1.2 eq of di-O-
acetylcaffeoyl chloride under standard conditions affording the ester 64 in an 
88% yield. No esterification was observed at the C-1 hydroxyl group due to 
the steric effect. Global deprotection was accomplished with 1 N HCI to 
afford 3-CQA 1 in an 81% yield (Scheme 6). Hydrolysis of ester 64 was also 
observed in this reaction as described above. 
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Scheme 6. Synthesis 96 of 3-CQA 1 from quinic acid 5. Reagents and conditions: a) i) 
Dowex 50 H+, MeOH, refluxed, 15 h, ii) 2,2,3,3,-tetramethoxybutane, camphosulforic acid, 
reflux, 22 h, 81% b) di-O-acetylcaffeoyl chloride, pyridine, room temperature, 24 h, 88%; 
c)1N HCI, room temperature, 7 days, 81%. 
 
1.6.2 Synthesis of 5-O-feruloylquinic acid 
 
In 2008 Smarrito et al.98 reported the total synthesis of 5-feruloylquinic acid 
10. 5-O-feruloylquinic acid 10 was synthesised from commercially available 
quinic acid 5. Compound 65 was obtained by reacting 5 with benzaldehyde 
and p-TsOH in toluene under reflux for 16 h to afford 65 in a 92% yield 
(Scheme 7). 
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Scheme 7. Reagents and conditions: a) PhCHO, p-TsOH, toluene, reflux, 16 h, 92%. 
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The C-1 hydroxyl group was benzylated using NaH and benzyl bromide in 
DMF to afford 66 in an 87% yield (Scheme 5). Hydrolysis of 66 was achieved 
with NaOH in THF-H2O at room temperature. This was followed by 
benzylation of the resulting carboxylate using Cs2CO3 and benzyl bromide to 
afford the benzyl ester 67 in an excellent 94% yield (Scheme 8).  
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Scheme 8. Reagents and conditions: a) NaH, DMF, 0 oC, 30 min then BnBr, DMF, room 
temperature, 12 h, 87%; b) NaOH, THF-H2O, room temperature, 40 min, quant; c) Cs2CO3, 
MeOH-H2O, room temperature, 20 min then BnBr, DMF, room temperature, 8 h, 67, 94%. 
 
The secondary hydroxyl group was esterified utilising Meldrum’s acid, to 
afford the malonate 68 in a 92% yield. Deprotection of the benzyl groups was 
achieved with Pd/C 5%, in MeOH/H2O to affording 69 in a 70% (Scheme 9). 
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Scheme 9. Reagents and conditions: a) Meldrum’s acid, toluene, reflux, 3 h 30 min, 92%. 
b)H2, Pd/C 5%, MeOH-H2O, room temperature, 40 h, 70%. 
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In the final step of the synthesis Smarrito et al.98 employed the Knoevenagel 
condensation reaction utilising DMAP, vanillin and malonate 67 affording the 
target 5-O-feruloylquinic acid 10 in a moderate 40% yield (Scheme 10). The 
advantage of this methodology is that the aldehyde and quinic acid fragment 
are not required to be protected in the final step of the synthesis. 
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Scheme 10. Reagents and conditions: a) vanillin, DMAP, piperidine, DMF, room 
temperature, 7 days, 9 40%. 
 
1.7 Aim of Research 
 
The aim of this project was to obtain, by chemical synthesis, the potential 
human metabolites of 3,5-DCQA 11. These compounds will be used as  
standards in order: i) to make other derivatives; ii) identify the potential 
human circulating forms of 3,5-DCQA 11 and iii) assess biological activity.  
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Figure 14. Structure of 3,5 DCQA 11. 
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As outlined previously 3,5-DCQA 11 is one of the constituents of coffee and 
artichokes extracts.15 However, the metabolic pathway of this product in 
humans has never been studied in detail, although it is believed that 
caffeoylquinic esters in general, are cleaved into caffeic acid 3, which is 
further metabolised. 
 
However, recent studies have suggested through appropriate testing, that 3-
CQA 1 could actually be absorbed intact, and that conjugated forms of 3-
CQA 1 circulate in the plasma.  The exact nature of the conjugates is 
uncertain in the absence of a fully characterised standard compounds hence 
it is likely that a similar situation occurs in the case of 3,5-DCQA 11. 
 
1.8 Retrosynthetic Analysis 
 
The general approach to the synthesis of 3,5-DCQA 11 is illustrated, in 
retrosynthetic format, in Scheme 8. 3,5-DCQA 11 could be derived from 
advance intermediate 72 through a straightforward sequence of 
deprotections. It was envisaged that intermediate 72 could be formed in a 
single operation through an esterification reaction between 71 and caffeoyl 
chloride. Cleavage of the ester linkage in 72 could provide compound 71 as a 
potential precursor. Saponification of the lactone ring in 70 could secure  
intermediate 71. Compound 69 could be formed from 68 using TBS ether 
protection, and diol 68 could be derived in two steps through a 
straightforward sequence of reaction from quinic acid 5. 
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Scheme 8. Retrosynthetic approach to 3,5-DCQA. 
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Chapter Two 
 
2.1 Synthesis of 3,5-O-dicaffeoylquinic acid via 
esterification 
 
In line with our synthetic plan, the synthesis of 3,5-DCQA 11 began with the 
preparation of quinide 73 (Scheme 9) a compound used previously as a key 
intermediate in number of syntheses of quinic acid derivatives.99 Cyclisation 
of quinic acid 5 to the lactone 73 was achieved using p-toluenesulfonic acid 
monohydrate in a 1:5 mixture of DMF/toluene, according to the method of 
Kaila et al.99 This afforded lactone 73 in excellent yield (Scheme 9). The 
structure of lactone 73 was confirmed by analysis of the 1H NMR spectrum, 
which was found to be in close agreement with the literature data.99 Further 
confirmation was provided by mass spectral analysis, which gave a signal at 
174 Daltons, corresponding to the expected molar ion of  [M+H]+ C7H10O5.   
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Scheme 9. Reagents and conditions: a) p-TsOH, toluene, DMF, reflux, 12 h, Dean-Stark, 
99%. 
 
 
Regioselective O-benzylation of the C-3 hydroxyl group was achieved by 
treatment of lactone 73 with dibutyltin oxide and benzyl bromide in toluene 
and DMF to afford diol 68 in a good 68% yield (Scheme 10). This yield was 
improved by the application of the conditions reported by Desai et al.100 The 
use of dibutyltin oxide, tetrabutylammonium iodide and benzyl bromide in 
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refluxing acetonitrile afforded diol 68 in much improved 90% yield (Scheme 
10). 
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Scheme 10. Reagents and conditions: a) Bu2SnO, Bu4NI, CH3CN, BnBr, reflux, 12 h, 90%. 
 
Elegant studies on the regioselective dibutylstannylation of polyols, such as 
carbohydrates, and their subsequent acylation or alkylation based on the 
nucleophilic enhancement of the oxygen atoms have been reported by David 
and Hanessian.101, 102 Bu2SnO was employed in a catalytic fashion to form 
the dibutylstannylene acetal under neutral conditions. The regioselective O-
benzylation can be rationalised based on the stannylene structure. The two 
oxygen atoms of the diol are differentiated in the stannylene, one being in an 
equatorial position, and the other one in an apical position in a trigonal 
bipyramid centered on the tin atom.101-103 The apical oxygen of the stannane 
complex is more reactive than the equatorial and reacts preferentially with 
the benzyl bromide (Figure 15).  
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Figure 15. Proposed mechanism of the regioselective benzylation of the C-3 hydroxyl group 
using Bu2SnO. 
 
The exact structure assignment was based on a literature study.103 The 1H 
NMR spectrum displayed the requisite resonances. In particular, the aromatic 
protons appeared as a multiplet between δ 7.31-7.20 ppm. The benzylic 
protons appeared as an AB system at δ 4.54-4.44 ppm, with a geminal 
coupling constant of 12.0 Hz. The hydroxyl groups C-1 and C-4 appeared as 
a singlet at δ 5.93 ppm and as doublet at 5.21 ppm respectively. The methine 
protons H-5, H-4 and H-3 appeared as an apparent triplet at δ 4.60 ppm (J = 
5.4, Hz), multiplets at δ 4.14-4.09 ppm and doublet of doublet of doublet at δ 
4.19 ppm (J = 4.7, 4.7, 4.5 Hz). The methylene protons H-2 and H-6 
appeared as an apparent doublet at δ 2.26 ppm (J = 11.2 Hz), multiplets at δ 
2.16-1.20 ppm, δ 1.98-1.94 ppm and as an apparent triplet at δ 1.72 ppm (J 
= 11.6 Hz) (Figure 16). The mass spectrum gave a signal at 263 
corresponding to the molecular ion [M+H]+ expected for C14H16O5. 
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Figure 16. 1H NMR spectrum of 68 in DMSO-d6. 
 
The synthesis of diol 68 has previously been reported by Hanessian et al.104 
using a one-pot strategy. This protocol began with quinic acid 5 and p-
toluenenesulfonic acid in DMF/toluene (1:1) as solvent, followed by the 
addition of dibutyltin oxide and benzyl bromide to the crude intermediate 
(Scheme 11). 
 
OH
OHHO
OH
a O
O
OHBnO
OH
5 68
CO2H
 
Scheme 11. Reagents and conditions: a) p-TsOH, toluene, DMF, Bu2SnO, BnBr, reflux, 6 h, 
30%. 
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However, in our hands, this method afforded diol 68 in a poor 30% yield 
compared with the 81% obtained in the original report.104 The two step 
method described above was the method of choice because it gave 90% 
yield in comparison with 81% yield reported by Hanessian et al.104 over one 
step. 
 
The next goal was the O-silylation of the 1- and 4-hydroxyl groups as tert-
butyldimethylsilyl (TBS) ether. Initial reaction of diol 68 was attempted with 
imidazole in DMF at 0 ºC, followed by addition of TBS chloride. The mixture 
was then stirred at 0 ºC for 30 min and 1 h at room temperature.105 The 
reaction was monitored by TLC, which indicated the formation of one less 
polar product as well as unreacted starting materials. Alcohol 74 was isolated 
in 70% yield after column chromatography (Scheme 12) as the only product. 
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Scheme 12. Reagents and conditions: a) Imidazole, TBS-CI, DMF, 0  ºC for 30 min and then 
1 h at room temperature, 70%. 
 
The 1H NMR spectrum of the isolated product showed diagnostic resonances 
at δ 0.78 ppm due to the t-butyl group at δ 0.00 and δ at -0.02 ppm due to 
the methyl groups of the TBS group. On close analysis of the spectrum it was 
clear that only one hydroxyl group had been protected. Mono-protection was 
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confirmed by the observation of a signal at 379 Daltons in the mass 
spectrum, corresponding to C20H30O5Si. This was judged to be the C-4 
hydroxyl group due to the absence of 4-OH signal in the 1H NMR spectrum at 
δ 5.32 ppm, implying that the product was the alcohol 74 rather than the 
desired bis-TBS lactone 69 (Figure 17). The selectivity is entirely consistant 
with tertiary hydroxyl group at C-1 is more sterically hindered and less 
reactive than the secondary 4-OH hydroxyl group. 
 
Figure 17. 1H NMR spectrum of 74 in DMSO-d6. 
 
A further attempt at protection of the 1- and 4- hydroxyl groups employed 
adaptations of literature methods,105 using 3 equivalents of TBS chloride, but 
they was unsuccessful. However, a larger excess of both TBS chloride (6 eq) 
and imidazole (4 eq) and a higher reaction temperature of 100 ºC as well as 
the inclusion of DMAP (0.01 eq) as a catalyst was successful. DMAP was not 
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used in the previous literature (Scheme 13). This reaction proceeded 
smoothly affording the desired bis-TBS ether 69 in 86% yield following 
purification by column chromatography. The structure of 69 was confirmed by 
1H NMR spectroscopy (Figure 18) and mass spectral analysis, which gave a 
signal at 515 Daltons, corresponding to the sodium adduct [M+Na]+  
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Scheme 13. Reagents and conditions: a) Imidazole, TBS chloride, DMAP, DMF, 100 ºC, 12 
h, 86%. 
 
 
Figure 18. 1H NMR spectrum of 69 in DMSO-d6. 
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Following the protection of the 1- and 4-hydroxyl groups to give ether 69, 
several unsuccessful attempts were made at hydrogenolysis of the benzyl 
protecting group using various palladium catalysts (Scheme 14).  
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Scheme 14. Reagents and conditions: a) H2, 10% Pd/C or Pd/(OH)2, MeOH, EtOAc, or THF, 
room temperature 
 
In all cases an unexpected cleavage of the TBS group at the C-1 position 
was observed giving compound 75 (Table 2). The 1H NMR spectrum had 
diagnostic resonances at δ 0.78 ppm due to the t-butyl group and at δ 0.00 
and δ -0.02 ppm. The integrals indicated the presence of only one hydroxyl 
group, which appears to be that at C-4 due to the absence of 4-OH signal in 
the 1H NMR spectrum. The structure was supported by mass analysis which 
gave a molecular ion of m/z 288 Daltons. It was concluded that the cleavage 
reaction of TBS with 5% and 10% Pd/C was promoted by the acid 
contamination in the 5% or 10% Pd/C catalysts. The results are shown in 
Table 2. 
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Table 2. Cleavage of the TBS ether 69 in the presence of Pd catalyst and hydrogen. 
Entry Pd Solvent Temp Time (h) Product Yield % 
1 5% Pd/C MeOH r.t 12 h 75 95% 
2 5% Pd/C MeOH r.t 1 h 69 no reaction 
3 5% Pd/C EtOAc r.t 12 h 75 95% 
4 5% Pd/C THF r.t 12 h 75 95% 
5 10% Pd/C MeOH r.t 12 h 75 95% 
6 10% Pd/C EtOAc r.t 12 h 75 95% 
7 10% Pd/C THF r.t 12 h 75 95% 
8 Pd/(OH)2 MeOH r.t 12 h 75 95% 
9 Pd/(OH)2 EtOAc r.t 12 h 75 95% 
10 Pd/(OH)2 THF r.t 12 h 75 95% 
 
  
Unexpected cleavage of silyl protected alcohols such as TBS and DEIPS 
ethers under various hydrogenolysis conditions has been previously 
reported.106-108 In 2004 Ikawa et al.106 reported the cleavage of TBS and TES 
ethers under hydrogenation conditions using 10% Pd/C in MeOH at room 
temperature (Scheme 15). 
 
Ph OTES Ph OH
76 77TBS
a
 
Scheme 15. Reagents and conditions: a) H2, 10% Pd/C, MeOH, room temperature, 12 h.106 
 
In a separate reported by Prunet et al.107 the cleavage of a TES ether using 
10% Pd/C in MeOH or 95% EtOH at room temperature in the absence of a 
hydrogen atmosphere was also reported (Scheme 16). 
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Scheme 16. Reagents and conditions: a) without H2, 10% Pd/C, MeOH or EtOH, room 
temperature, 12 h.107 
 
These observations are in agreement with our findings. Palladium chloride in 
concentrated hydrochloric acid solution is generally used for the preparation 
of Pd/C catalysts. The palladium chloride is absorbed on to heavy metal free 
activated charcoal and reduced using a suitable reductant. It may therefore 
be contaminated by a trace amount of retained hydrochloric acid, and/or 
residual palladium chloride due to incomplete reduction during the production 
process, even after washing with distilled water.106 
 
To counter this problem, it was decided to use palladium black in MeOH at 
room temperature under a hydrogen atmosphere for 36 h. Under these new 
conditions the desired alcohol 70 was achieved in quantitative yield. This 
reaction proved to be clean and no further purification of the alcohol 70 was 
required. The 1H NMR spectrum of alcohol 70 displayed the expected 
resonances (Figure 19). The absence of the aromatic protons at δ 7.26-7.15 
ppm was indicative of cleavage of the benzyl ether. The TBS groups 
appeared as singlets at δ 0.77 ppm, 0.76 ppm due to the t-butyl groups and δ 
0.02, 0.00, -0.00, -0.02 ppm due to the methyl groups. An absorption in the 
infrared spectrum at 3300 cm-1 was indicative of the alcohol functionality and 
mass spectral analysis gave a signal at 403 Daltons, corresponding to the 
molecular ion [M+H]+ expected for C19H38O5Si2 (Scheme 17). 
 
 43 
O
O
OTBSHO
OTBS
aO
O
OTBSBnO
OTBS
7069  
Scheme 17. Reagents and conditions: a) H2, Pd/black, MeOH, room temperature, 36 h, 
99%. 
 
 
Figure 19. 1H NMR spectrum of alcohol 70 in DMSO-d6. 
 
The next step in the proposed synthesis was ring opening of the lactone. 
Hydrolysis of the lactone 70 with a catalytic amount of LiOH in THF/H2O at 
room temperature was exploved. However, this led to the removal of the TBS 
group at C-4. Further attempts towards lactone ring opening without the 
cleavage of the TBS group at C-4 position, were carried out as shown in 
Table 3. Replacing LiOH with NaOH, as well as decreasing the reaction 
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temperature and duration of the reaction all failed to give the desired product 
(Table 3). 
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Scheme 18. Reagents and conditions: a) Table 2 
 
Table 3. Hydrolysis of lactone 70 using LiOH and NaOH at various temp and time. 
Entry Reagent Solvent Temp Time (h) Product Yield % 
1 LiOH (1.1 eq) THF/H2O 0 °C 0.5 h 70+80 89%+11% 
2 LiOH (1.1 eq) THF/H2O 0 °C 1 h 70+80 67%+33% 
5 LiOH(1.1 eq) THF/H2O r.t 6 h 80 68% 
7 LiOH (2.1 eq) THF/H2O r.t 24 h 80 99% 
8 NaOH (1.1 eq) THF/H2O 0 °C 1 h 70+80 60+40% 
9 NaOH (2.1 eq) THF/H2O r.t 6 h 80 76% 
10 NaOH (2.1 eq) THF/H2O r.t 24 h 80 92% 
 
 
The 1H NMR spectrum of the hydrolysis product showed the presence of only 
one silyl protecting group with diagnostic resonances at δ 0.83 ppm (9H) for 
the t-butyl group, and δ 0.00 and 0.03 ppm for to the methyl groups. Further 
confirmation came via HRMS (ES-) 305.1420 for C13H25O6Si indicating the 
presence of only one silyl group. 
 
With triol 80 in hand, the possibility of the coupling reaction with diacetyl 
caffeoyl chloride 82 was investigated to determine which hydroxyl groups 
would react.95 Diacetyl caffeoyl chloride 82 was obtained from caffeic acid 2 
in two steps. Acetylation of caffeic acid 2 with Ac2O and DMAP, in pyridine 
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afforded 81 in a 95% yield. Reaction of 81 with 2 eq. of oxalyl chloride 
provided the diacetyl caffeoyl chloride 82 in an excellent 98% yield (Scheme 
19).95 
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Scheme 19. Reagents and conditions: a) DMAP, pyridine, acetic anhydride, DMF, 0 ºC, 1 h, 
95 %, b) oxalyl chloride, -5 ºC, 3 h room temperature, 98%. 
 
Treatment of triol 80 with diacetyl caffeoyl chloride 82 (2.2 eq) in the 
presence of DMAP at room temperature95, 96 gave the 3,4-dicaffeoyl ester 83 
and not the desired 3,5-dicaffeoyl ester 72 (Scheme 20). 
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Scheme 20. Reagents and conditions: a) DMAP, diacetyl caffeoyl chloride, 12 h, room 
temperature. 63%. 
 
The axial 5-hydroxyl group is more sterically hindered, at C-1 and less likely 
to react, owing to the proximity of the carboxylated group also in an the axial 
orientation. 
 
The 1H NMR spectrum of 83 was found to be in close agreement with a 
previous literature report.109 The alkene protons appear as a doublet at δ 
6.66 ppm and δ 6.54 ppm. COSY NMR analysis shows strong coupling 
between the methine proton at δ 3.85 ppm and the H-3, H-5, respectively. 
This methine proton was assigned to H-4 because only this proton can show 
homonuclear coupling with H-3 and H-5 and not to H-2 and H-4 respectively. 
More evidence came from the observation that OH-C showed connectivity to 
C-5 or C-3, whereas it was not connected to C-4 (Figure 21). This 
assignment was further confirmed by HSQC (Figure 22). 
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Figure 21.1H -1H COSY spectrum of 3,4 dicaffeoyl ester 83 in DMSO-d6. 
 
Figure 22.1H -13C-HSQC spectrum of 3,4 dicaffeoyl ester 83 in DMSO-d6. 
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Various efforts to remove the protecting groups of coupled product 83 were 
unsuccessful (Scheme 21).  
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Scheme 21. Reagent and conditions: a) Table 4. 
Using 0.5 N HCI in THF for 5 days, no reaction was observed when 
monitoring the reaction by TLC. Increasing the reaction time to 10 days at the 
same concentration had no effect on the observed outcome. Increasing the 
concentration of HCI from 0.5 N to 1 N HCI had a significant effect on the 
reaction (Table 4). Analysis the 1H NMR spectrum of this product after 
isolation and purification by column chromatography indicated the cleavage 
of both ester groups. 
 
Table 4. Attempted cleavage of the protecting group using HCI. 
Entry HCI Days Temp Product 
1 0.5 N  5 days r.t no reaction 
2 0.5 N  10 days r.t no reaction 
3 1 N  10 days r.t hydrolysis 
4 2 N 1 days r.t no reaction 
5 2 N  5 days r.t no reaction 
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2.2 An Alternative to the TBS ether Protecting Group. 
 
In the preceding sections the initial unsuccessful efforts to synthesise 3,5-
DCAQ 11 using the TBS ether protecting group were discussed. This 
necessitated the shift to an alternative silyl protecting group. The 
triisopropylsilyl (TIPS) ether protecting group was chosen because it was 
believed that the bulkier TIPS silyl ether group would have greater stability 
towards acid and base hydrolysis. Table 5 shows the half-lives for cleavage 
of the two silyl ethers.110 
 
Table 5. Half-lives in the cleavage of silyl ethers.110 
Protecting Groups Si Acida Baseb Fluoridec 
t-BuMe2Si 4 min 26 h 76 min 
i-Pr3Si 100 min 44 h 137 min 
 
a 1% HCI/95% EtOH, 22.5 °C; b 5% NaOH/ 95% EtOH, 90 °C; c 2 equiv TBAF/ THF 22.5 °C 
 
The initial steps of the synthesis were as before. The protection of diol 68 
was then investigated using 2,6-lutidine in DMF at 0 ºC with iPr3SiOTf as the 
source the silyl group.111 The mixture was stirred at room temperature for 6 
h. Under these conditions protection of only the 4-hydroxyl group was 
observed (Scheme 22). 
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Scheme 22. Reagents and conditions: a) iPr3SiOTf, 2,6 Lutidine, DMF, 0 ºC to room 
temperature, 89%. 
 
However, increasing the reaction temperature to 70 ºC with 4.1 equiv of 
iPr3SiOTf and increasing the reaction time to 8 h afforded the bis-TIPS ether 
85 in a good (78%) yield (Scheme 23).  
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Scheme 23. Reagents and conditions: a) iPr3SiOTf, 2,6 lutidine, DMF, room temperature to 
70 ºC, 78%. 
 
The structure of bis-TIPS ether 85 was initially confirmed by 1H NMR 
spectroscopy (Figure 23). This showed the absence of both hydroxyl groups 
at δ 6.06 ppm and δ 5.40 ppm respectively. The methine protons H-5 and H-
4 appeared as an apparent triplet at δ 4.60 ppm (J = 5.4, Hz) and δ 4.22 ppm 
(J = 4.4, Hz) respectively. H-3 appeared as a multiplet between δ 3.37-3.32 
ppm. The methylene H-2 appeared as an apparent doublet at δ 2.41 ppm (J 
= 11.3 Hz) and a multiplet at δ 2.23-2.16 ppm. H-6 appeared as a multiplet at 
δ 1.98-1.92 ppm and as an apparent triplet at δ 1.72 ppm (J = 11.0 Hz). The 
TIPS ether protecting groups appeared as multiplets at δ 0.93-0.90 ppm 
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(42H). An accurate mass measurement displayed a signal at 599 Daltons, 
corresponding to that expected for the sodium adduct [M+Na]+ 
C31H60O2Si4Na. 
 
Figure 21. 1H NMR spectrum of 85 in DMSO-d6. 
 
Next came the crucial step involving the opening of the lactone ring without 
the concomitant cleavage of the TIPS ether groups at the C-1 and C-4 
positions. Using LiOH in THF-H2O at room temperature for 45 min, it was 
observed that the TIPS at the C-4 position was retained intact while the TIPS 
group at the C-1 position was cleaved (Scheme 24). 
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Scheme 24. Reagents and conditions: a) Table 6. 
 
This is in contrast to the original conditions, which utilised the TBS protecting 
group (previously) where the TBS ether group at the C-1 position was 
retained while the TBS group at the C-4 position was cleaved. Several further 
attempts to open the lactone ring without the cleavage of the TIPS group at 
the C-1 position were conducted. The result of which are summarised below 
(Table 6). Replacing LiOH with NaOH as well as decreasing the reaction 
temperature and increasing the time failed to give the desired product (Table 
6). 
Table 6. Hydrolysis of lactone 85 using LiOH and NaOH at various temp and time. 
Entry Reagent Solvent Temp Time (h) Product Yield % 
1 LiOH (1.1 eq) THF/H2O 0 °C 0.5 h 85+87 93%+7% 
2 LiOH (1.1 eq) THF/H2O 0 °C 1 h 85+87 72%+28% 
3 LiOH (1.1 eq) THF/H2O r.t 6 h 87 65 
7 LiOH (1.1 eq) THF/H2O r.t 24 h 87 99% 
8 NaOH (1.1 eq) THF/H2O 0 °C 1 h 85+87 92%+8% 
9 NaOH (1.1 eq) THF/H2O r.t 6 h 87 67% 
10 NaOH (2.1 eq) THF/H2O r.t 24 h 87 99% 
 
 
The structure of diol 87 was confirmed by NMR spectroscopy (Figure 22). 
The 1H NMR of spectrum of the diol 87 displayed the appropriate 
resonances. In particular, the aromatic protons appeared as a multiplet 
between δ 7.42-7.29 ppm (5H). The benzylic proton appeared as an AB 
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system at δ 4.62-4.51 ppm, with a coupling constant of 12.2 Hz. The methine 
H-4 and H-5 appeared as a series of multiplets between δ 4.03-3.99 ppm 
and 3.87-3.80 ppm. The methine H-3 appeared as doublets of triplets at δ 
3.90, which coupling constant of 11.1 and 2.8 Hz respectively. The 
methylene H-2 and H-6 appeared as multiplets at δ 2.44-2.40 ppm, δ 2.37-
2.31 ppm, and δ 1.98-1.82 ppm, respectively. The TIPS ether protecting 
group appeared as multiplets at δ 1.04-1.00 ppm. 
 
Figure 22. 1H NMR spectrum of diol 87 in DMSO-d6. 
 
The 2 dimensional (2D) 1H, 29Si correlation experiment further revealed that 
the remaining silyl protecting group was at the C-4 position and also 
confirmed that only one silyl protecting group was present (Figure 23). 
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Figure 23.1H-29Si correlation experiment. 
 
It was speculated that the TIPS ether group at the C-1 position was cleaved 
due to the greater relief of steric strain. It was also believed that the coupling 
of the caffeoyl chloride to the C-3 and C-5 positions could be efficiently 
carried out with no protection of the C-1 hydroxyl group due to the steric 
effects hindering reaction at this position. 
 
Therefore, next goal was the selective deprotection of the benzyl protecting 
group on the 3-hydroxyl group without cleavage of the TIPS group at the C-4 
position. This was achieved using 10% Pd/C in EtOH at 60 ºC under a 
hydrogen atmosphere for 36 h. Under these conditions the triol 88 was 
obtained in 82% yield (Scheme 26).  
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Scheme 26. Reagents and conditions: a) H2, 10% Pd/C, EtOH, 60 ºC, 82%. 
 
The 1H NMR of the isolated triol 88 showed the absence of aromatic protons 
between δ 7.31-7.29 ppm and the benzylic protons at δ 4.52-4.44 ppm. The 
methine protons at H-3, H-5 and H-4 appeared as multiplets between δ 4.08-
3.92 ppm, and δ 3.72-3.59 ppm. The remaining signals, which can be 
attributed to the methylene groups appear as a multiplet between δ 1.87-1.51 
ppm (4H), and the protons at δ 1.03-101 ppm (21H) pertain to the TIPS ether 
protecting group. The structure was supported by mass spectrometry which 
gave a molecular ion of m/z 347 indicating the absence of the benzyl 
protecting group.  
 
However, when this protocol was attempted using 10% Pd/C in EtOH at 
room temperature for 36 h, incomplete conversion of diol 87 to the desired 
product triol 88 was observed. Only a poor 8% yield of the desired product 
triol 88 was observed with the remaining 92% being unreacted starting 
material 87 (Scheme 27). 
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Scheme 27. Reagents and conditions: a) H2, 10% Pd/C, EtOH, room temperature, 36 h, 8% 
(88), 92% (87) 
 
With triol 88 in hand, the next task was to introduce the caffeoyl groups at the 
C-3 and C-5 positions. This was achieved by adopting the methodology 
reported by Sefkow et al.95, 96 It was first decided to use 3,4-
dimethoxycinnamic acid to investigate the coupling at the C-3 and C-5 
positions, because the tetramethylated product would be easier to handle 
and purify. Simple deprotection of just one silyl group at the C-4 position 
would then give one of the target molecules. The required 
3,4,dimethoxycinnamyl chloride 90 was obtained from 3,4,-
dimethoxycinnamic acid 89 using oxalyl chloride in toluene and a catalytic 
amount of DMF affording 90 in 92% yield (Scheme 28). 
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Scheme 28. Reagents and conditions: a) toluene, cat. DMF, oxalyl chloride, -5 ºC to room 
temperature, 3 h, 92% 
 
Treatment of triol 88 with DMAP (0.01 eq) and 3,4,dimethoxycinnamyl 
chloride 90 (2.2 eq) in pyridine at room temperature for 12 h afforded the 3,5-
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coupled product 91 in an excellent 92% yield after column chromatography 
(Scheme 29).   
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Scheme 29. Reagents and conditions: a) DMAP, 3,4-dimethoxycinnamoyl chloride, pyridine, 
CH2CI2, room temperature, 12 h, 92%. 
 
The vinyl protons appeared as two doublets at δ 7.56 and 6.69 ppm. These 
downfield signals were deemed to be consistent with the β-protons of an α,β-
unsaturated carbonyl system, with the large reciprocal coupling of 16.0 Hz. 
Tables 7 and 8 show 1H NMR analysis of the quinic acid moiety and the 
caffeoyl moiety. 
Table 7. 1H NMR data for the quinic acid moiety of 91. 
signal assignment shifta 
ppm 
multi- 
plicityb 
Hzc 
3 or 5 axial 5.34 - 5.24 m - 
3 or 5 axial 4.19 - 4.09 m - 
4 equatorial 3.94 - 3.88 m - 
6 axial/equatorial 2.40 - 2.32 m - 
2 axial/equatorial 2.00 - 1.93 m - 
 
a In ppm, relative to DMSO-d6 at 2.50; b m =multiplet, c Hz coupling constants.         
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Table 8. 1H NMR data for the caffeoyl moiety of 91. 
signal assignment shifta 
ppm 
multi- 
plicityb 
Hzc 
7ʼ - 7.56 d 16.0 
7ʼʼ - 7.48 d 16.0 
2ʼ - 7.32 s - 
2ʼʼ - 7.26 s - 
5ʼ - 7.18 d 8.6 
5ʼʼ - 7.18 d 8.6 
6ʼ - 6.98 dd 8.6, 1.6 
6ʼʼ - 6.96 dd 8.6,1.6 
8ʼ - 6.49 d 16.0 
8ʼʼ - 6.40 d 16.0 
-OCH3 - 3.80 s - 
-OCH3 - 3.78 s - 
a In ppm, relative to DMSO-d6 at 2.50; b s= singlet, d = doublet, c Hz coupling constants. 
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The next step, O-desilylation of the TIPS ether protecting group proved to be 
problematic. Treatment of TIPS-ether 91 with TBAF in THF under various 
reaction conditions failed to produce the desired product 92 (Scheme 30), but 
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instead gave the lactone 93, as was confirmed by mass spectroscopetry 
which gave a molecular ion of m/z 364. 
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Scheme 30. Reagents and conditions: a) Table 9 
 
Table 9. Cleavage of the silyl protecting group at various temp and time. 
 
Entry Reagent Temp Time (h) Product Yield % 
1 TBAF/THF r.t 3 h 93 66% 
2 TBAF/THF r.t 1 h 93 57% 
3 TBAF/THF 0 °C 0.5 h 93 35% 
4 TBAF/THF 0 °C 1 h 93 48% 
 
                             
The best conditions for this deprotection involved the treatment of 91 with 
HF-pyridine in THF at 0 ºC and allowing the resultant reaction mixture to 
warm up to room temperature overnight.112 The desired product 92 was 
exclusively obtained in an excellent 98% yield following column 
chromatography (Scheme 31).  
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Scheme 31. Reagents and conditions: a) HF-pyr, THF, 0 ºC to room temperature, 12 h, 
98%. 
 
The structure of this compound 92 was initially confirmed by its 1H NMR 
spectrum, which showed the absence of the silyl protecting group and the 
presence of an additional hydroxyl group at δ 4.95 ppm. The vinyl protons 
appeared as doublets at δ 7.38, 7.37, 6.33 and 6.27 (Figure 24). 
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Figure 24. 1H NMR spectrum of 92 in DMSO-d6. 
 
The infrared spectrum of 92 displayed an absorption at 3054 cm-1 and 1707 
cm-1, consistent with the presence of a hydroxyl group and a carbonyl group, 
respectively. The mass spectrum gave a signal at 595 Daltons, 
corresponding to the sodium adduct [M+Na]+ expected for C29H32O12Na. 
 
The purity of compound 92 was determined by reverse phase HPLC in 
methanol and H2O (70:30) (using a Kingsorb 5u C18 column) giving a single 
peak with a retention time of 8.30 min (Figure 25). 
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Figure 25. Reverse phase HPLC of compound 92 after initial purification. 
 
With compound 92 in hand, investigation of the synthesis of 3,5-FQA 96 was 
then conducted. The synthesis of 3,5-FQA 96 was expected to be more 
difficult than that of 92 due to the increased polarity of the compound. As a 
starting point for the synthesis it was decided to use the TBS ether protecting 
group for the protection of the ferulic acid 3 because it would be an 
advantage to cleaved all the protecting group in the final step of the synthesis 
using HF-pyridine. O-Silylation of ferulic acid 3 with TBS and imidazole in 
anhydrous DMF gave silyl ether 93 in 96% yield. Treatment of 93 with oxalyl 
chloride and catalytic amount of DMF at room temperature afforded 94 in 
78% yield (Scheme 32). 
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Scheme 32. Reagents and conditions: a) imidazole, anhydrous DMF, TBS chloride, 96 ºC, 3 
h, 90%; b) toluene, cat. DMF, oxalyl chloride, -5 ºC to room temperature, 3 h, 78%. 
 
Treatment of triol 88 with 95 (2.2 eq), under the conditions used for the 
previous coupling, afforded 96 in 88% yield following column 
chromatography (Scheme 33).   
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Scheme 23. Reagents and conditions: a) DMAP, 95, pyridine, CH2CI2, room temperature, 12 
h, 88%. 
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Global deprotection of the silyl protecting groups was accomplished as 
described previously affording the target 3,5-FQA 97 in an excellent 91% 
yield (Scheme 34). 
 
a O
CO2H
OHO
OH
97
O
OH
O
OCH3
OH
OCH3
O
CO2H
OHO
OTIPS
96
O
OTBS
O
OCH3
OTBS
OCH3
 
Scheme 34. Reagents and conditions: a) HF-pyr, THF, 0 ºC to room temperature, 12 h, 
91%. 
 
This represents the first efficient synthesis of the 3,5-FQA 97. The structure 
of 3,5-FQA 97 was initially confirmed by 1H NMR spectroscopy. The H-3 or 5 
and H-3 or 5 of the quinic acid moiety appeared as doublet of doublet of 
doublet at δ 5.24 ppm (J = 3.5, 3.5, 4.1 Hz) and as a complex multiplet 
between δ 4.10-4.07 ppm. The H-4, H-2 and H-6 appear as multiplets at 
between δ 3.64-3.58 ppm, δ 2.38-2.23 ppm and 1.98-187 ppm respectively 
(Figure 26). 
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Figure 26. 1HNMR spectrum of 3,5-FQA 97 in DMSO-d6. 
 
The 2D 1H, 1H COSY of the caffeoyl moiety of 3,5-FQA 97, (Figure 27) 
showed the presence of the (E)-double bonds at δ 7.54, 7.53, 6.45, and 6.39 
with a large reciprocal coupling constant of 16.0 Hz. The H-2’/2’’appear as 2 
doublets at δ 7.32/7.30 ppm, with coupling constants of 1.8 Hz. The H-6’/6’’ 
appears as 2 × doublets of doublet at δ 7.08/6.80, with coupling constants of 
8.1 and 1.8 Hz respectively. The H-5’/5’’ signals also coincide with each 
other appearing as a doublet at δ 6.80 ppm, with a coupling constant of 8.1 
Hz. The OCH3 of the caffeoyl moiety appear as singlets at 3.83 ppm and 3.82 
ppm. The hydroxyl group on the caffeoyl moiety appear as a singlets at δ 
9.63 ppm and 9.62 ppm respectively. The infrared spectrum of 3,5-FQA 97 
was found to contain a broad absorption band at 3460 cm-1, and further 
absorptions at 1696 and 1783 cm-1, which are indicative of the alcohol 
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functionality and the carbonyl groups. The mass spectrum gave a signal at 
543 Daltons, corresponding to the molecular ion [M-H]- expected for 
C27H27O12 m/z = 543 [M-H]-. An accurate mass measurement confirmed the 
expected molecular formula of C27H27O12. 
 
 
Figure 27. 2D 1H, 1H-COSY spectrum of caffeoyl moiety of 3,5-FQA 97. 
 
With 500 milligrams of crude product in hand, the purification of 3,5-FQA 97 
was embarked upon by reverse phase HPLC on a Kingsorb 5µ C18 column 
eluting with methanol and H2O (80:20). This gave a chromatograph with a 
single peak in the UV trace (254 nm) with a retention time of 3.87 min (Figure 
28). 
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Figure 28. Reverse phase HPLC of compound 3,5-FCQA 97 after initial purification. 
 
With the first two compounds 3,5-(3,4-dimethoxycinnamyl)quinic acid 92 and 
3,5-FQA 97 in hand, the synthesis of 3,5-DCQA 11 was then investigated. It 
was assumed that the synthesis of 3,5-DCQA 11 would be more problematic 
due to its higher polarity relative to 3,5-(3,4-dimethoxycinnamyl)quinic acid 
92 and 3,5-FQA 97. A suitably protected caffeoyl chloride 99 was prepared 
from caffeic acid 2. In this case, it was also decided to use TBS ether for the 
protection of caffeic acid 2 because all the protecting groups could be 
removed in one step using HF-pyridine. O-Silylation of caffeic acid 2 with 
TBS chloride and imidazole in anhydrous DMF as solvent afforded bis-TBS 
ether 98 in an excellent 94% yield. Treatment of 3,4-tert-butyldimethylsilyl 
caffeic acid 98 with 2 equivalents of oxalyl chloride afforded the desired 3,4,-
tert-butyldimethylsilyl caffeoyl chloride 99 in a good 86% yield (Scheme 35). 
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Scheme 35. Reagents and conditions: a) imidazole, anhydrous DMF, TBS chloride, 70 ºC, 3 
h, 94%; b) toluene, cat. DMF, oxalyl chloride, -5 ºC to room temperature, 3 h, 86%. 
 
Treatment of triol 88 with DMAP and 3,4-tert-butyldimethylsilyl chloride 99 
(2.2 eq) in pyridine at room temperature for 12 h afforded the adduct 100 in 
excellent 63% yield (Scheme 36).  
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Scheme 36. Reagents and conditions: a) DMAP, 99, pyridine, CH2CI2, room temperature, 12 
h, 63% 
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Cleavage of all protecting groups of adduct 100 was achieved by initial 
treatment with HF-pyridine using THF as solvent at 0 °C, allowing the 
resultant mixture to warm up to room temperature overnight, affording 3,5-
DCQA 11 in an excellent 92% yield following isolation and purification by 
column chromatography (Scheme 37).  
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Scheme 37. Reagents and conditions: a) HF-pyr, THF, 0 ºC to room temperature, 12 h, 
92%. 
 
Comparison of the spectral data obtained for the synthesised 3,5-DCQA 11 
with that from a previous report was undertaken,113 the results of which are 
presented below (Table 9). 
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Table 9. 1H and 13C NMR data comparison of the natural and synthetic 3,5-DCQA 11. 
 Natural Synthetic 
Position     δ  1Ha            δ 13Ca          δ  1Ha                        δ 13Ca 
Ph-OH     -                  -       9.59                             - 
Ph-OH     -                  -       9.16                             - 
7ʼ        7.48            144.2         7.47                        146.0 
7ʼʼ        7.46            144.2        7.46                        146.0 
2ʼ        7.05            114.3        7.04                        115.2 
2ʼʼ        7.03            114.3        7.05                        115.2 
6ʼ        7.00            120.9        7.00                        121.7 
6ʼʼ        6.97            120.9        6.99                        121.8 
5ʼ        6.76            115.4        6.77                        116.4 
5ʼʼ        6.76            115.4        6.77                        116.4 
8ʼ        6.22            114.4        6.20                        114.6 
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 Natural Synthetic 
8ʼʼ        6.22            114.4        6.19                        114.6 
5 or 3        5.27            71.1        5.25                         70.3 
1-OH     -                  -     4.95                            - 
4-OH     -                  -     4.59                            - 
5 or 3        5.16            72.5        5.12                         71.2 
4        3.72            69.9        3.65                         67.8 
2ax        2.11            35.9        2.37-2.26                 34.5 
2eq        1.76            35.9        2.37-2.26                 34.5 
6ax       1.94             38.8       1.95-1.88                  36.1 
6eq        1.81            38.8       1.95-1.88                  36.1 
            a In ppm, relative to DMSO-d6. 
 
No significant differences were identified between the 1H NMR spectra of the 
natural and the synthetic 3,5-DCQA 11 (Figure 29). Differences of between 
0.02 to -0.03 ppm were observed between the 1H NMR spectra of the natural 
and synthetic 3,5-DCQA 11. 
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Figure 29. 1H NMR chemical shift differences (ppm) natural and synthetic 3,5-DCQA 11. 
 
The 13C NMR spectra of the synthetic product was similar to the natural. The 
differences in the 13C spectra for the natural and the synthetic forms of 3,5-
DCQA 11 were between 0.2 to -1.8 ppm (Figure 30).  
Figure 30. 13C NMR chemical shift differences (ppm) natural and synthetic 3,5-DCQA 11. 
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Figure 31. 1H NMR spectrum of 3,5-DCQA 11 in DMSO-d6. 
 
Figure 32. 13C NMR spectrum of 11 in DMSO-d6. 
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The infrared spectrum contained a broad absorption band at 3019 cm-1, and 
absorptions at 1717 cm-1, indicative of the alcohol functionality and carbonyl 
groups. The mass spectrum gave a signal at 515 corresponding to the 
molecular ion [M-H]- expected for C25H23O12 m/z = 515 [M-H]-. An accurate 
mass measurement confirmed the expected 515.1190 molecular formula of 
C23H25O12. 
 
The purity of compound 3,5-DCQA 11 was determined by reverse phase 
HPLC using a Kingsorb 5µ C18 column eluting with methanol and H2O 
(80:20), displaying a single peak in the UV (254nm) with a retention time of 
9.30 min (Figure 33). 
 
Figure 33. Reverse phase HPLC of compound 3,5-DCQA 11 after initial purification. 
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Conclusion 
 
A novel synthetic protocol for the synthesis of 3,5-DCQA 11 and its 
derivatives was developed the details of which were discussed. The strategy 
employed quinic acid as a reagent for the formation of these types of 
compounds. In the original approach the quinide 73 was assembled followed 
by the regioselective benzylation of the 3-hydroxyl group on 73. Compound 
68 was fully protected utilising the TBS ether protecting group which afforded 
69. Hydrogenolysis of the benzyl ether was eventually achieved with 
Pd/black after several attempts affording alcohol 70. However, in an 
unexpected reaction the silyl protecting group at the C-4 position underwent 
nucleophilic attack during the lactone hydrolysis step resulting in the 
cleavage of the silyl ether protecting group at the C-4 position to give 
compound triol 80. Coupling of triol 80 with diacetyl caffeoyl chloride afforded 
the undesired product 93. 
 
An alternative protocol was developed utilising an alternative protecting 
group strategy for the synthesis of 3,5-DCQA 11 and its derivatives. Quinide 
68 was protected using the TIPS protecting group affording 85. Hydrolysis of 
the lactone ring of 85, however lead to the cleavage of the silyl protecting 
group at the C-1 position. Debenzylation of 85 was achieved using Pd/C. In 
the last few steps of the synthesis triol 88 was coupled with 3-methoxyl-4-O-
tert-butyldimethylsilyloxycinnamyl chloride 95, 3,4-tert-butyldimethylsilyl 
caffeoyl chloride 99 and 3,4 dimethoxycinnamyl chloride 90 followed by 
cleaved of the silyl protecting groups. The target compounds 3,5-DCQA 11, 
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3,5-FQA 97, and 3,5-(3,4-dimethoxycinnamyl)quinic acid 92 were achieved 
over 7 steps in 30%, 36%, and 38% yield respectively. 
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Chapter Three 
 
3.0 Synthesis of 3,5-O-dicaffeoylquinic acid via 
Knoevenagel condensation 
 
In Chapter 2, the synthesis of 3,5-DCQA 11 was described by final 
esterification of a suitably protected quinic acid with 3,4-O-tert-
butyldimethylsilyl caffeoyl chloride. However, an alternative approach 
towards the synthesis of 3,5-DCQA 11 was also investigated. 
 
3.1 Retrosynthetic Analysis 
 
The general features of a second synthesis of 3,5-DCQA 11 are outlined in 
Scheme 38. The target compound 3,5-DCQA 11 could be formed via 
condensation of the aldehyde with malonate 106 using the Knoevenagel 
methodology developed by Smarrito et al.98 Advantageously, the 
condensation reaction does not require protection of the aldehyde or the 
dimalonyl quinic acid derivative 106, in contrast with the esterification 
methodology described in section 2.1, where the quinic acid fragment 88 had 
to be fully protected until the last step of the synthesis. Compound 106 can 
be derived in one step from intermediate 105. The fully protected 105 could 
be fashioned from diol 104 through a coupling reaction with Meldrum’s acid. 
The diol 104 can be obtained through cleavage of the silyl ether of 103. 
Benzylation of the carboxylic acid of 102 result in the formation of 
intermediate 103. Alcohol 102 could be obtained from hydrolysis of 101. 
Intermediate 101, can be derived in 3 steps from quinide 73. Compound 73  
can be prepared from quinic acid 5. 
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Scheme 38. Retrosynthetic analysis for 3,5-DCQA 11. 
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To begin, quinide 73 was selectively protected at the equatorial hydroxyl 
group (C-3) using a TBS ether according to the method of Glebocka et al.105 
The TBS protecting group was chosen because it was deemed robust 
enough to protect the 3-hydroxyl group of quinide 73 through several 
functional group manipulations. Thus, 73 was treated with imidazole in DMF 
at 0 °C, followed by addition of TBS chloride. The mixture was stirred at 0 °C 
for 30 min and then 1 h at room temperature to afford the protected diol 101 
in an excellent 83% yield after purification (Scheme 39). The structure of 101 
was conclusively confirmed by detailed analysis of the 1H NMR spectrum, 
which was found to be in close agreement with the original literature data.105 
Further confirmation was provided by mass spectral analysis, which gave a 
signal at 287 Daltons, corresponding to the molecular ion of expected for 
C13H24O5Si. 
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Scheme 39. Reagents and conditions: a) imidazole, DMF, TBS chloride, 0 °C for 30 min and 
1 h at room temperature, 83%. 
 
At this point a discussion on the selectivity of the equatorial hydroxyl over 
axial hydroxyl groups is pertinent. It was theorised that the low reaction 
temperature and the short reaction time led to the selective formation of 101, 
as the equatorial secondary hydroxyl group at C-3 is less hindered than the 
axial secondary hydroxyl group at C-4. However, when the reaction was 
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carried out at room temperature, we observed a mixture of TBS mono-
protection at 3- and 4-positions in a 50:50 ratio (Scheme 40). The 2D 1H, 29Si 
correlation experiment shows the present of two silyl groups, one at C-3 and 
the other at C-4 position (Figure 34). 
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Scheme 40. Reagents and conditions: a) imidazole, DMF, TBS chloride, room temperature 
,1h, 50% (101), 50% (108). 
 
Figure 34. 1H, 29Si-HMBC 
 
The regioselective O-silylation of the equatorial hydroxyl group of 73 has also 
been described by Manthey et al.97 using TBS chloride in DMF containing 
tetrabutylammonium iodide and triethylamine at 0 °C for 6 h. Under these 
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conditions the observed a mixture of TBS protection at the 3- and 4- position 
in a 97:3 ratio. 
 
The next goal was the O-benzylation of both the 1- and 4-hydroxyl groups 
(Scheme 41). In the event, exposure of diol 101 to a cold solution (0 °C) of 
sodium hydride in DMF, followed by addition of benzyl bromide afforded 
lactone 102 in 30% yield after column chromatography.99 The low yield in this 
reaction probably reflects the difficulties in the protection of the hindered 
tertiary hydroxyl group at C-1.97 
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Scheme 41. Reagents and conditions: a) DMF, NaH, BnBr, 0 °C for 30 min and 21 h at 60 
°C, 60%. 
 
After extensive experimental work, It was observed that the best conditions 
for the protection of the 1- and 4- hydroxyl groups involved warming the 
reaction up to 60 °C for 12 h as shown in Table 10. Under these conditions, 
the desired lactone 102 was obtained in 60% yield. 
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           Table 10. Reaction conditions for the dibenzylation of diol 101.  
Entry Reagent Solvent Temp Time (h) Product Yield % 
1 NaH/BnBr DMF r.t 3 h 102 15% 
2 NaH/BnBr DMF r.t 6 h 102 18% 
3 NaH/BnBr DMF r.t 12 h 102 31% 
4 NaH/BnBr DMF 60 °C 3 h 102 40% 
5 NaH/BnBr DMF 60 °C 12 h 102 60% 
 
The 1H NMR spectrum of 102 displays the appropriate resonances (Figure 
35). Notably, the aromatic protons appear as a multiplet at between δ 7.33-
7.14 ppm. The benzylic protons for 4-OCH2Ph and 1-OCH2Ph appear as an 
AB system patterns at δ 4.74-4.37 ppm and δ 4.49-4.45 ppm, respectively, 
with geminal coupling constants around 11.0 to 12.0 Hz. (Figure 36). An 
accurate mass measurement gave a signal at 491.2230 Daltons, 
corresponding to the sodium adduct [M+Na]+ for C27H36O5SiNa . 
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Figure 35. 1H NMR spectrum of 102 in DMSO-d6. 
 
Benzylation was followed by base catalysed hydrolysis of the lactone 102 in 
THF/H2O at room temperature for 12 h, which afforded the desired product 
103 in 90% yield (Scheme 42). 
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Scheme 42. Reagents and conditions: a) NaOH, THF-H2O, room temperature, 12 h, 90%. 
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The 1H NMR spectrum of compound 103 showed some differences when 
compared with that for lactone 102. The benzylic protons of 1-OCH2Ph were 
shifted downfield to 4.38-4.28 ppm, (J = 11.0 Hz) (Figure 36). 
 
Figure 36. 1H NMR spectrum of 103 in DMSO-d6. 
 
The H-4 proton is not apparent in the 1H NMR due to overlap with the H2O 
signal from DMSO-d6. In this case a 2D NMR experiment was carried out to 
determine the position of the H-4. The position of this proton is clearly seen 
from the HSQC experiment, around 3.44 ppm (Figure 37). The infrared 
spectrum also shows the presence of the OH group at 3495 cm-1. Further 
confirmation came via High Resolution MS, which gave a signal at 485.2359 
Daltons, corresponding to the molecular ion expected for C27H37O6. 
 85 
 
Figure 37. HSQC spectrum of compound 103. 
 
Selective benzylation of the carboxylic acid 103 was achieved utilising the 
method of Montchamp et al.114 Compound 103 was treated with Cs2CO3 (0.5 
eq) in MeOH-H2O at room temperature for 10 min. The solvent was then 
evaporated followed by the addition of benzyl bromide in DMF at 0 °C for 1 h 
before being allowed to warm up to room temperature stirring for a further 10 
h. This gave alcohol 104 in an excellent 95% yield (Scheme 43). 
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Scheme 43. Reagents and conditions: a) Cs2CO3, MeOH-H2O, room temperature, then 
BnBr, DMF, 1 h, 0 °C then room temperature, 12h, 95%. 
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The 1H NMR spectrum of 104 displayed the expected resonances (Figure 
38). Notably, the new AB system at δ 5.21-4.98 ppm which can be attributed 
to the benzyl ester 1-CO2CH2Ph, with a geminal coupling constant around 
12.0 Hz. The two remaining AB systems at δ 4.70-4.58 and 4.46-4.04 ppm 
are from the benzyl ethers, at the 4- and 1-positions, respectively. The 
infrared spectrum contained a broad band at 3421 cm-1 and absorption at 
1654 cm-1 indicative of both the alcohol and carbonyl groups, respectively. 
An accurate mass measurement displayed a signal at 599.2797 Daltons 
corresponding to that expected for the sodium adduct C34H44O6SiNa. 
 
Figure 38. 1H NMR spectrum of 104 in DMSO-d6. 
 
Having served its purpose, the TBS ether protecting group at C-3 position 
was then removed. Reaction of alcohol 104 with TBAF in THF resulted in 
cleavage of the TBS ether, but also the unexpected formation of the quinide 
 87 
lactone 109 (Scheme 44). The 1H NMR spectrum of 109 clearly shows the 
loss of the AB system for benzyl ester (Figure 39). 
 
aOH OBnTBSO
OBn
104
O OBn
HO
OBn
OBn
O
O
109
+
CH2OH
 
Scheme 44. Reagents and conditions: a) TBAF, THF, room temperature, 6 h, 88%. 
 
 
Figure 39. 1H NMR spectrum of 109 in DMSO-d6. 
 
The HSQC spectrum shows that the multiplet at 5.13-5.18 ppm, is made up 
of two protons, which do not correlate with any carbon atom and must 
therefore be due to the hydroxyl groups (2 × OH) (Figure 40). 
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Figure 40. HSQC spectrum of compound 109. 
 
The COSY NMR experiment showed that one of the OH groups couples with 
the doublet CH2 at 4.45 ppm. This suggests the presence of a free benzyl 
alcohol (Figure 41). Further confirmation was provided by mass spectral 
analysis, which gave a signal at 354 Daltons, corresponding to the molecular 
ion of expected for C21H22O5. 
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Figure 41. COSY spectrum of lactone 109. 
 
Several attempts were made to cleave the TBS protecting group without the 
formation of the lactone ring, the results of which are shown below (Table 
11). 
 
Table 11. Attempt for the synthesis of diol 105. 
Entry Reagent Temp Time (h) Product Yield % 
1 TBAF r.t 6 109 87% 
2 TBAF r.t 3 109 69% 
3 TBAF r.t 1 105+109 58%+42% 
4 TBAF r.t 0.5 105+109 91%+9% 
5 TBAF 0 °C 0.5 105+109 91%+9% 
6 TBAF 0 °C 1 105+109 69%+31% 
7 TBAF 0 °C 3 109 55% 
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In all cases, both lactone 109 and unreacted starting material were isolated. 
Decreasing the reaction temperature to 0 °C and reducing the duration of the 
reaction gave lactone 109 and starting material. A proposed mechanism for 
this reaction is shown below (Scheme 45). Compound 104 is particularly 
base-sensitive and cyclises quickly to form the lactone in the presence of 
fluoride (F-). The hydroxyl group is deprotonated by fluoride ion followed by 
intramolecular attack at the carbonyl to form the lactone.  
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Scheme 45. Proposed mechanism of the lactone formation. 
 
The strategy for resolving this problem was based upon treatment of alcohol 
104 with TFA in THF at 0 °C before allowing the reaction warm up to room 
temperature and then stirring at this temperature for a further 12 h. This 
methodology was utlised by White et al.115 in the synthesis of cis-9,10-
dehydroepothilone D. The White group removed two TBS ether protecting 
groups using trifluoroacetic acid in CH2CI2 at 0 °C for 8 h in the presence of 
base sensitive protecting groups.115  
 
In the event, reaction of alcohol 104 with trifluoracetic acid115 or HF-
pyridine112 in THF at 0 °C before warming to room temperature and stirring 
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for 12 h successfully furnished compound 105 a good in 89% yield, setting 
the stage for the endgame of the synthesis (Scheme 46). 
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Scheme 46. Reagents and conditions: a) TFA or HF-pyridine, THF, 0 °C to room 
temperature, 89%, 83%. 
 
1D and 2D NMR experiments were carried out to confirm the structure of diol 
105. The 1H NMR spectrum of 105 displayed the appropriate resonances 
(Figure 42). The TBS ether protecting group at δ 0.83, 0.00 and -0.01 was 
absent but all the benzyl groups were still observed. The position of the 
methine proton H-4 was again not apparent from the 1H NMR spectrum due 
to overlap with the H2O signal from the DMSO-d6 solvent as shown 
perviously for lactone 109. The HSQC NMR experiment revealed the 
presence of H-4 at around δ 3.48 ppm (Figure 43). Further confirmation was 
provided by mass spectral analysis, which gave a signal at 485 Daltons 
corresponding to the sodium adduct ion expected for C28H30O6Na. 
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Figure 42. 1H NMR spectrum of diol 105 in DMSO-d6. 
 
Figure 43. HSQC spectrum of compound diol 105. 
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A critical stage in the synthesis was thus reached. The next task was 
coupling of the diol 105 with Meldrum’s acid, employing the methodology of 
List et al.116 The diol 105 was treated with 2.1 eq of Meldrum’s acid in toluene 
under reflux for 3 h.117 However, under these conditions the desired product 
was not obtained. Instead compound 110 was isolated in 73% yield (Scheme 
56) with 1H NMR spectrum showing the loss of the benzyl ester at 5.24-5.09 
ppm (Figure 44). Further confirmation was provided by mass spectral 
analysis, which gave a signal at 372 Daltons, corresponding to the molecular 
ion of expected for C21H24O6. 
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Scheme 47. Reagents and conditions: a) Meldrum’s acid, toluene reflux, 3 h,THF, 73%. 
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Figure 44. 1H NMR spectrum of 110 in acetone-d6. 
 
The experimental conditions were then altered to attempt to obtain the 
desired product and the results are shown below in Table 12. Treatment of 
diol 105 with Meldrum’s acid in toluene at room temperature for 6 or 12 h, 
failed to produce the desired product. However, changing the temperature 
from room temperature to 60 °C afforded the malonate 106 in a good 79% 
yield with retention of all the benzyl protecting groups (Scheme 48). 
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Scheme 48. Reagents and conditions: a) Meldrum’s acid, 4 h, 60 °C, 79%. 
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The mechanism for reaction of Meldrum’s acid with diol 105 is shown on 
Scheme 49. 
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Scheme 49. Mechanism of reaction of Meldrum’s acid with the diol 106. 
 
In the 1H NMR spectrum the methylene groups of the malonates were 
impossible to see due to the overlap with H2O signal from the DMSO-d6 
(Figure 45). Attempts to dissolve this compound in different solvents (CDCI3, 
acetone-d6, methanol-d4, and acetonitrile-d3) were unsuccessful. 
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Figure 45. 1H NMR spectrum of adduct 106 in DMSO-d6. 
 
The 2D NMR experiments, in particular the HSQC experiment, showed the 
presence of a CH2 (Figure 46). Further confirmation was provided by mass 
spectral analysis, which gave a signal at 657 Daltons, corresponding to the 
molecular ion of expected for C34H34O12. 
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Figure 46. HSQC spectrum of 106. 
 
The HMBC experiments showed two carbonyls at around 168 and 166 ppm 
which showed connectivity with the CH2 groups of the dimalonate. The 
resonance with the lower chemical shift shows connectivity with the H-3 or H-
5 (Figure 47). 
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Figure 47. HMBC spectrum of adduct 106. 
 
1D NMR experiments at 330 K were also conducted, in order to visualise the 
CH2 more clearly (Figure 48). The CH2 signal of the malonate appeared at δ 
3.23-318 ppm (AB system, J = 16.0 Hz). 
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Figure 48. 1H NMR spectrum of 106 in DMSO-d6 at 330K. 
 
The next step was cleavage of all three benzyl groups. Initial 10% Pd/C-
catalysed hydrogenolysis failed to produce the desired product. The starting 
material was fully recovered. Increasing the reaction temperature to 60 °C 
resulted in addition to removal of the benzyl groups, hydrolysis of both 
malonate esters (Scheme 50). It was believed that the hydrolysis of the 
malonate esters occurred because of acid contamination in the palladium 
catalyst. 
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Scheme 50. Reagents and conditions: a) Pd/C, EtOH, 60 °C, 12 h, quantitative yield. 
 
To avoid this problem, it was decided to use Pd(OH)2 in EtOH at room 
temperature under a hydrogen atmosphere for 36 h. Under these 
experimental conditions the desired diol 107 was successfully obtained in 
quantitative yield (Scheme 51) 
 
a O
O
O
OH
CO2H
OHO OH
O
OH
O
O
O
O
OBn
CO2Bn
OBnO OH
O
OH
O
106 107  
Scheme 51. Reagents and conditions: a) Pd(OH)2, EtOH, room temperature, 36 h, 
quantitative yield. 
 
The 1H NMR spectrum confirmed the structure of diol 107, via the absence of 
all the signals due to the benzyl protecting groups. Further confirmation was 
provided by mass spectral analysis, which gave a signal at 387.0541 
Daltons, corresponding to the molecular ion expected for C13H16O12. 
 
In the final step of the synthesis, the List et al.116 protocol was adapted. 
Treatment of diester 107 with DMAP, 3,4-dihydroxybenzaldehyde and a 
catalytic amount of piperidine in anhydrous DMF at room temperature for 8 
days afforded the desired 3,5-DCQA 11 in 68% yield (Scheme 52). Spectral 
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data were identical to those reported for 3,5-DCQA 11 in chapter two, which 
were identical to previous literature data.  
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Scheme 52. Reagents and conditions: a) 3,4-dihydroxybenzaldehyde, DMAP, piperidine, 
room temperature, 8 days, DMF, 68%. 
 
Conclusion 
 
The development of a novel protocol for the synthesis of 3,5-DCQA 11 was 
described. Using this protocol the synthesis of 3,5-DCQA 11 was achieved in 
a 20% overall yield over eight steps. While this is fewer synthetic steps and 
poorer overall yield than the synthesis in Chapter 2 it is the preferred one. 
Only two of the eight steps require column chromatography, all other steps 
can be used without further purification.  The previous seven steps synthesis 
requires extensive purification at each step. As such the eight step process is 
preferred as material can be accessed more quickly. Additionaly the reagents 
used are less toxic and in particular the use of tin is no longer required. In the 
final step of the synthesis, following the deprotection of the dimalonyl quinic 
acid derivative 107, the (E)-double bond was formed by condensation of the 
aldehyde with malonate. Advantageously this condensation reaction did not 
require protection of the phenol and or the dimalonyl quinic acid derivative 
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107. This was in contrast with the previous methodology, which required the 
protection of the quinic fragment until the final step of the synthesis. Using 
this approach the purification of the target molecule was easier in 
comparison with the methodology described in Chapter 2. This methodology 
could be applied in the future to the synthesis of unsymmetrical derivatives of 
3,5-DCQA 11. 
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Chapter Four 
 
4.0 Synthesis of possible metabolites of quinic acid 
conjugates 
 
 
4.1 Introduction 
 
It was decided to investigate the synthesis of compound 132 because there 
is evidence that such molecules are metabolised by glucuronidation. 118 
 
Glucuronidation is a major phase II pathway for drug metabolism,118, 119 
where it is common in the metabolism of a range of endo- and xenobiotics. 
After gluruconic acid conjugation, the substances become more hydrophilic 
and are more easily excreted from the body.120  
 
O-Glucuronides can be divided into three classes by their aglycone groups: i) 
aryl (paracetamol glucuronide 112), ii) alkyl (11β-hydroxyprogesterone 
glucuronide 113 and iii) acyl (valproic acid glucuronide 114).121 They are 
generally the β-anomers 
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In fact, some of the same synthetic methods may be used for both aryl and 
alkyl glucuronides, and both of these exhibit good chemical stability.121, 122 
 
4.2 Chemical synthesis of Glucuronides 
 
4.2.1 The Knoenings-Knorr method 
 
One of the most traditional method for the synthesis of glucuronide, is the 
Knoenigs-Knorr method. The Knoenigs-Knorr method uses 1α-bromo sugar 
115 as donor in the synthesis of a wide range of alkyl and aryl 
glucuronides.123 The mechanism involves elimination of AgBr followed by the 
formation of a 1,2-acyloxonium ion 116 by the participation of the adjacent 
acetyl group. The alcohol nucleophile attack from the β-face to give the β-O-
glucuronide 117 (Scheme 53). 
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Scheme 53. The Koenigs-Knorr reaction.123 
 
The acetyl groups can be removed by a selection of methods, such as 
MeONa/MeOH,124 KCN/EtOH,125 K2CO3/MeOH,126 and Et3N/MeOH.127 
 
In 1956 Lunsford et al.128 described the synthesis of O-carboxyphenyl β-D-
glucopyranosiduronic acid 118 using 1α-bromo sugar 115 and silver oxide 
(Scheme 54). 
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Scheme 54. Reagents & Conditions: a) methyl salicylate, isoquinoline, silver oxide, 0 °C, 20 
min, 57%.128 
 
Hosoda et al.129 described the synthesis of 20β-cortolonic acid 3-
glucuronides 121 using the Koenigs Knorr methodology (Scheme 55). 
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Scheme 55. Reagents & Conditions: a) toluene, silver carbonate, room temperature, 20 h, 
57%. b) potassium hydroxide, MeOH, room temperature, 3h.129 
 
4.2.2 Trichloroacetimidate method (Schmidt) 
 
Schmidt’s pioneering studies on glycosidation using trichloroacetimidates 
have led to an increase in their application to glucuronidation.130 The 
relatively mild catalysis required and very high β-stereoselectivity make 123 
an attractive intermediate. Glucuronyl trichloroacetimidates can be prepared 
using a variety of methods. In fact, both the α-and β-anomers of the 
glucuronyl trichloroacetimidates can be prepared in pure form depending on 
which base is used for the deprotonation of the hemiacetal 123. In 1984 
Grundler and Schmidt131 showed the synthesis of both α-and β-anomers of 
glycosyl trichloroacetimidates. The α anomer (axial) can be obtained using 
NaH, CCI3CN in CH2CI2 at room temperature,132 while the β-anomer 
(equatorial) can be achieved using a weak base K2CO3 and CI3CCN at room 
temperature.133 
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Scheme 56. Reagents & Conditions: a) CI3CCN, base.120 
 
In 2007, Engstrom et al.134 described the synthesis of a glucuronide 
metabolite of ABT-751 125 employing the Schmidt trichloroacetimidate 
methodology (Scheme 57) in the presence of BF3-Et2O. ABT-751 125 is used 
in the treatment of pediatric neuroblastoma. 
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Scheme 57. Reagents & Conditions: a) BF3.Et2O, CH2CI2, room temperature, b) LiOH-H2O, 
MeOH, room temperature.134 
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Glucuronides can also be synthesised by enzymatic methods. Enzymes that 
are involved in the glucuronidation of xenobiotics are known as UDP-
glucuronosyltransferases (UDPGTs). UDPGTs are transmembrane proteins 
located in the endoplasmic reticulum of cells from a number of tissues 
especially the liver.121 The families of UDPGTs play an important role in the 
metabolism of a variety of endogenous and various food chemicals.121 
 
The proposed mechanism involved in the glucuronidation of substance 
(ROH) is illustrated in Scheme 58. The enzymatic glucuronidation reaction is 
believed to be a SN2 reaction where the aglycone substrate (ROH) attacks 
the UDPG 126.121 The reaction inversion an inversion of configuration, thus 
converts the glucuronic acid from the α- to the β-anomer 127. 
 
OHO
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HO2C
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UDP
+ UGT OHOHO
OH
HO2C
O-R + HO-UDP
R-OH
126 127  
Scheme 58. Glucuronidation of compound ROH. The UGT-catalysed reaction produces β-D 
-glucuronides from α-anomeric UDP and aglycone substrate. 
 
4.3 Retrosynthetric Analysis 
 
The strategy adopted for the synthesis of 131 involved the coupling of sugar 
130 with 107 for which the Knoevenagel condensation methodology could be 
employed. It was decided to employ Schmidt trichloroacetimidate 
glycosidation methodology to assemble a glucuronidated vanillin derivative. 
The Schmidt methodology has been successfully employed to make a 
number of phenol glucuronides. The aldehyde could then be attached to the 
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3,5-dimalonyl derivative of quinic acid 130, prepared previously, via the 
Knoevenagel condensation reaction. The glucuronyl trichloroacetimidate 123, 
would be assembled stepwise from D-glucurono-6,3-lactone 128 in 3 steps 
(Scheme 59). 
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Scheme 59. Retrosynthetic analysis for compound 131. 
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4.2 Synthesis of Glucuronyl Donor 
 
The sugar 132 was synthesised utilising the method of Nakajima et al.135 A 
catalytic amount of sodium hydroxide was dissolved in methanol followed by 
treatment with D-glucurono-6,3-lactone 128. Further portions of sodium 
hydroxide were added to achieve a pH of 8-9 and the reaction stirred at room 
temperature for 1 h affording 132 as a viscous oil (Scheme 60). 
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Scheme 60. Reagents & conditions: a) NaOH, MeOH,room temperature,1h. 
 
The mechanism for the lactone hydrolysis under basic condition is shown in 
Scheme 60. The reaction was initiated by the nucleophilic attack of methanol 
on the carbonyl of the lactone. The tetrahedral intermediate formed quickly 
collapses back to a carbonyl centre via the opening of the five member ring, 
generating a free hydroxyl group. Finally, the aldehyde for the ribofuranose 
ring, which is in equilibrium with its hemiacetal form, undergoes alternative 
ring closing with the free OH group, that forms farvourable pyranose six-
membered ring structure 132. 
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Scheme 61. Mechanism of lactone hydrolysis. 
 
Acetylation of crude 132 with acetic anhydride and pyridine at 30 °C for 16 h 
resulted in the formation of compound 129 in quantitative yield over two 
steps (Scheme 62).136 The 13C and 1H NMR spectral data showed that 129 
contained one anomeric 13C at δ 91.3 (C-1) that correlated to the proton 
signal at δ 6.42 (1H, d, J = 7.7 Hz, H-1) indicating the presence of one sugar 
unit in the beta form. 
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Scheme 62. Reagents & conditions: a) acetic anhydride, pyridine, 30 °C, 16 h, quant. 
 
With a substantial quantity of 129 in hand, attention was focused on the 
selective deacylation of the acetyl group, using ethylenediamine in THF at 
room temperature.137 Extensive monitoring of the reaction by TLC showed 
one product after 2 h, which was more polar than the starting material 
(Scheme 63). Purification by column chromatography afforded the 2,3,4,6-O-
protected sugar as a mixture of α-and β-anomers (1:1.4). The 13C NMR 
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spectroscopic data revealed the presence of only three acetyl carbons 
between 20.9 ppm and 21.0 ppm respectively. 
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Scheme 63. Reagents & conditions: a) ethylenediamine, THF, room temperature 2 h, quant.  
 
Under these conditions, the reaction could not be run at room temperature 
for more than 2 h, because the fully deacylated product compound was 
obtained from compound 129 (Table 12). An alternative procedure by Zhang 
et al.137 used ethylenediamine in a mixture with acetic acid to overcome this 
problem. 
 
Table 12. Selective deacylation of anomeric center  
Entry Ethylenediamine Solvent Time (h) Temperature Product Yield % 
1 1.1 eq THF 1 r.t 129 + 122 41%+69% 
2 1.1 eq THF 2 r.t 122 99% 
3 1.1 eq THF 8 r.t 132 95% 
 
 
The resulting hemiacetal 122 was then used for the preparation of the 
glucuronyl trichloroacetimidate. Treatment of hemiacetal 122 with DBU in 
CH2CI2 led to the anomeric oxyanion, which added across the nitrile bond of 
trichloroacetonitrile affording the desired glucuronyl trichloroacetimidate 
donor 123 (Scheme 64). 
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Scheme 64. Reagents & conditions: a) DBU, CI3CCN, CH2CI2, 0 °C to room temperature, 2 
h, 93%. 
 
The 1H NMR spectrum of the glucuronyl trichloroacetimidate donor 123 
displayed the appropriate resonances (Figure 49). The appearance of an NH 
proton singlet at δ 8.74 ppm confirmed the formation of the glucuronyl 
trichloroacetimidate donor 123. The anomeric proton H-1 appeared as a 
doublet, with a small coupling constant of J = 3.5 Hz. The coupling constant 
of J = 3.5 Hz is indicative of an axial-equatorial coupling between H-1 and H-
2 which suggests that only the alpha anomer was formed. The anomeric 
proton appears at δ 5.59 ppm due to the electron withdrawing glucuronyl 
trichloroacetylimidoyl group. The protons on H-3 and H-4 appear as triplets at 
δ 5.64 ppm and 5.28 ppm with coupling constants of 10.1 Hz. The H-2 proton 
appears as a doublet of doublets at 5.16 ppm with a coupling constants of 
3.5 Hz and 10.1 Hz. The H-5 proton appears as a doublet at δ 4.51 ppm with 
a coupling constant of 10.1 Hz. The remaining protons are attributed to the 
methyl ester (3.76, s, 3H) and acetyl-CH3 (2.08, 2.07, 2.04). 
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Figure 49. 1H NMR spectrum of 123 glucuronyl trichloroacetimidate donor in CDCI3 . 
 
With the glucuronyl trichloroacetimidate donor 123 in hand, it was assumed 
that vanillin could be coupled to 123 under suitable acidic conditions. 
However, treatment of a cooled (-50 °C) solution of 122 and vanillin in dry 
CH2CI2, containing pre-activated 4 Å molecular sieves, with boron trifluoride 
etherate, failed to give the desired product 130 (Scheme 65). 
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Scheme 65. Reagents & conditions: a) CH2CI2, BF3-Et2O, 0 °C to room temperature, 4 Å 
molecular sieves 2 h. 
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Unfortunately, all further attempts to couple 123 with vanillin also failed to 
generate the desired product. The results of these studies are summarised in 
Table 13. In entries 1 and 2, the reaction temperature was increased from -
50 °C to 0 °C, while for entries 3-5, the reaction temperature and reaction 
time were increased. In entries 6 and 7 both the reaction temperature as well 
as the quantity of the BF3-Et2O were increased. 
 
Table 13. Summary of studies conducted towards the synthesis of 133. 
Entry BF3•Et2O (eq) Temperature Time Results 
1 0.1 eq -50 °C 6 h no reaction 
2 0.1 eq 0 °C 6 h no reaction 
3 0.1 eq r.t 12 h no reaction 
4 0.1 eq r.t 24 h no reaction 
5 0.1 eq r.t 36 h no reaction 
6 0.5 eq r.t 12 h  no reaction 
7 1.0 eq r.t 24 h no reaction 
 
 
 
Attempts to resolve this problem were then focused on the Lewis acid 
catalyst used in the reaction. Unfortunately, a switch to TMSOTf also failed to 
afford the desired product 130.  
 
To overcome the poor reactivity of trichloroacetimidate donor 123. It was 
decided to utilised the N-(4-methoxylphenyl)trifluoroacetimidate donor 133 
methodology developed by Yu et al.138 and used previously in house.139, 140 
Former projects within the Botting group accomplished the synthesis of 
various isoflavone glucuronides using methyl 2,3,4-triacetyl-D-
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glucopyranosidunoryl 1-(N-4-methoxy-phenyl)-trifluoroacetimidate donor 133 
(Scheme 66).139, 140 
 
O
OMeO
O
AcO
AcO
CF3
N
OMe
O
O
O
O
MeO
HO
a
+
O
O
O
O
MeO
O
O
OMeO
AcO
AcOb
OH
O
O
MeO
O
O
OHO
OH
HO
HO
133 134
135136
AcO
AcO
 
 
Scheme 66. Reagents & conditions: a) CH2CI2, BF3•Et2O, room temperature, 4 Å molecular 
sieves, 6 h, 78% b) K2CO3, acetone, H2O, MeOH-THF, 40 °C, 5 h, room temperature, 
90%.139, 140 
 
This new strategy commenced with the synthesis of the methyl 2,3,4-
triacetyl-D-glucopyranosidunoryl 1-(N-4-methoxy-phenyl)-trifluoroacetimidate 
133, which was prepared from N-4-methoxyphenyltrifluoroacetimidoyl 
chloride 139. 
 
The N-4-methoxyphenyltrifluoroacetimidoyl chloride 139 was itself prepared 
by the reaction of trifluoroacetic acid 137 with 4-methoxyaniline 138, 
triphenylphosphine, triethylamine and carbon tetrachloride (Scheme 67). The 
structure of 139 was confirmed by analysis of the 1H NMR spectrum, which 
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was found to be in close agreement with the literature data.141 Further 
confirmation was provided by mass spectral analysis, which gave a signal at 
238 Daltons, corresponding to the expected molecular ion [M+H]+ for 
C4H5N3O3F5. 
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Scheme 67. Reagents & conditions: a) Ph3P, Et3N, CCI4, reflux, 3 h 91%.141 
 
Treatment of 121 with N-4-methoxyphenyltrifluoroacetimidoyl chloride 139 in 
the presence of K2CO3 in acetone and H2O at room temperature gave 
compound 140 as a mixture of α and β-anomers (1.22:1) in an excellent 76% 
yield (Scheme 68). 
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Scheme 68. Reagents & conditions: a) K2CO3, acetone, H2O, room temperature 3 h, 76%. 
 
The 1H NMR spectrum of the glucuronyl trifluoroacetimidate donor 140 
displayed the appropriate resonances, which were also in close agreement 
with the data reported by Al-Maharik and Botting140 (Figure 50). The aromatic 
proton appears as multiplet between δ 6.72-6.85 ppm. The anomeric protons 
Hα-1 and Hβ-1 appear as broad singlets at δ 6.46 and 5.85 ppm, respectively. 
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The H-2 proton appears as a doublet of doublets at δ 5.14 ppm with coupling 
constants of J = 10.2 and J = 3.9 Hz. Other resonances between δ 5.21 and 
5.34 ppm (3H, s), 4.42 ppm, 3.73 ppm, 3.76 ppm, 3.77 ppm, (12H, s), 2.016 
ppm, 2.02 ppm, 2.03 ppm, 2.05 ppm (18H, s) were attributed to the sugar 
moiety and the methoxy group of the aromatic ring. 
 
 
Figure 50. 1H NMR spectrum of glucuronyl trichloroacetimidate 140 in CDCI3. 
 
However, it was observed that the glucuronyl trifluoroacetimidate 140 was 
unstable at room temperature and was therefore kept at -78 °C. With donor 
140 in hand the next step was the synthesis of 130. Treatment of vanillin with 
the glucuronyl trifluoroacetimidate 140 donor in dry CH2CI2 containing pre-
dried 4Å molecular sieves and BF3-Et2O at room temperature for 6 h 
afforded the desired coupling product 130 in an excellent yield 81% (Scheme 
69). It is believed that the boron trifluoride initiated cleavage of the anomeric 
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trichloroacetimidate on 140 afforded the transient acetoxonium ion, which in 
turn subsequently reacted with the phenol group in a stereoselective fashion. 
In fact, the configuration of the anomeric carbon in 140 is not important to the 
stereochemical outcome of the glycosidation step because both anomers of 
140 couple streoselectively with the phenol to give the exclusively the β-
glucuronide 130. 
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Scheme 69. Reagents & conditions: a) CH2CI2, BF3•Et2O 0 °C to room temperature, 4 Å 
molecular sieves, 6 h, 81%. 
 
The 1H NMR spectrum of 130 displayed the appropriate resonances (Figure 
51). The appearance of a singlet at δ 9.89 ppm confirmed the presence of 
the aldehyde. The aromatic protons appeared as a doublet at δ 7.54 ppm (J 
= 8.1 Hz), a doublet of doublets at δ 7.52 ppm (J = 8.1, 1.8 Hz) and a doublet 
at δ 7.39 ppm (J = 8.1 Hz). The anomeric proton H-1 appeared as a doublet 
at 5.61 ppm with a large coupling constant J = 7.7 Hz. This coupling constant 
implied an axial-axial coupling between H-1 and H-2 which suggested that 
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only the β-anomer had been formed. The proton at H-3 appeared as a triplets 
at δ 5.48 ppm (J = 10.1 Hz) while those on H-2 and H-4 appeared as 
multiplets at between δ 5.31 and δ 5.22 ppm. The proton at H-5 appeared as 
a doublet at δ 4.51 ppm (J = 10.1 Hz). The H-5 proton appeared as a doublet 
at δ 4.60 ppm (J = 10.1 Hz). 
 
The remaining protons are attributed to the methyl ester (3.39, s, 3H), 
methoxy (3.92, s, 3H) and acetyl (2.03, 2.01, 2.00). The 13C NMR spectral 
data also showed that 130 contained one anomeric carbon at δ 99.6 ppm (C-
1) that correlated to the proton signals at δ 5.61 (1H, d, J = 7.7 Hz), indicating 
the presence of one sugar unit in the β-form. An accurate mass 
measurement displayed a signal at 491.1165 Daltons corresponding to that 
expected for the sodium adduct C21H24O12Na. 
 
Figure 51 1H NMR spectrum of 130 in Acetone-d6. 
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A key stage in the synthesis was thus achieved and attention was then 
turned to the deprotection of the acetyl protecting groups. An initial attempt 
involving treatment of 130 with K2CO3 in mixture of MeOH-THF and H2O at 
40 °C for 5 h failed to give the desired product 141 (Scheme 70). 
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Scheme 70. Reagents & conditions: a) K2CO3, MeOH-THF, H2O, 40 °C 5 h. 
 
Under these conditions, the acetyl protecting groups were only partially 
removed. A summary of the various conditions attempted during the 
optimisation of the conditions for the deprotection of the acetyl groups are 
shown below (Table 12). Treatment of 130 with 3 equivalents of K2CO3 in 
MeOH-THF and H2O at room temperature for 5 h failed to furnish compound 
141 (Entry 1). Increasing the temperature from room temperature to 40 °C 
also failed to give the desired product (Entry 2 and 3). Similarly, increasing 
the temperature and time of the reaction from 5 h to 3 days (Entry 4) and 
increasing the amount of K2CO3 used from 3 to 6 equivalents also failed 
(Entry 5).  
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Table 12. Reaction conditions for the deprotection of acetyl groups. 
Entry K2CO3 Solvent Temperature Time Product 
1 3 eq MeOH-THF r.t 5 h partial deacetylation 
2 3 eq MeOH-THF 40 °C 5 h partial deacetylation 
3 3 eq MeOH-THF 40 °C 24 h partial deacetylation 
4 3 eq MeOH-THF 40 °C 3 days partial deacetylation 
5 6 eq MeOH-THF 40 °C 6 days partial deacetylation 
 
 
After extensive experimental work, it was found that the best conditions for 
the deprotection involved treatment of 130 with LiOH in MeOH-H2O (50:50) 
at room temperature for 48 h (Scheme 71).142 Under these conditions the 
desired product was obtained in 71% yield. 
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Scheme 71. Reagents & conditions: a) LiOH, MeOH-H2O, room temperature, 48 h, 71%. 
 
The structure of 141 was confirmed by 1H NMR spectroscopy, which showed 
the absence of methoxy ester at δ 3.92 ppm (s, 3H), and acetyl groups at δ 
2.03 ppm, 2.01 ppm, 2.00 ppm (Figure 52). An accurate mass measurement 
displayed a signal at 327.0716 Daltons, corresponding to that expected for 
C14H16O9. 
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Figure 52. 1H NMR spectrum of 141 in D2O. 
 
In the final step of the synthesis, treatment of 141 with 107 in the present of 
DMAP and a catalytic amount of piperidine in anhydrous DMF at room 
temperature for 8 days failed to give the desired product 131 (Scheme 72).116 
 
 
 
 
 
Scheme 72. Reagents and conditions: a) DMAP, piperidine, room temperature, 8 days, 
DMF.  
 
In an attempt to further investigate the feasibility of this coupling reaction, a 
study was carried out with model substrate 142, which resembles the 
dimalonate functionality of 106. This was treated with 141 under the same 
conditions. However, no coupling products were observed after 8 days of 
reaction (Scheme 73). 
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Scheme 73. Reagents and conditions: a) DMAP, piperidine, room temperature, 8 days, 
DMF.  
 
A probable explanation for this failed reaction was due to the formation of 
anionic species for both substrates. The glucuronic acid moiety of 141, will 
become deprotonated and will exist as the glucuronate anion, while the 
dimalonic acids 107 and 142 will also become deprotonated, and probably 
exist as dimalonate species, under the basic reaction conditions.  
 
Since the two substrates exist as anions in the reaction mixture, the negative 
charges they carry will cause them to repel and avoid coming into proximity 
of each other, therefore hindering any reaction. 
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When the reaction was attempted with a crude mixture of partially 
deprotected product, coupling product was observed by MS and NMR. Thus, 
the failure may be attributed to the free carbonxylic acid on 141. 
Unfortunately the reaction gave an inseparable mixture of coupling products.   
 
 
Conclusion 
 
A novel synthetic strategy was developed and applied towards the synthesis 
of 3,5-FQA glucuronyl. The synthesis of glucuronyl trichloroacetimidate 123 
was accomplished over 3 steps. However, the coupling of glucuronyl 
trichloacetimidate 123 with vanillin proved to be more difficult than originally 
anticipated. The coupling reaction was achieved using a coupling protocol 
developed within the Botting group for the synthesis of isoflavone 
glucuronides. This new strategy employed glucuronyl trifluoroacetimidate 140 
as the donor. The glucuronyl trifluoroacetimidate 140 was coupled with 
vanillin in a stereoselective fashion affording compound 130. Cleavage of the 
protecting groups from 130 was achieved after several attempts with LiOH in 
H2O-MeOH for 36 h. In the final step of the synthesis a Knoevenagel 
condensation reaction of 141 and a dimalonate ester of quinic acid 107 failed 
to give the target compound 131. 
 
 
 
 
 
 
 127 
Chapter Five 
 
5.0 Attempted synthesis of unsymmetrical quinic acid 
conjugates 
 
In this chapter the studies undertaken in an attempt to synthesise 
unsymmetrical quinic acid conjugates are described. The synthesis of these 
unsymmetrical quinic acid conjugates are based on the previously developed 
methodology described in chapters 2 and 3. 
 
5.1 Retrosynthetic Analysis 
 
A proposed strategy for the synthesis of an unsymmetrical quinic acid 
conjugate is depicted below (Scheme 74), which would have a 
dimethoxycinnamyl ester at C-5 and a ferulyl ester at C-3. It was envisioned 
that the protected quinic acid 87 could be reacted with Meldrum’s acid to 
afford the intermediate 143. Cleavage of the benzyl ether by hydrogenolysis 
would then leave the 3-hydroxyl group free for reaction. At this point a 
cinnamyl group could be attached via a simple esterification reaction. 
Removal of the TIPS group would then be followed by Knoevenagel 
condensation with vanillin to attach a ferulyl group at C-5. 
 
 
 
 
 
 
 
 
 128 
 
OHBnO
OTIPS
OH
CO2H
OHBnO
OTIPS
O
CO2H
OH
O
O
OHHO
OTIPS
O
CO2H
OH
O
O
OHO
OTIPS
O
CO2H
OH
O
O
O
H3CO
H3CO
OHO
OH
O
CO2HO
H3CO
H3CO
O
OCH3
OH
147
144 145
143 87
OHO
OH
O
CO2H
OH
O
O
O
H3CO
H3CO
146
 
 
Scheme 74. Retrosynthetic analysis of unsymmetrical quinic acid conjugates. 
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5.1 Synthesis of unsymmetrical quinic acid conjugates 
 
The first step of the synthesis involved the refluxing of diol 87 in toluene with 
1.1 eq of Meldrum’s acid for 3 hours.117 Under these conditions the desired 
product 143 was obtained in a moderate 45% yield (Scheme 74). The 
structure of the malonate 143 was confirmed by both 1H NMR and mass 
spectrometry (m/z 524 corresponding to the molecular ion [M+H]+ expected 
for C26H40O9Si). When, the amount of Meldrum’s acid was increased to 2.0 
eq, this afforded the fully protected compound 148 (Scheme 75). 
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Scheme 75. Reagents & conditions: a) Meldrum’s acid (1.1 eq), toluene, 3 h, reflux, 45% b) 
Meldrum’s acid (2.0 eq), toluene, 3 h, reflux, 89%. 
 
With malonate 143 in hand, the next step was the cleavage of the benzyl 
protecting group at the 3-position. This was achieved by hydrogenolysis 
using 10% Pd/C in EtOH at room temperature for 58 hours. These conditions 
afforded the desired product 144 in an excellent 98% yield (Scheme 76). 
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Scheme 76. Reagents & conditions: a) 10% Pd/C, EtOH, room temperature, 48 h, 60%. 
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The structure of compound 144 was confirmed once again by both 1H NMR 
spectroscopy and mass spectrometry (m/z 434 corresponding to the 
molecular ion [M+H]+ expected for C19H34O9Si).  
 
Completion of the synthetic sequence to give 147 would require the coupling 
of 144 with 3,4-dimethoxycinnamyl chloride 90 to give 145 followed by the 
cleavage of the silyl protecting group (Scheme 77).  
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Scheme 77. Proposed final stages in the synthesis of 146. Proposed Reagents and 
conditions: a) DMAP, 3,4-dimethoxycinnamoyl chloride, pyridine, CH2CI2, room temperature, 
12 h; b) HF-pyr, THF, 0 ºC to room temperature, 12 h. 
 
It was envisioned that the final step of the synthesis could be achieved by the 
Knoevenagel condensation of 146 and vanillin to afford the target compound 
147 (Scheme 78). 
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Scheme 78. Proposed final stages in the synthesis of 147. Proposed Reagents and 
conditions: a) 3,4-dihydroxybenzaldehyde, DMAP, piperidine, room temperature, DMF. 
 
 
Conclusion 
 
An attempt was made to synthesise unsymmetrical conjugates of 3,5-DCQ 
utilising the methodology previously developed and described in Chapters 2 
and 3. The strategy is based on the late stage Knoevenagel condensation 
reaction between the advanced of intermediate 146 and vanillin. Some 
progress has so far been made, however due to the time constrains the last 
steps of the synthesis are yet to be completed. 
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Chapter Six 
 
Conclusion and Future work 
 
In conclusion, novel synthetic methodologies for the synthesis of 3,5-DCQA 
and its derivatives were developed. Two distinct synthetic protocols were 
developed both of which utilise quinide 73 as a starting point. In the original 
protocol, (a 7 step sequence beginning with quinic acid 2), the key steps 
involved are the regioselective benzylation of the C-3-hydroxyl group 
followed by silyl protection of the 1- and 4- hydroxyl groups. Deprotection of 
the benzyl group by hydrogenolysis and opening of the lactone ring provided 
the 3,5 diol. In the final steps of the synthesis 3,5-DCQA derivatives were 
prepared by selective esterification of the secondary hydroxyl groups 
followed by removal of the silyl protecting groups.  
 
In the alternative route, (an 8 step sequence begining with quinic acid 2), the 
key step is the late stage Knoevenagel condensation between vanillin and a 
malonate ester of quinic acid 107. Using this protocol, the target molecule 
was obtained directly without protection of the quinic acid fragment 107. 
 
In chapter four the synthesis of compound 131 was described. The synthesis 
of advanced intermediate 130 was achieved in 6 steps starting from 128. The 
key intermediate 140 was prepared in a 5 step sequence starting from D-
glucurono-6,3-lactone 128. The second intermediate, malonate 107, was 
prepared by esterification of the quinic fragment with Meldrum’s acid. In the 
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final step of the synthesis a Knoevenagel condensation reaction of 141 and a 
malonate ester of quinic acid 107 failed to give the target compound 131. 
 
In the final Chapter, an attempt to adapt the methodologies developed in 
Chapters 2 and 3 to the synthesis of unsymmetrical quinic acid conjugate 
was described. The key intermediate in this sequence was the malonate 144, 
which could then be coupled to 3,4-dimethoxycinnamyl chloride 90 thus in 
turn allowing the synthesis of the unsymmetrical quinic acid conjugates 147 
to be completed  
 
In future it is envisaged that these methodologies could be applied to the 
synthesis of various unsymmetrical quinic acid conjugates or for the 
synthesis of potential human metabolites. A possible approach to the 
synthesis of sulfated conjugates is depicted below, (Scheme 78).  
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Scheme 78. Proposed synthesis of 150. Proposed Reagents and conditions: a) NaHMDS, 
THF, -15 °C, 20 min. b) sodium azide, DMF, 70 °C, 12 h. 
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Experimental Procedures 
 
General Procedures 
 
Proton (1H), carbon (13C) and fluorine (19F) NMR spectra were recorded on a 
Bruker Avance 300 spectrometer operating at 300.1 MHz for 1H, 75.5 MHz 
for 13C and 282 MHz for 19F, Bruker Avance II 400 operating at 400.1 MHz for 
1H and 100 MHz for 13C and Bruker Avance 500 operating at 499.90 MHz for 
1H, 125.71 MHz for 13C and 470.26 for 19F. Chemical shifts were recorded at 
δ values in parts per million (ppm). Spectra were acquired in CDCl3, DMSO-
d6, CD3OD, acetone-d6 or deuterium oxide at ambient temperature unless 
otherwise specified. For 1H and 13C NMR spectra recorded in CDCl3, DMSO-
d6, CD3OD and deuterium oxide, the peak due to residual CDCl3 (7.27 ppm 
for 1H, 77.00 ppm for 13C), DMSO-d6 (2.5 ppm for 1H, 39.5 ppm for 13C), 
CD3OD (3.31, 4.79 ppm for 1H, 49 ppm for 13C) or water (4.72 ppm for 1H) 
was used as the internal reference. 1H NMR data are reported as follows: 
chemical shift (δ), relative integral, multiplicity (defined as: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet), coupling 
constant(s) J (Hz), assignment. The assignments of signals observed in 
various NMR spectra were assisted by conducting homonuclear (1H-1H) 
correlation spectroscopy (COSY), heteronuclear (1H-13C) correlation 
spectroscopy (HMQC) and long-range heteronuclear (1H-13C) correlation 
spectroscopy (HMBC) experiments.  
 
HRMS and LRMS (High and Low resolution Electrospray mass spectrometry) 
was recorded on a water micromass, LCT to Time of Flight mass 
spectrometer, coupled to a water 2975 hplc. Chemical ionisation (CI) was 
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recorded on a waters micromass GCT Time of Flight mass spectrometer. 
The parent ion (M+, [M+H]+ or [M+Na]+) is quoted, followed by significant 
fragments with relative intensities.  
 
Infrared spectra were recorded on a Perkin-Elmer GX FT-IR spectrometer 
with the absorptions recorded in wavenumbers (cm-1). The bands associated 
with C-H stretching frequencies (2960-2850 cm-1) were ubiquitous and have 
been omitted. Samples were analyzed as thin films on NaCl discs.  
 
Optical rotations were measured with a Perkin-Elmer model 341 polarimeter, 
referenced to the sodium D line (589 nm) at 20 °C, using the spectroscopic 
grade solvents specified and at the concentration (c, g/100 mL) indicated. 
The measurements were carried out in a cell with a 1 dm path length. 
 
Melting points were recorded on a Gallenkamp hot-stage apparatus, and are 
uncorrected. 
 
Analytical thin layer chromatography (tlc) was conducted on Merck pre-
coated (25 µm) silical gel 60F254 plates or on aluminium-backed 0.2 mm thick 
silical gel 60 F254 plates (Merck) and the plates were visualized under a 254 
nm UV lamp and/or by treatment with either anisaldehyde dip or alkaline 
potassium permangate dip, followed by heating with a heat gun. The 
retention factor (Rf) quoted is rounded to the nearest 0.01. Flash 
chromatography was conducted using silica gel 60F254 as the stationary 
phase and the solvent indicated. 
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Reagent and solvents were purified by standard means. Methanol was 
distilled from calcium hydride in a recycling still under nitrogen.143 
Dichloromethane (DCM), toluene, tetrahydrofuran (THF) and diethyl ether 
(Et2O) were dried by passage through two coloumns of alumina using a 
MBRAUN (SPS-800) solvent purification system. Anhydrous DMF was 
purchased from Aldrich UK and dried by distillation from 4 Å molecular sieves 
under a nitrogen atmosphere. All reagents and starting materials were used 
as purchased from Aldrich UK, Acros UK or Alfa Aesar UK, except where 
otherwise stated in the experimental procedures.  
 
Reactions employing air and/or moisture-sensitive reagents were performed 
under an atmosphere of nitrogen (unless otherwise specified) in flame-dried 
apparatus. Anhydrous reagents were handled under nitrogen using standard 
techniques. 
 
Room temperature varied between 19-25 °C. “Removed at reduced 
pressure” refers to the use of a rotary evaporator with the water bath 
temperature generally not exceeding 40 °C. 
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Quinide(73)97, 99 
2HO
OH
OH
O
O
73
1
3
4 5 6
 
 
A mixture of quinic acid 5 (10 g, 52 mmol) and p-toluenesulfonic acid 
monohydrate (0.99 g, 5.2 mmol) in DMF (25 mL) and toluene (90 mL) was 
heated under reflux with azeotropic removal of water (Dean-Stark 
apparatus). After 12 h the solution was cooled to room temperature. The 
solvent was removed under reduced pressure to give a solid, which was then 
heated under reflux in ethyl acetate (100 mL) for 4 h and the solution was 
cooled to room temperature. The solvent was then removed under reduced 
pressure to give quinide 73 as a colorless solid (9 g, 99%); m.p. 182-183 °C; 
(lit.,97 184-185 °C); Rf 0.2 (petroleum ether:EtOAc, 80:20); vmax(film)/cm-1 
3349, 1790; δH (300 MHz, DMSO-d6) 5.98 (1H, s, 1-OH), 5.32 (1H, d, J = 4.4 
Hz, 4-OH), 4.91 (1H, d, J = 7.0 Hz, 3-OH), 4.68 (1H, apparent d, J = 5.4, Hz, 
5-H), 3.88 (1H, ddd, J = 4.7, 4.7, 4.5 Hz, 4-H), 3.61-3.50 (1H, m, 3-H), 2.33 
(1H, apparent d, J = 11.2 Hz, 6a-H), 2.21-2.14 (1H, m, 6b-H), 1.95-1.98 (1H, 
m, 2a-H), 1.76 (1H, apparent t, J = 11.6 Hz, 2b-H); m/z (ES+) 174 [(M+H)+, 
100%]. The data were in good agreement with the literature value.97, 99 
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(1S,3R,4R,5R)-3-(benzyloxy)-1,4-dihydroxy-6-oxabicyclo[3.2.1]octan-7-
one (68).104 
 
O
O
OHBnO
OH
68  
 
Method 1: 
A stirred solution of quinide 73 (1.8 g, 10 mmol) and Bu2SnO (3.1 g, 12 
mmol) in toluene (10 mL) was heated under reflux with azeotropic removal of 
water (Dean-Stark apparatus). After 4 h, the solution was cooled to room 
temperature before benzyl bromide (2 mL, 16.8 mmol) and DMF (5 mL) were 
added. The reaction mixture was heated under reflux for 6 h. The solvents 
were removed under reduced pressure. Flash column chromatography on 
silica eluting with petroleum ether:EtOAc (80:20) gave 68 as a colorless solid 
(0.82 g, 30%); m.p. 154-155 °C (lit.,104 153-154 °C); Rf 0.5 (petroleum 
ether:EtOAc, 80:20); [α]D -50 (c 0.33, CHCl3) (lit., 104 -48, c 0.33, CHCl3); 
vmax(film)/cm-1 3423, 1773, 1628; δH (300 MHz, DMSO-d6) 7.31-7.20 (5H, m, 
Ar-H), 5.93 (1H, s, 1-OH), 5.21 (1H, d, J = 5.0 Hz, 4-OH), 4.60 (1H, apparent 
t, J = 5.4, Hz, 5-H), 4.54-4.40 (2H, AB system, J = 12.0 Hz, PhCH2), 4.19 
(1H, ddd, J = 4.7, 4.7, 4.5, 4-H), 3.42-3.36 (1H, m, 3-H), 2.26 (1H, apparent 
d, J = 11.2 Hz, 6a-H), 2.16-1.20 (1H, m, 6b-H), 1.98-1.94 (1H, m, 2a-H), 1.72 
(1H, apparent t, J = 11.6 Hz, 2b-H); m/z (ES-) 263 [(M-H)-, 100%]. The data 
were in good agreement with the literature value. 104 
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(1S,3R,4R,5R)-3-(benzyloxy)-1,4-dihydroxy-6-oxabicyclo[3.2.1]octan-7-
one (68).100 
 
O
O
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Method 2: 
A mixture of quinide 73 (10.0 g, 57.3 mmol), Bu2SnO (15.5 g, 62.2 mmol), 
tetrabutylammonium iodide (20.0 g, 54.2 mmol) and benzyl bromide (30.0 g, 
175.4 mmol) in acetonitrile (100 mL) was stirred under reflux with removal of 
water via Soxhlet apparatus filled with 3 Å molecular sieves. After 12 h the 
solution was concentrated at reduced pressure. The residue was then 
suspended in water (80 mL) and extracted with ethyl acetate (250 mL). The 
organic fractions were combined, stirred with saturated NaHCO3 solution (30 
mL), filtered over Celite, then washed with brine (30 mL) and dried over 
Na2SO4. The solvents were removed under reduced pressure. Flash column 
chromatography on silica eluting with petroleum ether/EtOAc (80:20) gave 68 
as a colorless solid (13.8 g, 91%). The data were in good agreement with the 
literature value. 104 
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3-O-Benzyl-4-O-tert-butyldimethylsilyl quinide (74). 
 
O
O
OHBnO
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To a stirred solution of 73 (5.0 g, 18.9 mmol) and imidazole (5.0 g, 76.0 
mmol), in anhydrous DMF (30 mL) was added tert-butyldimethylsilyl chloride 
(18.0 g, 118.0 mmol) at 0 °C. The mixture was stirred at 0 °C for 30 min and 
1 h at room temperature, poured into water (100 mL) and extracted with ethyl 
acetate (40 mL) and diethyl ether (40 mL). The organic layer was washed 
several times with water (3 × 100 mL), dried over Na2SO4 and the solvents 
removed under reduced pressure to give a solid residue. The residue was 
purified by flash chromatography on silica eluting with petroleum ether:EtOAc 
(70:30) to give 74 as a colorless solid (5.5 g, 76%). m.p. 100-103 °C; Rf 0.66 
(petroleum ether/ EtOAc, 70:30); [α]D -38.0 (c 0.33, CHCI3) vmax(film)/cm-1 
3422, 3056, 1791, 1463; δH (300 MHz, DMSO-d6) 7.30-7.20 (5H, m, Ar-H), 
5.96 (1H, s, 1-OH), 4.56 (1H, apparent t, J = 5.4,  Hz, 5-H), 4.44 (2H, s, 
PhCH2), 4.19 (1H, apparent t, J = 4.5, Hz, 4-H), 3.38-3.30 (1H, m, 5-H), 2.23 
(1H, apparent d, J = 11.2 Hz, 6a-H), 2.15-2.08 (1H, m, 6b-H), 1.99-1.91 (1H, 
m, 2a-H), 1.65 (1H, apparent t, J = 11.2 Hz, 2b-H), 0.78 (9H, s, SitBu), 0.00, -
0.02 (6H, 2 × s, Si[CH3]2); δc (75.4 MHz, DMSO-d6) 177.0 (C=O), 138.2 (2 x 
C-Ar), 128.1 (2 x C-Ar), 127.4 (2 x C-Ar), 75.3 (C-1), 73.0 (C-3), 71.4 (C-4), 
64.1 (C-5), 64.9 (PhCH2), 36.7 (C-6), 36.2 (C-2), 25.6 (SitBu), 17.7 (SitBu), -
4.6 (Si[CH3]2), -4.9 (Si[CH3]2); m/z (CI+) 379 [(M+H)+, 100%]; HRMS (CI+) 
[Found: (M+H)+, 379.1941, C20H30O5Si requires 379.1941]. 
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3-O-Benzyl-1,4-O-di-tert-butyldimethylsilyl quinide (69).144 
 
O
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To a stirred solution of 68 (5.0 g, 18.9 mmol), imidazole (8.0 g, 66.0 mmol) 
and DMAP (5.0 g, 38.0 mmol) in anhydrous DMF (30 mL) was added TBS 
chloride (18.0 g, 119.4 mmol) at room temperature. The mixture was stirred 
at 100 °C for 12 h, poured into water (10 mL) and extracted with ethyl acetate 
(80 ml) and diethyl ether (80 mL). The organic layer was washed with water 
(3 x 100 mL), dried over Na2SO4 and the solvents removed under reduced 
pressure to give a solid residue. The residue was purified by flash 
chromatography eluting with EtOAc: petroleum ether (40:60) to afford the 
desired product 69 as an oil (8.1 g, 86%); Rf 0.68 (petroleum ether:EtOAc, 
90:10); [α]D -13.0 (c 1.4, CHCI3) , (lit.,144 [α]D -14.0, c 1.4, CHCI3); δH (300 
MHz, DMSO-d6) 7.26-7.15 (5H, m, Ar-H), 4.58 (1H, apparent t, J = 5.4, Hz, 3-
H), 4.42 (2H, s, PhCH2), 4.18 (1H, apparent t, J = 4.5,  Hz, 4-H), 3.39-3.31 
(1H, m, 5-H), 2.32 (1H, apparent d, J = 11.4 Hz, 6a-H), 2.22-2.17 (1H, m, 6b-
H), 1.98-1.92 (1H, m, 2a-H), 1.72 (1H, apparent t, J = 11.2 Hz, 2b-H), 0.76 
(18H, s, SitBu), 0.01, 0.00, -0.02, -0.04 (12H, 4 × s, 2 × Si[CH3]2); m/z (ES+) 
515 [(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+, 515.2625, 
C26H44O5NaSi2 requires 515.2624]. The data were in good agreement with 
the literature value. 144 
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3-O-Benzyl-1-O-tert-butyldimethylsilyl quinic acid (137). 
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A solution of 69 (7.80 g, 15.9 mmol) in THF/H2O (120:60 100 mL) was 
treated with LiOH (0.5 g, 20.8 mmol) at room temperature for 45 min. The 
mixture was taken up into water (80 mL) and extracted with EtOAc (180 mL). 
The organic layer was dried over Na2SO4, and the solvent removed under 
reduced pressure. Flash column chromatography of the residue 
(CH2CI2:MeOH, 90:10) gave 137 as a colorless solid (5.8 g, 92%) m.p. 238-
240 °C; Rf 0.20 (CH2CI2 : MeOH, 90:10); [α]D -38.6 (c 0.5, MeOH); 
vmax(film)/cm-1 3100, 1680; δH (300 MHz, DMSO-d6) 7.35-7.19 (5H, m, Ar-H), 
4.44 (2H, s, PhCH2), 3.95-3.89 (1H, m, 5-H), 3.81-3.77 (1H, m, 3-H), 3.55-
3.50 (1H, m, 4-H), 1.97-180 (3H, m, 6a-H, 6b-H,and 2a-H), 1.63 (1H, d, J = 
13.6 Hz, 2b-H), 0.83 (9H, s, SitBu), 0.00, -0.03 (6H, 2 × s, Si[CH3]2); δc (75.4 
MHz, DMSO-d6) 178.9 (C=O), 139.0 (2 × C-Ar), 127.9 (2 × C-Ar), 127.0 (2 × 
C-Ar), 74.0 (C-4), 72.4 (C-1), 71.9 (C-5), 69.7 (C-3), 69.6 (PhCH2), 35.6 (C-
6), 35.4 (C-2), 25.7 (SitBu), 17.8 (SitBu), -4.5 (Si[CH3]2), -5.1 (Si[CH3]2); m/z 
(ES-) 395 [(M-H)-, 100%)]; HRMS (ES-) [Found: (M-H)-, 395.1901, 
C19H35O3Si3 required 395.1894]. 
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1,4-O-Di-tert-butyldimethylsilyl quinide (70).144 
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A suspension of the disilyl ether 69 (8.0 g, 16.2 mmol) and palladium black 
(0.3 g, 2.8 mmol) in ethanol (50 mL) was stirred under a hydrogen 
atmosphere at room temperature for 48 h. The mixture was filtered over 
Celite, and the residue was washed with ethanol (30 mL). The filtrate and 
washings were evaporated under reduced pressure to yield alcohol 70 (6.5 g, 
99%) as colorless needles; m.p. 106-107 °C (lit., 144 107-108 °C); Rf 0.45 
(petroleum ether:EtOAc, 90:10); δH (300 MHz, DMSO-d6) 4.78 (1H, d, J = 6.0 
Hz, 3-OH), 4.53 (1H, apparent t, J = 5.4, Hz, 5-H), 3.87 (1H, apparent t, J = 
4.7, Hz, 4-H), 3.50-3.40 (1H, m, 3-H), 2.28 (1H, apparent d, J = 11.1 Hz, 6a-
H), 2.18-2.12 (1H, m, 6b-H), 1.79-1.72 (1H, m, 2a-H), 1.66 (1H, apparent t, J 
= 11.2 Hz, 2b-H), 0.77 (9H, s, SitBu), 0.76 (9H, s, SitBu), 0.02, 0.00, -0.00, -
0.02 (12H, 4 × s, 2 × Si[CH3]2); m/z (CI+) 403 [(M+H)+, 100%]. The data were 
in good agreement with the literature value. 144 
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1-tert-Butyldimethylsilyl quinide (75). 
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A suspension of the disilyl ether 70 (8.0 g, 16.2 mmol) and 5% Pd/C (0.3 g, 
2.8 mmol) in ethanol (50 mL) was stirred under a hydrogen atmosphere at 
room temperature for 48 h. The mixture was filtered over Celite, and the 
residue was washed with ethanol (30 mL). The filtrate and washings were 
evaporated under reduced pressure to yield alcohol 75 (6.5 g, 99%) as an oil; 
Rf 0.25 (CH2CI2:MeOH, 90:10); [α]D -1.5 (c 1.1, CHCI3); vmax(film)/cm-1 3440, 
1439; δH (300 MHz, DMSO-d6) 4.76 (1H, d, J = 6.0 Hz, 3-OH), 4.50 (1H, 
apparent t, J = 5.4 5-H), 3.86 (1H, ddd, J = 4.7, 4.7, 4.5, Hz, 4-H), 3.52-3.40 
(1H, m, 3-H), 2.26 (1H, apparent d, J = 11.1 Hz, 6a-H), 2.16-2.11 (1H, m, 6b-
H), 1.79-1.72 (1H, m, 2a-H), 1.65 (1H, apparent t, J = 11.2 Hz, 2b-H), 0.76 
(9H, s, SitBu), -0.00, -0.02 (6H, 2 × s Si[CH3]2); δc (75.4 MHz, DMSO-d6) 75.8 
(C-1), 75.6 (C-4), 71.4 (C-5), 66.9 (C-3), 38.6 (C-6), 37.3 (C-2), 25.8 (SitBu), 
25.7 (SitBu), -3.0 (Si[CH3]2) -4.4 (Si[CH3]2); m/z (ES+) 289 [(M+H)+, 100%]; 
HRMS (ES+) [Found: (M+H)+, 289.1391, C14H24O5Si, required 289.1393]. 
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1-O-tert-Butyldimethylsilyl quinic acid (80). 
 
OH
CO2H
OTBSHO
OH
80  
 
A solution of 75 (6.5 g, 16.1 mmol) in THF/H2O (120:60 180 mL) was treated 
with LiOH (1.0 g, 41.0 mmol) was stirred at room temperature for 45 min. The 
mixture was taken up into water (50 mL) and then extracted with EtOAc (180 
mL) and dried over Na2SO4. The solvents were removed under reduced 
pressure. Flash column chromatography of the residue (EtOAc:petroleum 
ether, 40:60) gave 80 as a white solid (4.1 g, 83%); m.p. 85-90 °C; Rf 0.42 
(CH2CI2:MeOH, 90:10); [α]D +2.5 (c 0.86, MeOH); vmax(film)/cm-1 3439, 1638; 
δH (300 MHz, DMSO-d6) 4.08-4.05 (1H, m, 5-H), 3.96-3.91 (1H, m, 3-H), 
3.52-3.48 (1H, m, 4-H), 1.75-1.69 (1H, m, 6a), 1.61 (1H, apparent t, J = 11.2 
Hz, 2a-H), 151-1.44 (1H, m, 6b and 2b-H), 0.84, 0.82 (9H, 2 × s, SitBu), 0.03, 
0.02 (6H, s, Si [CH3]2); δc (75.4 MHz, DMSO-d6) 75.5 (C-1), 75.0 (C-4), 70.1 
(C-5), 66.6 (C-3), 40.4 (C-6), 36.9 (C-2), 25.7 (SitBu), 25.6 (SitBu), -3.2 (Si 
[CH3]2) -4.4 (Si [CH3]2); m/z (ES-) 305 [(M-H)-, 100%], HRMS (ES-) [ Found: 
(M-H)-, 305.1420, C13H25O6Si required 305.1424]. 
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Di-O-acetylcaffeic acid (81). 95 
 
AcO
AcO
O
OH
1
2
3
4
5
6
7
8
9
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To a solution of caffeic acid 2 (7.20 g, 40 mmol) and DMAP (0.12 g, 1 mmol) 
in pyridine (20 mL) was added acetic anhydride (9.4mL, 0.1 mol) at 0 °C. The 
reaction mixture was stirred for 1 h at room temperature and then poured 
onto crushed ice. The aqueous phase was acidified with HCl (2N, pH ≈ 2) 
and extracted with EtOAc/THF (3:1, 3 × 80 mL). The combined organic 
extracts were dried over MgSO4 and the solvents were removed under 
reduced pressure. Trituration of the residue with light petroleum containing a 
small amount of EtOAc afforded di-O-acetylcaffeic acid 81 as a colorless 
powder (10.0 g, 95%); m.p. 189-190 °C (lit.,95 190-191 °C); δH (300 MHz, 
acetone-d6) 7.42 (1H, d, J = 16.0 Hz, 7-H), 7.49 (1H, d, J = 1.8 Hz, 2-H), 7.36 
(1H, dd, J = 8.4, 1.8 Hz, 6-H), 7.07 (1H, d, J = 8.4 Hz, 5-H), 6.29 (1H, d, J = 
16.0 Hz, 8-H), 2.29 (3H, s, CH3), 2.28 (3H, s, CH3). The data were in good 
agreement with the literature value. 95 
 
 
Di-O-acetylcaffeoyl chloride (82). 95 
 
AcO
AcO
O
Cl
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To a solution of 81 (10.4 g, 39 mmol) in toluene (200 mL) containing five 
drops of DMF, was added oxalyl chloride (7.0 mL) at -5 °C. After stirring for 3 
h at room temperature, all starting material had dissolved resulting in a pale-
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brown solution. Toluene and unreacted oxalyl chloride were removed under 
reduced pressure. The residual brownish product was recrystallised from 
toluene to afford the di-O-acetylcaffeoyl chloride 82 as a pale yellow powder 
(10.4 g, 93%). m.p. 78-80 °C (lit., 95 78-80 °C); δH (300 MHz, CDCl3) 7.77 
(1H, d, J = 16.0 Hz, 7-H), 7.46 (1H, d, J = 1.8 Hz, 2-H), 7.43 (1H, dd, J = 8.4 
Hz, 1.8 Hz, 6-H), 7.28 (1H, d, J = 8.4 Hz, 5-H), 6.49 (1H, J = 16.0 Hz, 8-H), 
2.32 (3H, s, CH3), 2.31 (3H, s, CH3). The data were in good agreement with 
the literature value. 95 
 
3-Methoxy-4-O-tert-butyldimethylsilyloxycinnamic acid (94).145, 146  
H3CO
TBSO
O
OH
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9
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To a stirred solution of ferulic acid 3 (1.0 g, 5.1 mmol), and imidazole (0.7 g, 
10.3 mmol) in anhydrous DMF (15 mL) was added TBS chloride (1.0 g, 6.6 
mmol) at room temperature. The mixture was stirred at 70 °C for 3 h, poured 
into water (50 mL) and extracted with diethyl ether (80 mL). The organic layer 
was washed several times with water (100 mL), dried over Na2SO4 and the 
solvent was removed under reduced pressure to give a solid residue. The 
resultant residue was purified by flash chromatography on silica eluting with 
petroleum ether:EtOAc (60:40) to give 3-methoxyl-4-O-tert-
butyldimethylsilyloxycinnamic acid 94 as a colorless solid (1.5 g, 94%); m.p 
118-120 °C; Rf: 0.4 (petroleum ether: EtOAc, 60:40); δH (300 MHz, acetone-
d6) 7.42 (1H, d, J = 15.5 Hz, 7-H), 7.16 (1H, d, J = 1.2 Hz, 2-H), 6.96 (1H, dd, 
J = 8.4, 1.2 Hz, 6-H), 6.72 (1H, d, J = 8.4 Hz, 5-H), 6.57 (1H, d, J = 15.5 Hz, 
8-H), 3.32 (3H, s, CH3), 0.81 (9H, s, SitBu), 0.00, -0.01 (6H, 2 × s, Si [CH3]2); 
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m/z (ES+) 331 [(M+H)+, 100%]. The data were in good agreement with the 
literature value. 145, 146 
 
3-Methoxy-4-O-tert-butyldimethylsilyloxycinnamyl chloride (95). 145, 146 
 
H3CO
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Cl
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To a solution of 94 (1.0 g, 3.2 mmol), in toluene (50 mL) containing five drops 
of DMF, was added oxalyl chloride (0.6 mL, 7.9 mmol) at -5 °C. After stirring 
for 3 h at room temperature, all starting material had dissolved resulting in a 
pale-brown solution. Toluene and unreacted oxalyl chloride were removed 
under reduced pressure to yield 3-methoxy-4-O-tert-
butyldimethylsilyloxycinnamyl chloride 95 as an oil (0.85 g, 80%), which was 
used without further purification; δH (300 MHz, acetone-d6) 7.64 (1H, d, J = 
16.0 Hz, 7-H), 7.31 (1H, dd, J = 8.4, 1.2 Hz, 6-H), 7.12 (1H, d, J = 1.2 Hz, 2-
H), 6.77 (1H, d, J = 8.4 Hz, 5-H), 6.58. (1H, d, J = 16.0 Hz, 8-H), 3.72 (3H, s, 
CH3), 0.80 (9H, s, SitBu), 0.00, -0.02 (6H, 2 × s, Si [CH3]2); m/z (ES-) 325 [(M-
H)-, 100%], HRMS (ES-) [ Found: (M-H)-, 325.1105, C16H23CIO3Si required 
325.1106]. The data were in good agreement with the literature value. 145, 146 
 
 
3,4-tert-Butyldimethylsilyl caffeic acid (98).147 
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To a stirred solution of caffeic acid 2 (5.0 g, 27.7 mmol), and imidazole (5.0 
g, 72.6 mmol) in anhydrous DMF (60 mL) was added TBS chloride (8.5 g, 
56.6 mmol) at room temperature. The mixture was stirred at 70 °C for 3 h, 
poured into water (100 mL) and extracted with diethyl ether (250 mL). The 
organic layer was washed several times with water (200 mL), dried over 
Na2SO4 and the solvent was removed under reduced pressure to give a solid 
residue. The resultant residue was purified by flash chromatography on silica 
eluting with petroleum ether:EtOAc (90:10) to give 98 as colorless solid (8.0 
g, 70%); m.p 151-154 °C, (lit.,147 152-155 °C); Rf: 0.23 (petroleum 
ether:EtOAc, 90:10); δH (300 MHz, CDCl3) 7.28 (1H, d, J = 15.5 Hz, 7-H), 
6.80 (1H, d, J = 1.2 Hz, 2-H), 6.78 (1H, dd, J = 8.4, 1.2 Hz, 6-H), 6.60 (1H, d, 
J = 8.4 Hz, 5-H), 5.99 (1H, d, J = 15.5 Hz, 8-H), 0.11 (18H, 2 × s, SitBu), 
0.00, -0.00 (12H, 2 × s, 2 × Si [CH3]2); m/z (ES+) 431 [(M+Na)+, 100%]. The 
data were in good agreement with the literature value. 147 
 
 
3,4-tert-Butyldimethylsilyl caffeoyl chloride (99). 147 
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To a solution of 98 (8.0 g, 19.6 mmol), in toluene (200 mL) containing five 
drops of DMF, was added oxalyl chloride (1.69 mL, 19.7 mmol) at -5 °C. After 
stirring for 3 h at room temperature, all starting material had dissolved 
resulting in a pale-brown solution. Toluene and unreacted oxalyl chloride 
were removed under reduced pressure to yield 3,4-tert-butyldimethyllsilyl 
caffeoyl chloride 99 as an oil (7.5 g, 90%), which was used without further 
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purification; δH (300 MHz, CDCl3) 7.74 (1H, d, J = 15.5 Hz, 7-H), 7.11 (1H, 
dd, J = 8.4, 2.0 Hz, 6-H), 6.89 (1H, d, J = 2.0 Hz, 2-H), 6.45 (1H, d, J = 8.4 
Hz, 5-H), 5.99 (1H, d, J = 15.5 Hz, 8-H), 1.03, 1.01 (18H, 2 × s, SitBu), 0.26, 
0.25 (12H, 2 × s, 2 × Si [CH3]2); m/z (ES+) 427 [(M+H)+, 100%]. The data 
were in good agreement with the literature value. 147 
 
 
3,4-Dimethoxycinnamyl chloride (90).148 
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To a solution of 3,4-dimethoxylcinnamic acid 89 (10 g, 48.0 mmol), in toluene 
(50 mL) containing five drops of DMF, was added oxalyl chloride (5.4 mL, 
63.0 mmol) at -5 °C. After stirring for 3 h at room temperature, all starting 
material had dissolved resulting in a pale-brown solution. Toluene and 
unreacted oxalyl chloride were removed under reduced pressure to yield 3,4 
dimethoxycinnamyl chloride 90 as an oil (10.1 g, 92%), which was used 
without further purification; δH (300 MHz, DMSO-d6) 7.51 (1H, d, J = 16.0 Hz, 
7-H), 7.30 (1H, dd, J = 8.4, 1.8 Hz, 6-H), 7.19 (1H, d, J = 1.8 Hz, 2-H), 6.96 
(1H, d, J = 8.4 Hz, 5-H), 6.44 (1H, d, J = 16.0 Hz, 8-H), 3.79 (3H, s, CH3), 
3.78 (3H, s, CH3); δC (75.4 MHz, DMSO-d6) 167.8 (C=O), 150.7 (Ar), 148.9 
(Ar), 144.0 (C=C), 127.0 (Ar), 122.6 (Ar), 116.6 (C=C), 111.4 (Ar), 110.2 (Ar), 
55.5 (CH3), 55.5 (CH3). The data were in good agreement with the literature 
value. 148 
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1-O-tert-Butyldimethylsilyl-3,4-di-O-acetylcaffeoylquinic acid (83). 
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DMAP (0.02 g, 0.16 mmol), and di-O-acetylcaffeoyl chloride 82 (0.5 g, 2.2 
mmol) were added at room temperature to a solution of triol 80 (0.2 g, 0.4 
mmol) in pyridine (2 mL) and CH2CI2 (5 mL). The reaction mixture was stirred 
at room temperature for 12 h and was then quenched by slow addition of 
aqueous HCl solution (1N, 8 mL). The aqueous organic phases were dried 
with MgSO4 and the solvents removed under reduced pressure. The 
resultant residue was purified by flash chromatography eluting with 
EtOAc:petroleum ether (40:60) to give 83 as a colorless crystals (0.32 g, 
62%); m.p. 128-131 °C; Rf: 0.24 (petroleum ether: EtOAC, 60:40); [α]D +40 (c 
0.1, CHCl3); vmax(film)/cm-1 3460, 1650; δH (300 MHz, DMSO-d6) 7.73 (1H, d, 
J = 1.8 Hz, 2’-H), 7.68 (1H, d, J = 1.8 Hz, 2’’-H), 7.66 (1H, dd, J = 8.1, 1.8 Hz, 
6’-H), 7.64-7.63 (1H, m, 6’’-H), 7.33 (1H, d J = 8.1 Hz, 5’-H), 7.31 (1H, d J = 
8.1 Hz, 5’’-H), 6.66 (1H, d, J = 16.0 Hz, 7’,7’’- H), 6.54 (1H, d, J = 16.0 Hz, 8’ 
and 8’’- H), 5.28-5.23 (1H, m, 5-H), 4.53-4.50 (1H, m, 3-H), 4.13 (1H, br, 5-
OH), 3.85 (1H, dd, J = 7.3, 3.0 Hz, 4-H), 2.30, 2.29, 2.28, 2.27 (12H, 4 × s, 
OCH3), 2.26-2.22 (2H, m, 2a and 2b-H), 2.19-2.07 (2H, m, 6b and 6b-H), 0.84 
(9H, s, SitBu), 0.09, 0.06 (6H, 2 × s, Si [CH3]2). δc (75.4 MHz, DMSO-d6) 
170.9 (C=O), 165.2 (C-9’, C-9’’), 145.2 (C-4’, C-4’’), 143.1 (C-7’, C-7’’), 142.8 
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(C-3’, C-3’’), 128.4 (C-1’,C-1’’), 127.1 (C-6’, 6’’), 124.5 (C-5’, 5’’), 123.4 (C-2’, 
2’’), 119.5 (C-8’, 8’’), 80.0 (C-1), 72.0 (C-5), 70.3 (C-3), 67.1 (C-4), 34.7 (C-
6), 34.6 (C-2); 27.9 (SitBu), 21.2 (SitBu), 18.1 (OCH3), -4.5 (Si [CH3]2); m/z 
(ES+) 821 [(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+, 821.2453, 
C39H46O16NaSi requires 821.2454]. 
 
 
3-O-Benzyl-1,4-O-ditriisopropylsilyl quinide (85). 
 
O
O
OTIPSBnO
OTIPS
85  
To a stirred solution of 68 (4.0 g, 15.1 mmol) and 2,6-lutidine (4.3 mL, 37.3 
mmol) in DMF (50 mL) at 0 °C was added TIPSOTf (8.0 mL, 39.2 mmol) and 
the mixture was heated at 70 °C. After 17 h, the reaction was quenched with 
methanol at 0 °C, diluted with diethyl ether (100 mL) and washed with water 
(200 mL) and brine (20 mL). The organic layer was dried over Na2SO4 and 
the solvents removed under reduced pressure. Flash column 
chromatography of the residue (petroluem ether:EtOAc, 90:10) gave the 
desired product 85 as a colorless solid (6.8 g, 78%); m.p 58-60 °C; Rf 0.26 
(petroleum ether); [α]D -42 (c 0.33, CHCl3); vmax(thin film)/cm-1 2944, 1463; δH 
(300 MHz, DMSO-d6) 7.23-7.15 (5H, m, Ar-H), 4.60 (1H, apparent t, J = 5.4, 
Hz, 3-H), 4.43-4.39 (2H, AB system, J = 12.2 Hz, PhCH2), 4.22 (1H, apparent 
t, J = 4.4, Hz, 4-H), 3.37-3.32 (1H, m, 5-H), 2.41 (1H, apparent d, J = 11.3 
Hz, 6a-H), 2.23-2.16 (1H, m, 6b-H), 1.98-1.92 (1H, m, 2a-H), 1.72 (1H, 
apparent t, J = 11.2 Hz, 2b-H), 0.90 (42H, s, iPr3Si); δc (75.4 MHz, DMSO-d6) 
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175.3 (C=O), 138.1 (C-Ar), 128.0 (2 × C-Ar), 127.6 (C-Ar), 127.4 (2 × C-Ar), 
75.1 (C-1), 73.5 (C-3), 73.4 (C-5), 70.6 (CH2Ph), 65.7 (C-4), 37.1 (C-6), 37.0 
(C-2), 17.7 (iPr3Si), 12.3 (iPr3Si), 12.0 (iPr3Si), 11.8 (iPr3Si); m/z (ES+) 599 
[(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+ , 599.3568, C32H56O5Si2Na 
requires 599.3568]. 
 
3-O-Benzyl-4-O-triisopropylsilyl quinic acid (87). 
 
OH
CO2H
OHBnO
OTIPS
87  
A solution of 85 (6.8 g, 11.8 mmol) in THF/H2O (120:60, 180mL) was treated 
with LiOH (0.4 g, 16.7 mmol) and the mixture was stirred at room 
temperature for 45 min. The reaction mixture was taken up into water (80 
mL) and then extracted with EtOAc (100 mL). The combined organic layers 
were dried over MgSO4 and the solvents removed under reduced pressure. 
Flash column chromatography of the residue (CH2CI2/MeOH, 80:20) gave 
the desired product 87 as a colorless solid (4.85 g, 94%); m.p. 198-200 °C; 
Rf 0.23 (CH2CI2:MeOH, 80:20); [α]D -21 (c 1.0, CHCl3); vmax(thin film)/cm-1 
2944, 1215, 1123; δH (300 MHz, DMSO-d6) 7.42-7.29 (5H, m, Ar-H), 4.62-
4.51 (2H, AB system, J = 12.2 Hz, PhCH2), 4.03-3.99 (1H, m, 4-H), 3.90 (1H, 
dt, J = 11.1, 2.8 Hz, 3-H), 3.87-3.80 (1H, m, 5-H), 2.44-2.40 (1H, m, 6a,-H), 
2.37-2.31 (1H, m, 2a-H) 1.98-1.82 (2H, m, 6b and 2b-H), 1.014-1.00 (21H, m, 
iPr3Si); δc (75.46 MHz, DMSO-d6) 175.7 (C=O), 139.2 (Ar), 127.8 (2 × C-Ar), 
127.6 (C-Ar), 127.4 (2 × C-Ar), 80.9 (C-1), 74.7 (C-3), 72.2 (C-4), 70.3 
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(PhCH2), 69.3 (C-5), 37.7 (C-6), 34.5 (C-2), 18.1 (iPr3Si), 12.0 (iPr3Si); m/z 
(ES-) 437 [(M-H)-, 100%]; HRMS (ES-) [Found: (M-H)-, 437.2359, C23H38O6Si 
requires 437.2359]. 
 
4-O-Triisopropylsilyl quinic acid (88). 
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A suspension of silyl ether 87 (1.01 g, 3.20 mmol) and 10% Pd/C (0.01 g, 
0.09 mmol) in ethanol (30 mL) was stirred under a hydrogen atmosphere at 
120 °C for 36 h. The mixture was filtered over Celite and the residue was 
washed with ethanol (30 mL). The filtrate and washings were evaporated 
under reduced pressure. Flash column chromatography of the residue 
(CH2CI2:MeOH, 70:30) gave the desired product 88 as a colorless solid (0.66 
g, 82%); m.p. 239-242 °C; Rf 0.23 (CH2CI2:MeOH, 70:30); [α]D -32 (c 1.0, 
CHCl3); vmax(thin film)/cm-1 3019, 1216; δH (300 MHz, DMSO-d6) 4.15 (1H, d, 
J = 5.0 Hz, 3-OH), 4.00-3.96 (1H, m, 3-H), 3.72-3.68 (1H, m, 5-H), 3.61-3.56 
(1H, m, 4-H), 1.80-1.68 (2H, m, 6a-H and 6b-H), 1.54-1.50 (2H, m, 2a-H and 
2b-H) 1.03-1.01 (21H, m, iPr3Si); δc (75.4 MHz, DMSO-d6) 74.4 (C-1), 73.1 
(C-5), 72.9 (C-3), 69.0 (C-4), 31.6 (C-6), 30.6 (C-2), 18.0 (iPr3Si), 17.9 
(iPr3Si); m/z (ES-) 347 [(M-H)-, 100%]; HRMS (ES-) [Found: (M-H)-, 347.1891, 
C16H31O6Si requires 347.1890]. 
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3,5-Di-O-dimethoxycinnamoyl-4-O-triisopropylsilylquinic acid (91). 
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To a solution of 88 (0.58 g, 1.6 mmol) and DMAP (0.05 g, 0.4 mmol), in 
CH2CI2 (30 mL) were added pyridine (2 mL) and 3,4 dimethoxycinnamyl 
chloride 90 (1.0 g, 4.7 mmol) at room temperature. The mixture was stirred at 
room temperature for 12 h and was then quenched by the slow addition of 
aqueous HCl solution (1N, 10 mL). The organic phases were dried with 
MgSO4 and the solvents removed under reduced pressure. The residue was 
purified by flash chromatography eluting with CH2CI2:MeOH (90:10) to give 
91 as a solid (0.87 g, 72%); m.p. 109-115 °C; Rf 0.25 (CH2CI2:MeOH, 90:10); 
[α]D +31 (c 0.30, MeOH); vmax(film)/cm-1 3054, 2305, 1717, 1421, 1263; δH 
(500 MHz, DMSO-d6) 7.56 (1H, d, J = 16.0 Hz, 7’-H), 7.48 (1H, d, J = 16.0 
Hz, 7’’-H), 7.32 (1H, s, 2’-H), 7.26 (1H, s, 2’’-H), 7.18 (2H, d, J = 8.6 Hz, 5’ 
and 5’’-H), 6.98 (1H, d, J = 8.6 Hz, 6’-H), 6.96 (1H, d, J = 8.6 Hz, 6’’-H), 6.49 
(1H, d, J = 16.0 Hz, 8’-H), 6.40 (1H, d, J = 16.0 Hz, 8’’-H), 5.34-5.24 (1H, m, 
5 or 3-H), 4.19-4.09 (1H, m, 3 or 5-H), 3.94-3.88 (1H, m, 4-H), 3.80 (3H, s, 
CH3), 3.78 (3H, s, CH3), 3.79 (6H, s, CH3), 2.40-2.32 (2H, m, 6a and 6b-H), 
2.00-1.93 (2H, m, 2a and 2b-H), 1.03-1.01 (21, m, iPr3Si); δc (75.4 MHz, 
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DMSO-d6) 165.3 (C-9’, C-9’’), 151.0 (C-4’, C-4’’), 148.9 (C-7’, C-7’’), 145.0 
(C-3’, C-3’’), 127.0 (C-1’), 126.7 (C-1’’), 122.7 (C-6’), 122.6 (C-6’’), 115.2 (C-
5’), 111.5 (C-5’’), 111.3 (C-2’), 110.3 (C-2’’), 110.1 (C-8’), 110.0 (C-8’’), 71.7 
(C-1), 70.1 (C-5), 66.9 (C-3), 64.7 (C-4), 55.5 (CH3), 34.2 (C-6), 29.3 (C-2), 
17.9 (iPr3Si), 11.9 (iPr3Si); m/z (ES-) 727 [(M-H)-, 100%]; HRMS (ES-) 
[Found: (M-H)-, 727.3154, C37H55O9Si3 requires 727.3157]. 
 
 
3,5-(3,4-Dimethoxycinnamyl)quinic acid (92) 
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To a stirred solution of 91 (0.12 g, 0.10 mmol) in THF (8 mL) in a 
polypropylene vessel at 0 °C was added HF•py (0.9 mL) dropwise. After 16 h 
at room temperature, the reaction mixture was recooled to 0 °C and a further 
aliquot of HF•py (1.2 mL) was added. Stirring was continued at room 
temperature for another 8 h. The mixture was then partitioned between 
aqueous NaHCO3 (20 mL) and CH2CI2 (6 x 30 mL). The organic phases 
were dried with MgSO4 and the solvents removed under reduced pressure. 
Flash chromatography MeOH/CH2CI2 (20:80) gave 92 as a solid (0.087 g, 
92%); m.p 110-115 °C; Rf: 0.25 (MeOH/CH2CI2 20:80); [α]D +52 (c 0.18, 
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MeOH); vmax(thin film)/cm-1 3054, 1707, 1631, 1263; δH (500 MHz, DMSO-d6) 
7.38 (1H, d, J = 16.0 Hz, 7’-H), 7.37 (1H, d, J = 16.0 Hz, 7’’-H), 7.15 (1H, d, J 
= 1.8 Hz, 2’-H), 7.13 (1H, d, J = 1.8 Hz, 2’’-H), 7.04 (1H, dd, J = 8.1, 1.8 Hz, 
6’-H), 7.01 (1H, dd, J = 8.1, 1.8 Hz, 6’’-H), 6.82 (2H, d, J = 8.1, 5’,5’’-H), 6.33 
(1H, d, J = 16.0 Hz, 8’-H), 6.27 (1H, d, J = 16.0 Hz, 8’’-H), 5.09-5.01 (1H, m, 
5 or 3-H), 4.70 (1H, d, J = 4.4 Hz, 1-OH), 3.91-3.82 (1H, m, 3 or 5-H), 3,62 
(3H, s, CH3), 3.61 (3H, s, CH3), 3.59 (6H, s, CH3), 3.43-3.37 (1H, m, 4-H), 
2.02-2.07 (2H, m, 6a and 6b-H), 1.75-1.67 (2H, m, 2a and 2b-H); δc (75.4 MHz, 
DMSO-d6) 173.0 (C-7), 166.4 (C-9’), 165.8 (C-9’’), 151.4 (C-4’, C-4’’), 149.4 
(C-7’, C-7’’), 145.4 (C-3’), 145.1 (C-3’’), 127.3 (C-1’, C-1’’), 123.6 (C-6’), 
123.4 (C-6’’), 116.2 (C-2’), 112.0 (C-2’’), 110.7 (C-8’), 110.5 (C-8’), 79.9 (C-
1), 71.5 (C-5), 70.5 (C-3), 68.0 (C-4), 56.0 (CH3), 36.3 (C-6), 34.5 (C-2); m/z 
(ES+) 595 [(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+, 595.1791, 
C29H32O12Na requires 595.1793]. 
 
 
3,5-Bis(((E)-3-(4-((tert-butyldimethylsilyl)oxy)-3-
methoxyphenyl)acryloyl)oxy)-1-hydroxy-4-
((triisopropylsilyl)oxy)cyclohexanecarboxylic acid (95). 
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To a solution of 88 (0.40 g, 1.1 mmol) and DMAP (0.05 g, 0.40 mmol), in 
CH2CI2 (10 mL) were added pyridine (2 mL) and 3-methoxy-4-O-tert-
butyldimethylsilyloxycinnamyl chloride 95 (1.5 g, 4.9 mmol) at room 
temperature. The mixture was stirred at room temperature for 12 h and was 
then quenched by the slow addition of 1N aqueous HCl solution (40 mL). The 
organic phases were dried with MgSO4 and the solvents removed under 
reduced pressure. The residue was purified by flash chromatography eluting 
with petroleum ether/ EtOAc (40:60) to give 96 as a solid (0.85 g, 79%); Rf 
0.14 (petroleum ether/EtOAc , 40:60); m.p. 87-89 °C; [α]D +38 (c 1.0, MeOH); 
δH (300 MHz, DMSO-d6) 7.58 (1H, d, J = 16.0 Hz, 7’-H), 7.56 (1H, d, J = 16.0 
Hz, 7’’-H), 7.31 (1H, s, 2’-H), 7.30 (1H, s, 2’’-H), 7.14 (2H, d, J = 8.6 Hz, 5’, 
5’’-H), 6.86 (1H, d, J = 8.6 Hz, 6’-H), 6.84 (1H, d, J = 8.6 Hz, 6’’-H), 6.42 (1H, 
d, J = 16.0 Hz, 8’-H), 6.35 (1H, d, J = 16 Hz, 8’’-H), 5.57-5.40 (1H, m, 5 or 3-
H), 4.38-4.30 (1H, m, 3 or 5-H), 4.27-4.20 (1H, m, 4-H), 3.87 (3H, s, CH3), 
3.86 (3H, s, CH3), 2.43-2.30 (2H, m, 6a and 6b-H), 2.20-2.07 (2H, m, 2a and 
2b-H), , 1.03-1.01 (21, m, iPr3Si), 0.78 (18H, s, SitBu), -0.01, 0.00, -0.02, 0.04 
(12H, 4 × s, 2 × Si[CH3]2) δC (75.46, DMSO-d6) 164.6 (C-9’), 164.5 (C-9’’), 
151.2 (C-4’), 151.1 (C-4’’), 149.8 (C-7’), 149.4 (C-7’’), 147.9 (C-3’), 141.5 (C-
3’’), 133.4 (C-1’, C-1’’), 133.1 (C-6’), 132.7 (C-6’’), 125.3 (C-5’, 5’’), 115.5 (C-
2’, 2’’), 111.3 (C-8’, 8’’), 87.0 (C-1), 81.9 (C-5), 72.9 (C-3), 61.5 (C-4), 58.5 
(CH3), 55.6 (CH3), 25.7 (C-6), 25.5 (C-2), 17.9 (SitBu), 17.8 (iPrSi), 11.9 
(iPrSi), -3.2 (Si[CH3]2), -3.3 (Si[CH3]2); m/z (ES-) 927 [(M-H)-, 100%]; HRMS 
(ES-) [Found: (M-H)-, 927.4571, C47H79O9Si5 requires 927.4568]. 
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3,5-Di-O-feruloycinnamic acid (97). 
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To a stirred solution of 96 (0.04 g, 0.04 mmol) in THF (2 mL) in a 
polypropylene vessel at 0 °C was added HF•py (0.12 mL) dropwise. After 16 
h at room temperature, the reaction mixture was re-cooled to 0 °C and a 
further aliquot to HF•py (0.6 mL) was added. Stirring was continued at room 
temperature for another 8 h. The mixture was then partitioned between 
aqueous NaHCO3 (20 mL) and CH2CI2 (4 × 10 mL). The organic phases 
were dried with MgSO4 and the solvents removed under reduced pressure. 
Flash chromatography MeOH:CH2CI2 (80:20) gave 97 as a yellow solid 
(0.021 g, 89%); m.p 148-150 °C; Rf 0.26 (CH2CI2:MeOH, 80:20); [α]D +39 (c 
0.5, MeOH); vmax(film)/cm-1 3460, 1592, 1513, 1270, 1158; δH (500 MHz, 
DMSO-d6) 9.63 (1H, s, Ph-OH), 9.62 (1H, s, Ph-OH), 7.54 (1H, d, J = 16.0 
Hz, 7’-H), 7.53 (1H, d, J = 16.0 Hz, 7’’-H), 7.32 (1H, d, J = 1.8 Hz, 2’-H), 7.30 
(1H, d, J = 1.8 Hz, 2’’-H), 7.11 (1H, dd, J = 8.1, 1.8 Hz, 6’-H), 7.08 (1H, dd, J 
= 8.1, 1.8 Hz, 6’’-H), 6.80 (2H, d, J = 8.1 Hz, 5’,5’’-H), 6.45 (1H, d, J = 16.0 
Hz, 8’-H), 6.39 (1H, d, J = 16.0 Hz, 8’’-H), 5.24 (1H, ddd, J = 3.5, 3.5, 4.1 Hz, 
5 or 3-H), 4.95 (1H, d, J = 4.4 Hz, 4-OH), 4.10-4.07 (1H, m, 3 or 5-H), 3.83 
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(3H, s, CH3), 3.82 (3H, s, CH3) 3.64-3.58 (1H, m, 4-H), 2.38-2.25 (3H, m, 2a-
H 2b-H and 6a-H), 1.95-1.87 (1H, m, 6b-H); δc (75.4 MHz, DMSO-d6) 172.5 
(C=O), 166.0 (C-9’), 165.4 (C-9’’), 149.3 (C-4’), 149.2 (C-4’’), 147.9 (C-7’), 
147.8 (C-7’’), 145.4 (C-3’), 145.0 (C-3’’), 125.5 (C-1’, C-1’’), 123.3 (C-6’), 
123.1 (C-6’’), 115.4 (C-5’, C-5’’), 114.6 (C-2’, C-2’’), 111.1 (C-8’), 110.8 (C-
8’’), 79.1 (C-1), 70.9 (C-5), 69.8 (C-3), 67.4 (C-4), 55.6 (CH3), 35.7 (C-6), 
34.0 (C-2); m/z (ES-) 543 [(M-H)-], 100%]; HRMS (ES-) [Found: (M-H)-, 
543.1500, C27H27O12 requires 543.1503]. 
 
 
3,5-Di-O-ditert-butyldimethylsilyl-4-O-triisopropylsilylquinic acid (100). 
 
 
O
O
OTBS
OTBS
OTIPS
OO
OTBS
OTBS
OH
CO2H
1
23
4 5 6
9''
8''
7''
6''
1''
2''
3''
4''
5''
9'
1'
2'
3'
4'
5'
6'
7'
8' 100
 
 
To a solution of 88 (0.58 g, 1.6 mmol) and DMAP (0.05 g, 0.4 mmol), in 
CH2CI2 (40 mL) were added pyridine (4 mL) and 3,4-tert-butyldimethylsilyl 
caffeoyl chloride 99 (2.5 g, 5.8 mmol) at room temperature. The mixture was 
stirred at room temperature for 12 h and was then quenched by the slow 
addition of 1N aqueous HCl solution (20 mL). The aqueous organic phases 
were dried with MgSO4 and the solvents removed under reduced pressure. 
The residue was purified by flash chromatography eluting with CH2CI2:MeOH 
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(90:10) to give 100 as a solid (1.19 g, 63%); m.p. 99-100 °C; [α]D +28 (c 1.0, 
MeOH); δH (300 MHz, DMSO-d6) 7.47 (1H, d, J = 16.0 Hz, 7’-H), 7.48 (1H, d, 
J = 16.0 Hz, 7’’-H), 7.07 (1H, dd, J = 8.1, 1.9 Hz. 6’-H), 7.03 (1H, dd, J = 8.1, 
1.9 Hz. 6’’-H), 6.99 (1H, d, J = 8.1, Hz, 5’-H), 6.96 (1H, d, J = 8.1, Hz, 5’’-H), 
6.69 (1H, d, J = 1.8 Hz, 2’-H), 6.67 (1H, d, J = 1.8 Hz, 2’’-H), 6.31 (1H, d, J = 
16.0 Hz, 8’-H), 6.26 (1H, d, J = 16.0 Hz, 8’’-H), 5.19-5.15 (1H, m, 5 or 3-H), 
4.92-4.88 (1H, m, 3 or 5-H), 3.96-3.90 (1H, m, 4-H), 2.47-2.42 (2H, m, 2a-H 
and 2b-H), 2,14-2.08 (2H, m, 6a-H and 6b-H), 0.85 (21, s, iPr3Si), 0.75, 0.76 
(36H, 2 × s, 4 × SitBu),0.01, -0.00, 0.02, -0.03, -0.02, -0.01 (24H, 6 × s, 4 × Si 
[CH3]2); δc (75.4 MHz, DMSO-d6) 172.3 (C=O), 165.4 (C-9’), 165.3 (C-9’’), 
149.4 (C-4’, C-4’’), 147.9 (C-7’), 147.8 (C-7’’), 146.7 (C-3’), 145.4 (C-3’’), 
127.8 (C-1’), 125.4 (C-1’’), 123.5 (C-6’), 122.9 (C-6’’), 115.6 (C-5’), 115.6 (C-
5’’), 144.1 (C-2’, C-2’’), 111.2 (C-8’), 111.1 (C-8’’), 79.0 (C-1), 78.9 (C-5), 
70.1 (C-3), 55.6 (C-4), 34.2 (C-6), 33.1 (C-2), 25.4 (SitBu), 17.9 (iPr3Si), 11.8 
(iPr3Si), -3.2 (Si [CH3]2) -4.6 (Si [CH3]2); m/z (ES-) 1127 [(M-H)-, 100%]; 
HRMS (ES-) [Found: (M-H)-,1127.6014, C54H103O13Si6 requires 1127.6001]. 
 
3,5-Di-O-dicaffeoylquinic acid (11) 
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To a stirred solution of 100 (0.12 g, 0.10 mmol) in THF (8 mL) in a 
polypropylene vessel at 0 °C was added HF•py (0.9 mL) dropwise. After 16 h 
at room temperature, the reaction mixture was re-cooled to 0 °C and a further 
aliquot of HF•py (1.2 mL) was added. Stirring was continued at room 
temperature for another 8 h. The mixture was then partitioned between 
saturated NaHCO3 (20 mL) and CH2CI2 (6 x 30 mL). The organic phases 
were dried with MgSO4 and the solvents removed under reduced pressure. 
Flash chromatography MeOH:CH2CI2 (30:70) gave 11 as a solid (0.051 g, 
93%); m.p 163-169 °C; Rf 0.13 (MeOH:CH2CI2, 30:70); [α]D +76 (c 0.1, 
MeOH); vmax(film)/cm-1 3019, 1717, 1216, 770; δH (500 MHz, DMSO-d6) 9.59 
(2H, s, Ph-OH), 9.16 (2H, s, Ph-OH), 7.47 (1H, d, J = 16.0 Hz, 7’-H), 7.46 
(1H, d, J = 16.0 Hz, 7’’-H), 7.04 (1H, d, J = 1.8 Hz, 2’-H), 7.05 (1H, d, J = 1.8 
Hz, 2’’-H), 7.00 (1H, dd, J = 8.1, 1.8 Hz, 6’-H), 6.99 (1H, dd, J = 8.1, 1.8 Hz, 
6’’-H), 6.77 (2H, d, J = 8.1 Hz, 5’,5’’-H), 6.20 (1H, d, J = 16.0 Hz, 8’-H), 6.19 
(1H, d, J = 16.0 Hz, 8’’-H), 5.25 (1H, td, J = 8.4, 3.9 Hz, 5 or 3-H), 4.95 (1H, 
s, 1-OH), 4.59 (1H, d, J = 4.3 Hz, 4-OH), 4.12-4.10 (1H, m, 5 or 3-H), 3.65-
3.58 (1H, m, 4-H), 2.37-2.26 (3H, m, 2a, 2b and 6a-H), 1.95-1.88 (1H, m, 6b-
H); δc (75.4 MHz, DMSO-d6) 172.9 (C-7), 166.4 (C-9’), 165.7 (C-9’’), 148.9 
(C-4’), 148.8 (C-4’’), 146.0 (C-7’, C-7’’), 145.9 (C-3’), 145.6 (C-3’’), 126.0 (C-
1’), 125.9 (C-1’’), 121.8 (C-6’). 121.7 (C-6’’), 116.2 (C-5’, C-5’’), 115.2 (C-2’, 
C-2’’), 114.6 (C-8’, C-8’’), 79.5 (C-1), 71.2 (C-5), 70.3 (C-3), 67.8 (C-4), 36.1 
(C-6), 34.5 (C-2); m/z (ES-) 515 [(M-H)-, 100%]; HRMS (ES-) [Found: (M-H)-, 
515.1190, C25H23O12 requires 515.1190]. The data were in good agreement 
with the literature value.113 
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1-O-tert-Butyldimethylsilyl quinide (101). 105 
O
O
OHTBSO
OH
101  
To a stirred solution of quinide 73 (1.80 g, 10.34 mmol) and imidazole (2.63 
g, 38.2 mmol) in anhydrous DMF (14 mL) was added TBS chloride (1.80 g, 
11.9 mmol) at 0 °C. The mixture was stirred at 0 °C for 30 min, 1 h at room 
temperature, and then poured into water (50 mL) and extracted with ethyl 
acetate (50 ml) and diethyl ether (40 mL). The organic layer was washed 
several times with water ( 3 × 100 mL), dried over Na2SO4 and the solvents 
removed under reduced pressure to give a solid residue, which was purified 
by flash chromatography eluting with EtOAc: petroleum ether (40:60) to 
afford the desired product 1-O-tert-butyldimethylsilyl quinide 101 as a solid 
(2.5 g, 83%); m.p 90-95 °C (lit., 105 90-94 °C); Rf 0.35 (petroleum 
ether/EtOAc, 90:10); [α]D -42 (c 1.0, CHCI3), (lit., 105 - 44 (c 1.0, CHCl3)); 
vmax(film)/cm-1 3422, 1773, 1638; δH (300 MHz, DMSO-d6) 5.92 (1H, s, 1-
OH), 4.99 (1H, d, J = 5.0 Hz, 4-OH), 4.60 (1H, apparent t, J = 5.4, Hz, 3-H), 
3.79-3.72 (1H, m 4-H), 3.65-3.59 (1H, m, 5-H), 2.25 (1H, apparent d, J = 11.2 
Hz, 6a-H), 2.102.03 (1H, m, 6b-H), 1.83-1.71 (2H, m, 2-H and 2b-H), 0.81 (9H, 
s, SitBu), 0.00, -0.01 (6H, 2 × s, Si[CH3]2); m/z (ES-) 287 [(M-H)-,100%]. The 
data were in good agreement with the literature value. 105 
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3-O-tert-Butyldimethylsilyl-1,4-O-dibenzyl quinide(102). 
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To a stirred solution of 101 (0.6 g, 2.08 mmol) in DMF (16 mL) at 0 °C was 
added NaH (0.32 g, 4.5 mmol, 60% dispersion in mineral oil). The reaction 
was stirred at 0 °C for 30 min. Benzyl bromide (1.2 mL, 8.7 mmol) was then 
added and the reaction left in the ice bath for 30 min. The ice bath was then 
removed and the reaction stirred at room temperature for 1 h, then at 60 °C 
for 12 h. The reaction was quenched with saturated aqueous ammonium 
chloride (5 mL) and extracted with EtOAc (80 mL). The organic layer was 
washed several times with water (2 × 100 mL), dried over Na2SO4 and the 
solvents removed under reduced pressure. The resultant residue was 
purified by flash chromatography eluting with hexanes:EtOAc gave pure 
product 102 as an oil (0.59 g, 60%). Rf 0.27 (petroleum ether:EtOAc, 90:10); 
[α]D -6.9 (c 1.0, CHCI3); vmax(film)/cm-1 2032, 2930, 1793, 1603, 1454; δH 
(300 MHz, DMSO-d6) 7.33-7.14 (10H, m, Ar-H), 4.84-4.80 (1H, m, 5-H), 4.74-
4.37 (2H, AB system, J = 11.0 Hz, 4-OCH2Ph), 4.49-4.45 (2H, AB system, J 
= 12.0 Hz, 1-OCH2Ph), 3.82-3.77 (2H, m, 4,3-H), 2.51(1H, ddd, J = 2.7, 6.2, 
11.2 Hz, 6a-H), 2.26 (1H, apparent d, J = 11.2 Hz, 6b-H), 2.00-1.93 (1H, m, 
2a-H), 1.90-1.84 (1H, m 2b-H), 0.78 (9H, s, SitBu), 0.00, -0.01 (6H, 2 × s, 
Si[CH3]2); δc (75.4 MHz, DMSO-d6) 174.6 (C=O), 138.4 (C-Ar), 137.9 (C-Ar), 
128.2 (2 × C-Ar), 128.1 (2 × C-Ar), 127.6 (2 × C-Ar), 127.5 (2 × C-Ar), 127.3 
(2 × C-Ar), 77.4 (C-4), 74.4 (C-1), 73.0 (C-3), 68.2 (C-5), 66.3 (PhCH2), 59.7 
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(PhCH2), 37.9 (C-6), 33.0 (C-2), 25.6 (SitBu), 20.7 (SitBu), 17.7 (Si[CH3]2), -
4.91(Si[CH3]2), -5.0 (Si[CH3]2); m/z (ES+) 491 [(M+Na)+, 100%]; HRMS (ES+) 
[Found: (M+Na)+, 491.2230, C27H36O5SiNa requires 491.2235]. 
 
3-O-tert-Butyldimethylsilyl-1,4-O-dibenzyl quinic acid (103). 
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A solution of 102 (0.6 g, 2.08 mmol) in THF/H2O (12:8, 20 mL) was treated 
with NaOH (0.2 g, 5 mmol) and the mixture was stirred at room temperature 
for 45 min. The residue was taken up into water (20 mL), extracted with 
EtOAc (3 × 10 mL) and the combined organic layers were dried over MgSO4 
and the solvents removed under reduced pressure to give a solid residue. 
The residue was purified by flash chromatography eluting with EtOAc: 
petroleum ether (40:60) to give 103 as a colorless solid (0.6 g, 96%); m.p 78-
83 °C; Rf 0.23 (CH2CI2:MeOH, 90:10); [α]D -7.4 (c 0.35, MeOH); vmax(film)/cm-
1 3495, 1607, 1065; δH (500 MHz, DMSO-d6) 7.33-7.15 (10H, m, Ar), 4.78-
4.59 (2H, AB, J = 12.0 Hz, 4-OCH2Ph), 4.38-4.28 (2H, AB system, J = 11.0 
Hz, 1-OCH2Ph), 4.10-4.07 (1H, m, 5-H), 3.80-3.77 (1H,m, 3-H), 3.33-3.31 
(1H, m, 4-H), 2.17-2.13 (1H, m, 6a-H), 2.01-1.98 (1H, m, 2a-H), 1.63 (1H, dd J 
= 3.9, 13.3 Hz, 6b-H), 0.86-0.80 (1H, m, 2b-H), 0.83 (9H, s, SitBu) 0.00, -0.01 
(6H, 2 × s, Si[CH3] 2); δc (75.46 MHz, DMSO-d6) 175.6 (C=O), 139.1 (C-Ar), 
138.8 (C -Ar), 128.2 (2 × C-Ar), 128.1 (2 × C-Ar), 127.5 (2 × C-Ar), 127.4 (2 × 
C-Ar), 127.3 (2 × C-Ar), 81.7 (C-4), 80.1 (C-1), 73.0 (PhCH2), 68.6 (C-5), 
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67.2 (C-3), 65.1 (PhCH2), 38.7 (C-6), 34.6 (C-2), 25.6 (SitBu), 17.7 (SitBu), -
4.9 (Si[CH3] 2), -5.0 (Si[CH3] 2); m/z (ES-) 485 [(M−H)-, 100%]; HRMS (ES-) 
[Found: (M-H)-, 485.2359, C27H37O6Si requires 485.2363]. 
 
Benzyl-3-O-tert-butyldimethylsilyl-benzyl-1,4-O-benzylquinate (104). 
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A solution of 103 (0.9 g, 1.80 mmol) in aqueous methanol (90%) was titrated 
with a solution of Cs2CO3 (0.3 g, 0.5 mmol) to pH 7. The solvent was 
evaporated at reduced pressure and then co-evaporated with toluene (2 × 10 
mL). The cesium salt thus obtained was suspended in anhydrous DMF (10 
mL), cooled to 0 °C, and treated with benzyl bromide (1.75 mL). After 1 h 
stirring, the solution was allowed to warm to room temperature and stirring 
was continued for a further 10 h before the solvent was removed under 
reduced pressure The residue was taken up into water (10 mL) and then 
extracted with EtOAc (3 × 10 mL) and the combined organic layers were 
dried over MgSO4 and the solvents removed under reduced pressure. Flash 
column chromatography of the residue (petroleum ether:EtOAc, 80:20) gave 
the desired product 104 as an oil (1.02 g, 95%); Rf 0.45 (petroleum 
ether:EtOAc, 80:20); [α]D -34 (c 0.2, CHCl3); vmax(film)/cm-1 3421, 1654 cm-1; 
δH (400 MHz, DMSO-d6) 7.40-7.15 (15H, m, Ar), 5.21-4.98 (2H, AB system, J 
= 12.2 Hz, 1-CO2CH2Ph), 5.04 (1H, d, J = 3.5 Hz, 5-OH), 4.76-4.58 (2H, d, J 
= 12.2 Hz, 4-OCH2Ph), 4.46-4.04 (2H, d, J = 12.2 Hz, 1-OCH2Ph), 4.28 (1H, 
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dt, J = 10.5, 3.4 Hz, 3-H), 3.92 (1H, dt, J = 6.9, 3.4 Hz, 5-H), 3.46-3.43 (1H, 
m, 4-H), 2.38-2.32 (1H, m, 2a-H), 2.23-2.17 (1H, m, 6a-H), 1.83-1.80 (1H, m, 
2b-H), 1.80-1.75 (1H, m, 6b-H) 0.84 (9H, s, SitBu) 0.00, -0.00 (6H, 2 x s, 
Si[CH3] 2); δc (75.46 MHz, DMSO-d6) 171.7 (C=O), 139.1 (C-Ar), 138.0 (C-
Ar), 136.0 (C-Ar), 128.3 (2 × C-Ar), 128.2 (2 × C-Ar), 128.1 (2 × C-Ar), 128.0 
(2 × C-Ar), 127.6 (C-Ar), 127.3 (2 × C-Ar), 127.2 (2 × Ar), 127.1 (2 × C-Ar), 
79.7 (C-4) 79.2 (C-1), 72.7 (PhCH2), 68.3 (C-3), 66.9 (C-5), 66.3 (PhCH2), 
65.1 (PhCH2) 36.4 (C-6), 35.8 (C-2), 25.7 (SitBu), 17.7 (SitBu), 14.0 (Si[CH3] 
2), -4.81 (Si[CH3] 2), -4.97 (Si[CH3] 2); m/z (ES+) 599 [(M+Na)+, 100%]; HRMS 
(ES+) [Found: (M+Na)+, 599.2797, C34H44O6SiNa requires 599.2796]. 
 
 
Benzyl 1,4-di-O-benzylquinate (105). 
 
OBn
HO
OH
OBn
CO2Bn
105  
To a stirred solution of 104 (0.2 g, 0.34 mmol) in THF was added TFA (0.06 
mL, 0.87 mmol) at 0 °C. The mixture was allowed to warm slowly to room 
temperature over 12 h, poured into water (5 mL) and extracted with EtOAc (2 
× 10 mL). The organic layer was dried over Na2SO4 and the solvents 
removed under reduced pressure. Flash column chromatography of the 
residue (petroluem ether:EtOAc, 80:20) gave the desired product 105 as an 
oil (0.15 g, 93%); Rf 0.1 (petroleum ether:EtOAc, 80:20); [α]D -6.0 (c 1.4, 
CHCI3); Vmax (thin firm)cm-1 3351, 1687; δH (500 MHz, DMSO-d6) 7.46-7.20 
(15H, m, Ar), 5.24-5.09 (2H, AB system, J = 12.4 Hz, 1-CO2CH2Ph), 4.78-
4.62 (2H, AB system, J = 12.2 Hz, 4-OCH2Ph), 4.35-4.11 (2H, AB system, J 
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= 12.2 Hz, 1-OCH2Ph), 4.19-4.17 (1H, m, 3-H), 4.04-3.90 (1H, m, 5-H), 3.48-
3.42 (1H, m, 4-H), 2.38-2.34 (1H, m, 2a-H), 2.17-2.09 (1H, m, 6b-H), 1.98-
1.86 (2H, m, 2a-H and 6b-H); δc (75.4 MHz, DMSO-d6) 171.8 (C=O), 139.3 
(C-Ar), 138.1 (C-Ar), 136.0 (C-Ar), 128.3 (2 x C-Ar), 128.0 (2 x C-Ar), 128.0 
(C-Ar), 127.9 (2 × C-Ar), 127.7 (2 × C-Ar), 127.3 (2 × C-Ar), 127.2 (2 × C-
Ar),127.1 (2 × C-Ar), 80.6 (C-4), 80.2 (C-1), 71.8 (PhCH2), 66.3 (PhCH2), 
66.0 (C-5), 65.7 (C-3), 65.6 (PhCH2), 37.6 (C-6), 35.1 (C-2); m/z (ES+) 485 
[(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+, 485.1940, C28H30O6Na 
requires 485.1946]. 
 
 
2,5-Bis(benzyloxy)-5(benzyloxy)carbonyl)cyclohexane-1,3-
diyl)bis(oxy)bis(3-oxopropanoic acid) (106). 
 
O
O
O
OBn
CO2Bn
OBnO OH
O
OH
O
106  
To a solution of diol 105 (1.66 g, 3.59 mmol) in anhydrous toluene (100 mL), 
Meldrum’s acid (1.4 g, 9.9 mmol) was added at room temperature. The 
mixture was heated at 60 °C for 5 h, poured into water (40 mL), extracted 
with CH2CI2 (80 mL) and the organic layer was dried over MgSO4. The 
solvent was removed under reduced pressure to give an oily residue, which 
was purified by flash chromatography on silica eluting with CH2CI2:MeOH 
(80:20) to give 106 as an oil (1.81 g, 79%); Rf 0.20 (CH2CI2:MeOH, 70:30); 
[α]D -15.6 (c 1.0, CHCI3); vmax(film)/cm-1 1724; δH (300 MHz, DMSO-d6) 7.40-
7.22 (15H, m, Ar), 5.48-5.45 (1H, m, 3 or 5-H), 5.27-5.23 (1H, m, 5 or 3-H), 
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5.22-5.16 (2H, AB system, J = 12.2 Hz, 1-CO2CH2Ph), 4.62-4.56 (2H, AB 
system, J = 12.2 Hz, 4-OCH2Ph), 4.41-4.29 (2H, AB system, J = 12.2 Hz, 1-
OCH2Ph), 3.81 (1H, dd, J = 8.0, 3.4 Hz, 4-H), 3.28 (2H, s, CH2), 3.19 (2H, s, 
CH2), 3.23-3.18 (4H, AB system, J = 16.0 Hz, CH2) 2.29-2.27 (3H, m, 6a,6b 
and 2a-H), 2.09 (1H, q, J = 7.1 Hz, 2b-H); δC (75.4 MHz, DMSO-d6) 171.1 
(C=O), 167.7 (C=O), 167.6 (C=O), 166.3 (C=O), 166.0 (C=O), 138.2 (C-Ar) 
137.7 (C-Ar), 135.5 (C-Ar), 128.4 (2 × C-Ar), 128.2 (2 × C-Ar), 128.1 (2 × C-
Ar), 128.0 (2 × C-Ar), 127.9 (2 × C-Ar), 127.6 (C-Ar), 127.5 (2 × C-Ar), 127.4 
(2 × C-Ar), 77.4 (C-4), 74.4 (C-1), 73.2 (PhCH2), 69.2 (C-5), 68.2 (C-3), 67.8 
(PhCH2), 66.2 (PhCH2), 43.4 (CH2), 43.3 (CH2), 36.2 (C-6), 33.2 (C-2); m/z 
(ES+) 657 [(M+Na)+, 100%]; HRMS (ES+) [Found: (M+Na)+, 657.1948, 
C34H34O12Na requires 657.1951]. 
 
 
5-Carboxy-2,5-dihydroxycyclohexane-1,3-diyl)bis(oxy)bis(3-
oxopropanoic acid (107). 
 
O
O
O
OH
CO2H
OHO OH
O
OH
O
107  
A suspension of 106 (1.2 g, 1.89 mmol) and 10% Pd(OH)2 (0.05 g, 0.47 
mmol) in ethanol (60 mL) was stirred under a hydrogen atmosphere at room 
temperature for 36 h. The mixture was filtered over Celite, and the residue 
was washed with ethanol. The filtrate and washings were evaporated under 
reduced pressure to yield 107 as an oil (0.66 g, 94%); [α]D -34 (c 0.5, CHCI3); 
Rf: 0.23 (EtOAc:H2O:MeOH, 8:1:1); vmax(film)/cm-1 3304, 1690; δH(300 MHz, 
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DMSO-d6) 5.27 (1H, br, OH), 5.07-5.01 (2H, m, 3 and 5-H), 3.71 (1H, dd, J = 
8.0, 3.4 Hz, 4-H), 3.46-3.41 (4H, AB system, J = 16.0 Hz, CH2), 2.11-1.88 
(4H, m, 6a-H, 6b-H 2a-H and 2b-H); δC (75.4 MHz, DMSO-d6) 174.4 (C=O), 
168.1 (C=O), 167.8 (C=O), 166.6 (C=O), 166.1 (C=O), 72.4 (C-1), 71.6 (C-4), 
67.9 (C-5), 66.1 (C-3), 55.9 (CH2), 37.0 (C-6), 35.6 (C-2); m/z (ES+) 387 
[(M+Na)+, 100%]; HRMS (ES+) [Found M+Na)+, 387.0541, C13H16O12Na, 
requires 387.0541. 
 
3,5-Di-O-dicaffeoylquinic acid (11). 
 
 
O
O
OH
OH
OH
OO
OH
OH
OH
CO2H
12
3
4 5 6
9'
8'
7'
6'1'
2'
3'
4'
5'
9'
1'
2'
3'
4'
5'
6'
7'
8' 11
 
 
To a solution of quinic acid derivative 107 (0.11 g, 0.31 mmol), 3,4-
dihydroxybenzaldehyde (0.1 g, 0.72 mmol) in anhydrous DMF (5 mL), DMAP 
(10 mg, 0.08 mmol) piperidine (90 µL, cat) was added at room temperature. 
The solution was then stirred for 9 days and then concentrated under 
reduced pressure. The resultant residue was purified by flash 
chromatography on silica eluting with CH2CI2:MeOH (70:30) to give 3,5-
DCQA11 as a yellow solid (0.11 g, 73%). Spectral data were identical to 
those reported previously. 
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Methyl 1,2,3,4-tetra-O-acetyl-β-D-glucopyranuronate (129). 149 
O
OAc
O OMe
AcO
AcO
OAc
129  
Sodium hydroxide (0.06 g, 1.5 mmol), was dissolved in methanol (160 mL) 
and D-glucurono-6,3-lactone 128 (21.42 g, 121.6 mmol) was added. Further 
sodium hydroxide was added (0.1 g) to achieve pH 8-9 and the reaction 
mixture was stirred at room temperature for 1 h. The mixture was then 
concentrated at reduced pressure to leave a viscous oil. Acetic anhydride (50 
mL) was added and the resulting mixture was stirred at approximately 30 °C 
for 2 h. Acetic anhydride (70 mL) in pyridine (50 mL) was added slowly 
enough to maintain the temperature under 40 °C. The reaction mixture was 
left stirring at 4 °C for 16 h. Concentration at reduced pressure yielded the 
crude product which was washed with diethyl ether (100 mL) to leave the 
desired product 129 (45 g, 98%) as a light brown solid; m.p. 176-177 °C (lit., 
149 178 °C); δH (400 MHz, CDCI3), 6.42 (1H, d, J = 7.7 Hz, H-1), 5.35-5.21 
(2H, m, H-2 and H-3), 5.17-5.11 (1H, m, H-4), 4.18 (1H, d, J = 9.4, H-5), 3.75 
(3H, s, OCH3), 2.12, 2.04, 2.03, 2.03 (12H, 4 × s, CH3); δC (100 MHz, CDCI3) 
169.9 (COCH3), 169.4 (COCH3), 169.1 (COCH3), 168.6 (COCH3), 166.8 
(CO2Me), 91.3 (C-1), 73.0 (C-5), 71.8 (C-4), 70.6 (C-3), 68.9 (C-2), 53.0 
(OCH3), 207, 20.5, 20.4, 20.3 (4 × CH3C). The data were in good agreement 
with the literature value.150 
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Methyl 2,3,4-tri-O-acetyl-α/β-D-glucopyranuronate (122).151 
O
OH
O OMe
AcO
AcO
OAc
122  
 
To a solution of 129 (20.0 g, 59.8 mmol) in THF (100 mL), ethylenediamine 
(5.0 mL, 83.3 mmol) was added at room temperature. The mixture was 
stirred at room temperature for 3 h, poured into water (80 mL) and extracted 
with EtOAc (250 mL) and the organic layer was dried over MgSO4. The 
solvent was removed under reduced pressure to give an oily residue, which 
was purified by flash chromatography on silica eluting with petroleum ether: 
EtOAc (40:60) to give 122 as an oil (17.7 g, 99%); m.p 114-116 °C (lit.,152 116 
°C); δH (400 MHz, CDCI3) 5.62-5.52 (1H, m, 3-H), 5.22-5.12 (1H, m, 4-H), 
4.90 (1H, dd, J = 3.7, 10.0 Hz, H-2), 4.59 (1H, d, J = 10.0 Hz, H-1β), 4.43 
(1H, s, br, H-1α), 3.74 (3H, s, OCH3), 2.08, 2.04, 2.03 (9H, 3 × s, CH3); δC 
(100 MHz, CDCI3) 170.2 (COCH3), 170.1 (COCH3), 169.7 (COCH3), 168.5 
(COCH3), 95.4 (C-1β), 90.2 (C-1α), 72.8 (C-3β), 72.5 9 (C-3α), 72.1 (C-5β), 
71.6 (C-5α), 70.8 (C-2β), 69.5 (C-2α), 69.1 (C-4β), 67.9 (C-4α), 53.0 and 52.9 
(OCH3), 21.0, 21.9, 20.8, 20.7, 20.6, 20.5 (6 × CH3C). The data were in good 
agreement with the literature value.152 
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Methyl 2,3,4-tri-O-acetyl-1-O-(trichloroacetylimidoyl)-α-D-
glucopyranuronate (123).153 
 
O
O OMe
AcO
AcO
123
O NH
CCI3
AcO
 
To a stirred solution of 122 (0.49 g, 1.47 mmol) in anhydrous DCM (20 mL) 
were added trichloroacetonitrile (5.5 mL, 54. 90 mmol) and DBU (0.04 mL). 
The reaction mixture was then stirred for 2 h at room temperature. The 
solvent was removed under reduced pressure to give an oily residue, which 
was purified by flash chromatography on silica eluting with petroleum 
ether:EtOAc, 60:40) yielding 123 a yellow solid (0.65 g, 93%); m.p 106-107 
°C, (lit.,132 108 °C) δH(400 MHz, CDCI3) 8.74 (1H, s, NH), 6.65 (1H, d, J = 3.6 
Hz, H-1), 5.64 (1H, t, J = 10.1 Hz, H-3 or H-4), 5.28 (1H, t, J = 10.1 Hz, H-3 
or H-4), 5.16 (1H, dd, J = 3.6 Hz, J = 10.1 Hz, H-2), 4.51 (1H, d, J = 10.1 Hz, 
H-5), 3.76 (3H, s, OCH3), 2.08, 2.07, 204 (9H, 3 x s, CH3); δC (100 MHz, 
CDCI3) 169.7 (COCH3), 169.5 (COCH3), 167.1 (COCH3), 160.6 (CO2Me), 
92.6 (C-1), 70.5 (C-5), 69.5 (C-4), 69.0 (C-3), 68.9 (C-2), 53.0 (OCH3), 207, 
20.5, 20.4 (3 × CH3C). The data were in good agreement with the literature 
value.132 
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Methyl 2, N-(p-anisyl)-2,2,2-trifluoroacetimidoyl chloride (139).141 
 
139
N
Cl CF3
OMe
 
To a stirred solution of Ph3P (34.5 g, 132 mmol) were added Et3N (7.3 mL, 
53 mmol), CCI4 (21.1 mL, 220 mmol), and TFA (3.4 mL, 44 mmol). After the 
solution was stirred for about 10 min at 0 °C, p-anisidine (6.48 g, 53 mmol) 
dissolved in CCI4 (21.1 mL, 220 mmol) was added. The mixture was then 
heated under reflux for 3 h. The solvents were removed under reduced 
pressure, and the residue was diluted with hexane (100 mL) and filtered. The 
filtrate was concentrated under reduced pressure, and the residue was 
distilled to afford 139 as a yellow oil (11.4 g, 91%); Bp: 97-98 °C (105 
MMHg); δH(400 MHz, CDCI3) 7.33-7.29 (2H, m, Ar-H), 6.97-6.93 (2H, m, Ar-
H), 3.83 (3H, s, OCH3); HRMS (ES+) [Found: (M+H)+, 238.0251, C4H5N3O3F5 
requires 238.0250]. The data were in good agreement with the literature 
value.141 
 
2,3,4-Tri-O-acetyl-D-glycopyranosiduronyl2,2,2-trifluoro-N-(p-
methoxyphenyl)acetamidate (140).140 
 
O
OMeO
O
AcO
AcO
140
CF3
N
OMe
AcO
 
 176 
N-(p-Methoxyphenyl)acetimidoyl chloride (0.4 g, 1.6 mmol) was slowly added 
to a suspension of sugar hemiacetal 121 (0.5 g, 1.5 mmol) and K2CO3 (0.45 
g, 3.2 mmol) in wet acetone (50 mL) at room temperature. After 3 h stirring at 
room temperature the solid was filtered off, and the solvent was evaporated 
off under reduced pressure. The residue was subjected to flash 
chromatography by using petroleum ether:EtOAc (60:40) to obtain 140 as a 
yellow viscous oil (0.61 g, 76%), δH (400 MHz, CDCI3) 6.87-6.75 (8H, m, Ph-
H), 6.58 (1H, s, br, 1-Hα), 5.87 (1H, s, br, 1-Hβ), 5.58 (1H, t, J = 9.9 Hz, H-3), 
5.36-5.21 (3H, m), 5.14 (1H, dd, J = 3.6 Hz, J = 10.1 Hz, H-2), 4.42 (1H, d, J 
= 10.1 Hz, H-5), 3.77, 3.76, 3.73 (12 H, 3 x s, 2 CO2CH3, 2 OCH3), 2.053, 
2.019, 2.016 (18H, 5 x s, 6 CH3C); m/z (ES+) 558 [(M+Na)+, 100%]. The data 
were in good agreement with the literature value.140 
 
 
2-(5-Formyl-2-methoxyphenoxy)-6-(methoxycarbonyl)tetrahydro-2H-
pyran-3,4,5-triyl triacetate (130). 
O
OMeO
OAc
AcO
AcO
O
OMe
HO
130
1'
2'
3'
4'
5'
6'
 
A mixture of 140 (3.94 g, 7.36 mmol), vanillin (1.3 g, 8.4 mmol), freshly dried 
molecular sieves (0.8 g) in dry dichloromethane (100 mL), and BF3 Et2O 
(0.13 mL, 1.0 mmol) was stirred under nitrogen at room temperature. After 6 
h, the solids were removed by filtration through a pad of Celite, and the 
filtrate was concentrated at reduced pressure. The residue was purified by 
flash chromatography with petroleum ether:EtOAc (60:40) to give 130 as a 
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brown solid (2.8 g, 81%); m.p. 59-60 °C; Rf 0.3 (petroleum ether:EtOAc, 
40:60); [α]D -54.6 (c 0.5, CHCl3); vmax(thin film)/cm-1 1755, 1686; δH (400 
MHz, acetone-d6) 9.93 (1H, s, CHO), 7.54 (1H, dd, J = 1.8, 8.0 Hz, 3’-H), 
7.52 (1H, d, J = 1.8 Hz 5’-H), 7.39 (1H, d, J = 8.0 Hz, 2’-H), 5.61 (1H, d, J = 
7.7, 1-H), 5.48 (1H, t, J = 10.1 Hz, 3-H), 5.31-5.22 (2H, m, 4 and 2-H), 4.60 
(1H, d, J = 10.1 Hz, 5-H), 3.92 (3H, s, OCH3), 3.69 (3H, s, CO2Me), 2.03, 
201, 2.00 (9H, 3 × s, 9 CH3); δC (100 MHz, CDCI3) 190.9 (CHO), 170.1 
(C=O), 169.3 (C=O), 169.2 (C=O), 166.8 (C=O), 151.0 (C-Ar), 150.8 (C-Ar), 
133.0 (C-Ar), 125.5 (C-Ar), 118.7 (C-Ar), 110.6 (C-Ar), 99.6 (C-1), 72.7 (C-3), 
71.5 (C-5), 70.9 (C-2), 69.0 (C-4), 53.0 (CH3C), 20.66 (CH3C), 20.64 (CH3C), 
20.55 (CH3C); m/z (ES+) 491 [(M+Na)+, 100%); HRMS (ES+) [Found: 
(M+Na)+, 491.1165, C21H24O12Na requires 491.1150]. 
 
 
6-(5-Formyl-2-methoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-
carboxylic acid (141). 
 
O
OHO
OH
HO
HO
O
OMe
HO
141
1'
2'
3'
4'
5'
6'
 
 
A solution of LiOH (0.16 g, 6.7 mmol) in MeOH-H2O (10:10 mL) was added to 
130 (0.5 g, 1.0 mmol), and the mixture was stirred at 0 °C for 22 h. The 
solution was then diluted with H2O, and the pH was adjusted to 4.0 with 
Amberlite IR 200 (H+). The resin was removed by filtration, the solution was 
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neutralised to pH 7.2 with diluted NaOH, and the solvent was evaporated off 
under reduced pressure. The residue was then purified by flash 
chromatography (EtOAc:MeOH:H2O, 7:2:1) to give 141 as a brown solid 
(0.08 g, 71%); m.p. 88-89 °C; Rf 0.22 (EtOAc:MeOH:H2O, 7:2:1); [α]D -10.2 (c 
0.4, H2O); vmax(thin film)/cm-1 3334, 2344; δH (400 MHz, D2O) 9.65 (1H, s, 
CHO), 7.46 (1H, dd, J = 1.8, 8.0 Hz, 3’-H), 7.41 (1H, d, J = 8.0 Hz, 5’-H), 7.17 
(1H, d, J = 8.0 Hz, 2’-H), 5.15 (1H, d, J = 7.7, 1-H), 3.81 (3H, s, OCH3), 3.61-
3.49 (4H, m, 2,3,4,5-H); δC (100 MHz, D2O) 194.6 (CHO), 151.1 (C-Ar), 
148.9 (C-Ar), 131.0 (C-Ar), 126.8 (C-Ar), 114.9 (C-Ar), 111.2 (C-Ar), 99.4 (C-
1), 76.3 (C-3), 75.1 (C-5), 72.5 (C-2), 71.5 (C-4), 55.8 (OCH3); m/z (ES-) 327 
[(M-H)-, 100%); HRMS (ES-) [Found: (M-H)-, 327.0716, C14H15O9 requires 
327.0716]. 
 
3-(Benzyloxy)-5-(2-carboxyacetoxy)-1-hydroxy-4-
((triisopropylsilyl)oxy)cyclohexanecarboxylic acid (143). 
OHBnO
OTIPS
O
CO2H
OH
O
O
143  
To a solution of 87 (1.00 g, 2.2 mmol) in anhydrous toluene (100 mL), 
Meldrum’s acid (0.4 g, 2.7 mmol) was added at room temperature. The 
mixture was heated at 60 °C for 5 h, poured into water (40 mL), extracted 
with CH2CI2 (80 mL) and the organic layer was dried over MgSO4. The 
solvent was removed under reduced pressure to give a solid residue, which 
was purified by flash chromatography on silica eluting with CH2CI2:MeOH 
 179 
(90:10) to give 143 as a white solid (0.6 g, 50%); m.p 260-261 °C; Rf: 0.2 
(CH2CI2:MeOH, 85:15); [α]D -3.4 (c 0.5, CHCI3); δH (300 MHz, DMSO-d6) 
7.46-7.15 (5H, m, Ar), 5.00-4.81 (1H, m, 4-H), 4.69 (2H, AB system, J = 12.2 
Hz, PhCH2), 4.06-3.82 (2H, m, 3 and 5-H), 3.56-3.53 (2H, AB system, J = 
16.0 Hz, CH2), 2.36-2.08 (2H, m ,6a-H and 6b-H), 1.94-1.59 (2H, m, 2a H and 
2b-H), 1.00 (21H, s, iPr3Si); δc (75.4 MHz, DMSO-d6) 175.0 (C=O), 167.7 
(C=O), 132.2 (Ar), 127.9 (2 × C-Ar), 127.3(2 × C-Ar), 127.1 (C-Ar), 76.9 (C-
4), 73.9 (C-1), 71.2 (C-3) 70.3 (C-5), 63.5 (PhCH2), 55.3 (CH2) 38.0 (C-6), 
37.6 (C-2), 17.9 (iPr3Si), 11.9 (iPr3Si); m/z (ES+) 547 [(M+H)+, 100%]; HRMS 
(ES+) [Found: (M+H)+, 547.2339, C26H40O9SiNa requires 547.2330]. 
 
 
3-(2-Carboxyacetoxy)-1,5-dihydroxy-4-
((triisopropylsilyl)oxy)cyclohexanecarboxylic acid (144). 
 
OHHO
OTIPS
O
CO2H
OH
O
O
144  
A suspension of the 143 (0.8 g, 1.5 mmol) and 10% Pd(OH)2 (0.06 g, 0.4 
mmol) in ethanol (40 mL) was stirred under a hydrogen atmosphere at room 
temperature for 36 h. The mixture was filtered over Celite and the residue 
was washed with ethanol. The filtrate and washings were evaporated under 
reduced pressure to yield 144 as an oil (0.67 g, 96%); Rf:0.15 
(CH2CI2:MeOH, 80:20); [α]D -9.3 (c 0.3, CHCI3); δH (300 MHz, DMSO-d6) 
4.99-4.79 (1H, m, 4-H), 4.04-3.80 (2H, m, 3 and 5-H), 3.56-3.52 (2H, AB 
system, J = 16.0 Hz, CH2), 2.35-2.07 (2H, m ,6a and 6b-H), 1.93-1.58 (2H, m, 
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2a-H and 2b-H), 1.01 (21H, s, iPr3Si); δc (75.4 MHz, DMSO-d6) 175.0 9C=O), 
167.7 (C=O), 76.9 (C-4), 73.9 (C-1), 71.4 (C-3) 70.2 (C-5), 55.9 (CH2) 38.2 
(C-6), 37.5 (C-2), 17.8 (iPr3Si), 11.7 (iPr3Si); m/z (ES+) 457 [(M+Na)+, 100%]; 
HRMS (ES+) [Found: (M+Na)+, 457.1870, C19H34O9SiNa requires 457.1866]. 
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